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Skin is a truly amazing organ, rarely properly
appreciated until it is missing.
[69, chapter 15]
Zusammenfassung
Verbrennungen entstehen in vielen verschiedenen Situationen im Leben und umfas-
sen z.B. Verbru¨hungen, Gasexplosionen, Unfa¨lle durch Chemikalien oder Grillunfa¨lle.
Wa¨hrend oberfla¨chliche Verbrennungen spontan und ohne Probleme heilen, fu¨hren
großfla¨chige und tiefe Verbrennungen ha¨ufig zu massiven Komplikationen wie Infektio-
nen oder der Verbrennungskrankheit. Um dieses zu verhindern und um die Regeneration
der Haut zu ermo¨glichen, werden die Wunden nach Entfernung der verbrannten Haut
mit autologer Haut gedeckt. Letztere reicht jedoch ha¨ufig nicht aus. Ebenfalls kommt
es zu Narbenbildung und damit zu Einschra¨nkungen auf a¨sthetischer und funktiona-
ler Ebene. Bisher stehen noch keine vollsta¨ndig zufriedenstellenden Hauta¨quivalente
fu¨r eine Therapie zur Verfu¨gung, da die vorhandenen weder Haarfollikel noch Talg-
oder Schweißdru¨sen beinhalten. Ferner wachsen große Transplantate aufgrund einer
ungenu¨genden Vaskularisierung oft nicht ein.
Daher besteht das Langzeitziel unserer Forschung in der Entwicklung eines Hauter-
satzes, welcher die Eigenschaften einer normalen Haut so gut wie mo¨glich nachbilden
kann. Außerdem soll er der schnellen und permanenten Wundbedeckung dienen. Mein
Kurzzeitziel war die Etablierung und die Nutzung des laserbasierten Bioprintings -
speziell des Laserinduzierten Vorwa¨rtstransfers (laser induced forward transfer, LIFT)
- fu¨r die Herstellung eines einfachen Hauta¨quivalentes mit seinem spezifischen drei-
dimensionalen (3D) Aufbau. Das Alleinstellungsmerkmal des Bioprintings besteht in
dessen Mo¨glichkeit, die gewu¨nschten Zellen in einem pra¨zisen ra¨umlichen Muster mit
einer hohen Auflo¨sung zu positionieren.
Verschiedene Zelltypen - einschließlich Zelllinien und prima¨re Zellen - wurden scha-
denfrei transferiert. Sie u¨berlebten den LIFT Prozess zu einem hohen Anteil und ohne
Vera¨nderungen des Pha¨notyps im Vergleich zu nicht-transferierten Kontrollzellen. Auch
transferierte mesenchymale Stammzellen exprimierten das gleiche Muster an Ober-
fla¨chenantigenen wie nicht-transferierte Zellen. Des Weiteren wurden hoch aufgelo¨ste
zwei-dimensionale (2D) Muster mit verschiedenen Zelltypen und in unterschiedlichen
Gro¨ßen gedruckt, z.B. ein Schachbrettmuster bestehend aus zwei Hautzelltypen.
Im weiteren Verlauf wurden auch erfolgreich 3D Gewebe hergestellt. Dafu¨r wurden
verschiedene Hydrogele gestestet, von denen sich jedoch nur Kollagen als geeignet fu¨r
den erfolgreichen Transfer und die anschließende Gewebebildung von Hautzellen erwies.
Die Gewebe bestanden aus Fibroblasten und Keratinozyten und wurden zum einen
in vitro, sowie zum anderen in vivo in der Ru¨ckenhautkammer in Ma¨usen kultiviert.
Im Vorfeld konnte ich zeigen, dass diese Kammern eine ada¨quate Methode darstel-
len, um in vivo durch Tissue Engineering hergestellte Hautkonstrukte zu evaluieren.
In den gedruckten Konstrukten entstanden Zell-Zell-Kontakte, insbesondere zwischen
den Keratinozyten, welche eine epidermis-a¨hnliche Struktur erzeugten. Zellproliferation
konnte u¨ber den gesamten Kultivierungszeitraum detektiert werden. Eine beginnende
Differenzierung der gedruckten Keratinozyten konnte in vivo nachgewiesen werden.
Um in Zukunft eine klinische Anwendbarkeit des LIFTs zu erreichen, muss der von
uns verwendete Aufbau vergro¨ßert und an sterile Transferbedingungen angepasst wer-
den. Ferner muss die Kultivierung der resultierenden großen Hauta¨quivalente etabliert
und deren Testung im Großtiermodell durchgefu¨hrt werden. Weitere Zelltypen sollen in-
tegriert werden, insbesondere vorgeformte Muster von Endothelzellen, um eine schnelle
Vaskularisierung und damit ein besseres Einwachsen des Hautersatzes zu erreichen.
Zusammenfassend kann gesagt werden, dass Bioprinting ein großes Potential im Be-
reich des Tissue Engineerings und seiner verschiedenen Anwendungen bietet, wobei die
verwendete Matrix - wie am Beispiel der Hautherstellung zu sehen ist - an die verwen-
deten Zellen angepasst werden muss.
Stichpunkte: Hautersatz, Verbrennungen, Laserinduzierter Vorwa¨rtstransfer (LIFT)
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Abstract
Burn injuries occur in many different situations in life, comprising e.g. sunburns, scald-
ing, explosions of gas, and chemical or barbecue accidents. While superficial burns
heal spontaneously without problems, large and deep burn injuries frequently cause
major complications like infections and burn disease. To avoid this and to enable the
regeneration of the skin, the wounds are covered with autologous skin subsequent to
the removal of the burned skin. However, this often does not suffice. Also, scarring
often occurs, leading to impairments on the aesthetical as well as on the functional
level. Up to now, no totally satisfactory skin equivalents for the treatment of burns
have been produced as the existing ones lack hair follicles and sebaceous and sweat
glands. Also, large grafts often do not grow in due to insufficient vascularisation.
Therefore, the long term aim of our research is the development of a skin equivalent
that is able to mimic the properties of a normal skin as well as possible and allows for
the fast and permanent wound coverage of burn injuries. My short term goal was the
establishment and use of a laser based bioprinting technique, namely the laser induced
forward transfer (LIFT), for the production of a simple skin equivalent with its specific
three-dimensional (3D) composition. As its unique feature, LIFT allows for the precise
spatial positioning of cells in a high resolution.
Several cell types - including cell lines as well as primary cells - were transferred
without harm and survived the LIFT process to a high degree, without changes in
their phenotype compared to non-transferred control cells. Transferred mesenchymal
stem cells expressed the same surface antigenes as non-transferred cells. Furthermore,
high resolution two-dimensional (2D) patterns of different cell types and different sizes
were printed, e.g. a chess board pattern composed of different skin cells.
Continuative, also 3D tissues consisting of keratinocytes transferred on top of fibrob-
lasts were printed. For the 3D printing process, different hydrogels were tested, but
only collagen was suitable for the successful transfer and subsequent tissue formation
of skin cells. The tissue was successfully cultured in vitro as well as in vivo employing
the dorsal skin fold chamber in mice. The chamber was previously shown by me to be
a suitable means for the in vivo assessment of tissue engineered skin constructs. Cell-
cell-contacts were established in our printed skin constructs, especially between the
keratinocytes, which formed an epidermis-like structure. Cell-proliferation could be
detected during the whole culturing period, while starting differentiation of the printed
keratinocytes could be perceived in vivo.
In future, to reach clinical applicability, our LIFT setup has to be expanded and
adapted to sterile transfer conditions. Furthermore, the cultivation of the resulting
large skin equivalents needs to be established and these large equivalents should be
tested in a large animal model. Further cells types should be included, especially
preformed patterns of endothelial cells to achieve a fast vascularisation and better
ingrowth of the skin substitutes.
In conclusion, it can be said that bioprinting offers a great potential in tissue engi-
neering und its various applications, but - as demonstrated by the skin tissue generation
- the used matrix needs to be adapted to the employed cell types.
Keywords: skin substitute, burn injuries, laser induced forward transfer (LIFT)
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1 Introduction
Burn injuries occur in many different situations in life, reaching from sunburn
or accidental scalding with hot coffee in everyday life to special injuries due to
electricity or chemicals. Burns can be caused by many means like heat, electricity,
chemicals, light, irradiation or friction in the form of liquid, gas, vapour, flames,
explosions, electric current, lightning or intense solar irradiation (sunburn). They
appear not only in form of domestic (e.g. scalding, barbecue accident) or work
accidents (e.g. chemicals) but also in traffic (e.g. cars, trains, planes) or military
actions (e.g. gunshot residues) [128], [69, chapter 2].
Light burn injuries occur with an incidence of 6, severe ones with 0.02 to
0.05, respectively [1]. The most frequent form of deep and large burn injuries
is the scalding with hot water, soups or sauces, especially when young children
or elderly persons are involved [69, chapter 2]. It accounts for up to 70 % of the
burns in toddlers [1]. The ranking order proceeds with flame burns, house fires,
and flash burns, the latter including explosions of natural gas, propane or gasoline
[69, chapter 2]. While adolescents are mainly hurt due to improper handling of
fire and flammable liquids (e.g. gasoline), with adults, flame burn is the most
common type of burn wounds, a third of them being work accidents [1]. The
next common type of injuries are contact burns, caused by hot metals, plastic,
glass, coals or stoves [69, chapter 9]. Electrical or chemical burn injuries are more
seldom. In any case, the extent of tissue destruction is always dependent on the
present temperature as well as the duration of contact and the thickness of the
involved skin [69, chapter 9].
Unfortunately, in case of large and deep burns, appropriate treatment only has
limited success (see section 1.2.2.4). After removal of the burned skin, autologous
split-thickness skin grafts are used to cover the burn wounds and to enable skin
regeneration and protection against infections as well as fluid and temperature
loss. Nevertheless, scarring often occurs. This is especially disturbing on the
aesthetic but also on the functional level as e. g. the fingers cannot be completely
stretched out any more. Skin substitutes do not provide hair follicles, sebaceous
or sweat glands and large grafts may fail to take due to insufficient vascularisation.
Therefore, a skin substitute as similar to physiological skin as possible is
needed. This, however, is the long term goal of our research. As a preparation,
this thesis focuses on the establishment of the laser induced forward transfer
(LIFT) for the production of a suitable skin equivalent. Transferred cells were
assessed for potential damage, hydrogels were tested for their suitability during
the transfer process and printed 3D skin constructs were examined for viability,
tissue formation, and keratinocyte differentiation in vitro as well as in vivo.
In the following, the introduction first describes the composition and organisa-
tion of skin, subsequently turning to burn injuries, which includes the occurring
problems and possible treatments. The field of tissue engineering and its chal-
lenges are specified. This is followed by an overview of skin equivalents used in
research. The existing methods of bioprinting as an important means for the
creation of engineered tissue are described. Subsequently, the bioprinting setup
used for the experiments of this thesis is depicted in detail.
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1.1 Skin - function and structure
1.1.1 Function
The skin is the largest organ in the human body, having a surface area of 1.5
to 2 m2 and a weight of 3 to 10 kg [155], [107], [156]. Covering the whole body,
it represents an effective barrier between the organism (inside) and the environ-
ment (outside). As such, it functions as a powerful protection against harmful
environmental influences. These comprise chemical, mechanical, and thermal
factors as well as pathogens and irradiation [155], [107], [156]. Regarding these
harmful factors, a very important function is the maintenance of temperature
and water balance homeostasis [107]. If this is impaired, liquid, electrolyte, and
protein losses can strongly damage the body, as in case of severe burns (see sec-
tion 1.2.1.3). Moreover, the skin plays a role in metabolism and is part of the
immune system. In this context, Langerhans cells are the antigen presenting cells
which can be found in the skin. They are, however, supported by macrophages,
leucocytes, plasma cells, mast cells and antimicrobial peptides (defensins) of the
innate immune system [155], [107], [156]. Also, the acid mantle of the skin, with
a pH of 5.5 to 5.7, plays an important role in the protection against pathogens
[107], [156]. Furthermore, the apical surface of the skin is inhabited by various
bacteria and fungi, which are the normal skin flora and contribute to its protect-
ing function. As commensals they protect their habitat - and thereby us - against
pathogenic microorganisms [155]. Finally, the skin acts as a sensory organ, being
able to detect pain, contact, pressure, vibration, itching, and temperature [107],
[156].
On the social level, the skin serves as a means for representation, communica-
tion, and displaying the current mood. Communication and expression of mood
are tightly connected, being shown by e.g. blushing or blanching. Representation
also affects our communication and serves as a statement about ourselves. De-
pending on age, situation and culture, e.g. a non-covered part of the body may
be understood as appropriate (e.g. on the beach) or unfitting (e.g. during busi-
ness meetings). Furthermore, the skin is also used to express oneself by tattoos.
Moreover, the skin colour may state a person’s likings and habits, e.g. having
tanned skin due to staying outside often in contrast to regularly visiting a so-
larium. Even hair can send optical signals with social, cultural, psychological or
political content. In this context, the form, colour, and presence/absence of the
scalp hair as well as the beard are of central significance [156].
1.1.2 Structure
The skin is composed of four layers, namely the epidermis, the basement mem-
brane, the dermis, and the hypodermis (see picture 1.1). All of these structures,
except the basement membrane, contain various specialised cell types and serve
different purposes.
1.1.2.1 Epidermis
The epidermis is the uppermost skin layer, consisting of a multi-layered stratified
squamous epithelium [155], [107], [156]. Depending on where on the body it is
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Figure 1.1: Structure of skin and pictures of skin cells The figure depicts
the structure of human skin, including the epidermis with its different layers (stratae),
the dermis, and the hypodermis (A). In the upper left corner, the dermal papillae can
be seen. The blood vessels form two connected networks, one at the connective zone
between the dermis and the hypodermis, while the other penetrates the dermal papillae
and as such supplies the epidermis with oxygen and nutrients. Nerves, sebaceous
glands, hair follicles/hairs, and sweat glands reside in the dermis and partially penetrate
through the epidermis. In (B) and (C), the cultured human cell lines I used in the
underlying experiments can be seen in phase contrast microscopy. (B = HaCaT, human
keratinocytes, C = NIH3T3, murine fibroblasts) (origin of (A) [2])
located, it is usually around 0.05 mm thick, but can reach a thickness of up to
several millimetres at the palms and the sole of the feet [156]. The epidermis
regenerates continuously throughout life with a turnover rate of about 30 to
56 days in healthy persons [84], [155] and comprises four layers (from bottom to
top):
• Basal layer (stratum basale)
• Spinous layer (stratum spinosum)
• Granular layer (stratum granulosum)
• Cornified layer (stratum corneum)
The main constituent of the epidermis - with up to 90 % - are keratinocytes.
Among those, epidermal stem cells, residing at the basal layer, are responsible
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Figure 1.2: Scheme of the different cell-cell and cell-matrix junctions in
epithelia Tight junctions at the apical part of the cells form a tight barrier between
the upper and the lower part of the epithelium. Adherens junctions are coupled to
actin filaments in the cells, and play a role in the mechanical stability of the epithelium
by providing a stable cell-cell contact. Desmosomes are responsible for the mechanical
stability as well, coupling neighbouring cells by connecting their intermediate filaments.
Together, these three types of junctions are called the junctional complex, and can often
be found close to each other. Gap junctions form channels between the cytoplasms of
neighbouring cells, contributing to cell-cell communication. Cell-matrix adhesion is
either imparted by hemidesmosomes, which couple the ECM to intermediate filaments,
or by actin-linked cell-matrix adhesions. (Scheme according to [4, chapter 19])
for the regenerative capacity of the epidermis, leading to a continuous turn-
over. They are characterized by a slow cell cycle, a long life span, and a high
proliferative potential. β1-Integrin imparts adhesion to the basal membrane and
is thought to inhibit differentiation of the stem cells [72]. The epidermal stem
cells express cytokeratins 5 and 14 and can be divided into interfollicular stem
cells, hair follicle stem cells, and sebaceous gland stem cells [84], [107].
Different cell-cell and cell-matrix junctions are needed to form a stable ep-
ithelium. Adherens junctions and desmosomes provide a mechanical connection
and thereby mechanical strength between neighbouring cells, while hemidesmo-
somes and actin-linked cell-matrix adhesions are responsible for the coupling of
cells to the underlying basement membrane (see picture 1.3 and table 1.1). Ad-
herens junctions contain classical cadherins as transmembrane adhesion proteins.
Especially e-cadherin is abundantly found in the epidermis. While in case of
adherens junctions the adhesion proteins are coupled to the actin filaments of
the cytoskeletton, in desmosomes they are connected to intermediate filaments.
A similar situation can be found in cell-matrix interactions. In hemidesmosomes
extracellular matrix (ECM) molecules are connected to the intermediate fila-
ments of the cells, whereas in actin-linked cell-matrix adhesions actin is linked
to the ECM. The cell-matrix adhesion is realised by integrins, which are situated
between the cell-originating filaments and the ECM molecules [4, chapter 19].
Tight junctions (see picture 1.3) close the intercellular space and thereby con-
stitute a tight barrier between the apical and the basal part of the epithelium,
contributing to its structural polarisation. The barrier, however, has a selective
permeability, which can be altered depending on the circumstances [4, chapter
19].
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Table 1.1: Anchoring junctions. (According to [4, chapter 19])
Junction Transmembrane
adhesion protein
extracellular
ligand
intracellular
cytoskeletal
attachment
intracellular
anchor proteins
Cell-cell
adherens
junction
cadherin
(classical
cadherin)
cadherin in
neighbouring cell
actin filaments e.g. α-catenin,
β-catenin,
plakoglobin
(γ-catenin)
desmosome cadherin
(desmoglein,
desmocollin)
desmoglein and
desmocollin in
neighbouring cell
intermediate
filaments
e.g. plakoglobin
(γ-catenin),
desmoplakin
Cell-matrix
actin-linked
cell-matrix
adhesion
integrins extracellular
matrix proteins
actin filaments e.g. talin,
vinculin,
α-actinin,
filamin
hemidesmosome integrin α6β4,
type XVII
collagen
extracellular
matrix proteins
intermediate
filaments
e.g. plectin,
dystonin
Moreover, gap junctions can be found to form channels between the cytoplasms
of neighbouring cells via transmembrane proteins (connexins). They serve the
exchange of low molecular substances (e.g. hormones, glucose, or vitamins) as
well as ions (e.g. electrical coupling in the heart muscle) and furthermore are
essential for cell-cell communication [4, chapter 19].
During their differentiation, keratinocytes undergo many biochemical and mor-
phological changes [84], [72], [138]. After the division of a stem cell, one daughter
cell may become a transit amplifying cell (TA) while the other remains a stem
cell. The TA completes a few more proliferation cycles before being submitted to
terminal differentiation. During this process, the TA looses its replicative capa-
bility and starts to produce different proteins, among which cytokeratins 1 and
10 can be found [107]. Profilaggrin is the major protein component of the now
occurring keratohyalin granules. When processed, the mature filaggrin helps the
cytokeratins to form tight bundles of intermediate filaments, which are important
for the structural integrity of the cell and finally promote the collapse of the cell
into a flattened shape [72].
The so-called cornified envelope (CE) develops just below the cytoplasmic
membrane, and consists of proteins like e.g. involucrin, loricrin (main protein com-
ponent), filaggrin, and trichohyalin as well as different lipids. The development
of the lipid part of the CE is connected to the degradation of the organelles and
is formed via fusion of their surrounding membranes with the plasma membrane
[72]. Thereby, also cell-cell junction proteins like the components of desmosomes
are incorporated into the CE. Both, proteins and lipids, are covalently linked,
with the linking being catalysed by three different transglutaminases (TGase).
The activity of the present TGases is induced by a rising calcium concentration
[44].
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Figure 1.3: Scheme of keratinocyte differentiation The keratinocytes in the
basal layer proliferate, being responsible for the turn-over of the skin. The differentiat-
ing keratinocytes produce different proteins, which form tight bundles of intermediate
filaments. Among these, cytokeratin 1, cytokeratin 10, profilaggrin, filaggrin, involucrin
and loricrin can be found. The proteins are connected covalently by transglutaminases.
Keratohyalin granules develop, being filled with e.g. profilaggrin. The cornified envelope
(CE) starts to develop directly beneath the cytoplasmic membrane, being composed
of the mentioned proteins as well as lipids. The cell organelles are destroyed and their
membranes are incorporated into the CE. In the last step, the cells die and form horny,
flat flakes, which are embedded into a self-produced intercellular lipid matrix.
In the transition phase the cells commit programmed cell death. They are
now called corneocytes, and are embedded into a self-produced intercellular lipid
matrix, comprising cholesterol, free fatty acids and other lipids. They form lateral
lipid lamellae with a repeating pattern, using ceramides (special lipids) as a
template. The low permeability of skin to water is due to these tightly packed
lipids. As such, the epidermis serves as a tight permeability barrier, starting with
the stratum corneum as the uppermost layer. Nevertheless, also the lower layers
contribute to the barrier function via the formation of tight junction. The cells
are now largely filled with intermediate filaments, while the plasma membrane is
replaced by the CE, the organelles are destroyed and the desoxyribonucleic acid
(DNA) is degraded. Several cells together form horny flakes, the uppermost layer
of the skin. The final shedding off of the corneocytes is called desquamation and
is imparted by the degradation of desmosomes [72].
The balance between proliferation and differentiation needs to be controlled
tightly. It is accompanied, and partly induced, by a rising intracellular Ca2+ con-
centration in direction to the apical surface, and among other regulative factors
p63 plays a central role in this situation [84]. If the differentiation is impaired, a
disturbance of the skin barrier may occur, resulting in the formation of inflam-
mation, dermatitis, ichthyosis, psoriasis, and the entry of pathogens [138].
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Apart from keratinocytes, melanocytes are resident in the epidermis. They are
located in the basal layer, having contact to the basement membrane and the
keratinocytes. Melanocytes exhibit a star shaped appearance and are responsible
for the skin colour. By synthesis of melanin and its distribution to the surround-
ing keratinocytes, melanocytes protect the skin cells against UV irradiation and
corresponding mutagenesis [155], [156].
Langerhans cells are the immune cells present in the epidermis, being respon-
sible for antigen presentation as well as activation of T-cells [155].
The epidermis is free of blood vessels, being supplied with nutrition and oxygen
by the dermis via diffusion [155], [107]. At the dermal-epidermal-junction both
layers interdigitate, forming the rete ridges (epidermal part) and the papillae
(dermal part) [107], [4, chapter 19]. This results in a high increase of the available
surface for diffusion (see also section 1.1.2.3). The rete ridges/papillae are also
very important for the mechanical stability of the skin, as they greatly increase
the resistance of skin against shear forces.
1.1.2.2 Basement membrane
The basement membrane consists of extracellular matrix and connects the epider-
mis to the dermis. It is essential for the attachment of the epidermal epithelium
to the connective tissue of the dermis. Furthermore, it stabilises the connection
between the epithelial cells of the basal layer and prevents them from sliding
apart. The basement membrane also promotes cell survival, proliferation and
differentiation of the cells [4, chapter 19]. It is partly secreted by the epidermal
cells and partly by the dermal cells, containing e.g. collagen type IV and VII,
glycoproteins like laminin and fibronectin, nidogen, proteoglycans, and integrins
[156]. Collagen type IV forms a felt-like network and gives the basement mem-
brane its tensile strength, while most of the other components are integrated in
this network. Collagen type VII forms anchoring fibrils, which help to attach the
basement membrane to the underlying connective tissue [4, chapter 19], [107].
The basement membrane keeps the keratinocytes and fibroblasts in their re-
spective spatial compartments, but can be passed by macrophages, lymphocytes
or nerve cells. These cells possess distinct enzymes, which can degrade the compo-
nents of the membrane [4, chapter 19]. Also, nutrients, oxygen, and metabolites
can pass the membrane [4, chapter 19].
1.1.2.3 Dermis
The dermis is located beneath the epidermis and the basement membrane and
varies between 0.6 mm thickness at the eyelids and more than 3 mm at the back
and the sole of the feet. Its uppermost part, the papillary region (stratum pap-
illare), contains most of the cells present in the dermis, while its lower part, the
reticular region (stratum reticulare), includes hair follicles and glands [155].
The dermis is composed of abundantly present ECM, which is secreted by
fibroblasts, the main cell type in the dermis [19]. The ECM contains proteogly-
canes and glycoproteins, which bind liquid in form of hydrated water [19]. The
resulting gel-like substance of the ECM can resist compressive forces very well,
while simultaneously permitting diffusion of nutrients, metabolites and hormones
[4, chapter 19]. Some free liquid resembles blood plasma and is collected by lym-
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phatic vessels. Interweaving collagen type I enhances the mechanical stability of
the dermis. The large elasticity of skin is manily due to elastic fibres formed by
elastin [4, chapter 19], [107]. The interaction between the ECM, the water, and
the cells is responsible for the pliability of the connective tissue. As such, the
dermis also serves as a layer between skin and muscles.
In contrast to the epidermis, the dermis is strongly perfused by two plexuses
of vessels. One is located directly above the hypodermis and comprises larger
vessels, while the second plexus consists of a tight network of capillaries reaching
into the papillae, the border zone to the epidermis [107], [156]. Apart from serv-
ing the nutrition of the dermis and epidermis, the blood vessels also supply the
present sebaceous and perspiratory glands as well as the hair follicles. Further-
more, the blood vessels play an important role in the temperature regulation of
the body [156]. Additionally, the dermis contains specialised nerves, which help
us to perceive sensations like pain, touch, itch, and temperature [155]. Finally,
cells of the innate as well as the adapted immune system are also located in the
dermis: mast cells, macrophages, leucocytes and plasma cells [19], [107], [156].
1.1.2.4 Hypodermis
The hypodermis consists of connective tissue and fat. It serves as energy store,
heat insulation, and protection against mechanical influences. Also, hormones are
synthesised there [156]. Furthermore, the hypodermis connects the upper skin
layers to the lower tissues, e.g. muscles, fascia, and bone. Apart from nerves,
sensory organs, and glands it also contains a plexus of vessels, which are larger
than those in the dermis, supplying the glands and hair bulges with nutrients
and oxygen. In the hypodermis, adipocytes [156] as well as stem cells [179] can
be found.
1.1.2.5 Cutaneous appendages
The skin not only forms different layers like the epidermis, dermis, and hypoder-
mis, but also contains several cutaneous appendages formed by their specific cells.
Those appendages comprise hair bulges/hair, nails, sebaceous glands, perspira-
tory glands, scent glands, and mammary glands [107], [156]. Mammary glands
are responsible for feeding the offspring. While perspiratory glands are involved
in temperature homoeostasis, the sebum produced by sebaceous glands keeps the
skin and the hair pliable. Hair growth is sex specific and hormone dependent.
Various specialized hair forms can be found as eyelashes, eyebrows, beard hairs,
pubic and axillary hair, and hair in the nose or the outer ear canal. Generally,
hairs protect the body from heat loss but are also involved in the tactile sensa-
tion [156]. An even more specialised version is represented by nails, which offer
protection against mechanical injuries as well as support for the tactile ability of
skin.
1.2 Burn injuries - problems and treatment
Large and severe burn injuries often change the patient’s and his/her relatives’
life profoundly. Questions concerning the injuries, as such, as well as their con-
sequences occur and reach from the actual treatment, pain, and the possible
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Figure 1.4: Scheme of the four degrees of burn injuries The figure shows
the different degrees of possible burn injuries. As can be seen by the red and brown
colour, respectively, different parts of the epidermis, dermis, hypodermis or underlying
tissue structures are destroyed in the different degrees. This may include hair follicles
(hf), nerves (n), sweat glands (sg) and blood vessels (bv).
aesthetic outcome, to doubts concerning self-esteem, future job possibilities, and
financial security of oneself and the family. Often, several plastic operations
may be required during the next years after the burn injury. Hence, stress with
respect to the actual trauma, but also to the healing process and the possible
disfiguration, frequently appears in the patients and their relatives. Therefore,
psychological support from the first days after the trauma to several years after-
wards is provided.
1.2.1 Frequent problems
1.2.1.1 Classification into four degrees
Burn injuries result in a local inflammatory response accompanied by reddening
and swelling. They are classified into four degrees, depending on which skin
structures are destroyed (see figure 1.4). If only the epidermis is concerned - like
in case of sunburn - the burn injury is classified as degree I and is accompanied by
weak to moderate pain and reddening. It normally heals without any problems.
Burns leading to blistering between the epidermis and the dermis are classified as
degree II and are characterized by strong pain and reddening. Here, a difference
is defined between II A and II B burn injuries. The first is relatively superficial,
only concerning the upper parts of the dermis. Thereby, the nerves, blood vessels
and the elasticity of the skin are only destroyed scarcely and the skin often
heals spontaneously without scarring. In contrast, in case of II B burns, the
deeper parts of the dermis are also affected and scarring occurs due to impaired
regeneration capacities, leading to irreversible damage. If all skin layers including
the hypodermis are affected, burns of degree III are existent. As also the nerves
are affected, no pain can be felt in the burned area. In case of even deeper burns
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including muscles and bones, degree IV burns are present. Degree III and IV
burn injuries include necrosis of the tissue and eschar formation and therefore
need surgical and intensive care treatment (see section 1.2.2). Both represent
irreversible damages to the included tissues.
Beside the depth and extent of the burn injuries, other factors, including the
patient’s age, are of central importance for the outcome. For example, victims of
traffic accidents often have other injuries as well (co-morbidities). The larger the
burned body surface and the deeper the burn, the worse the consequences and
the worse the prognosis [69, chapter 4]. The prognosis is even worse for patients
who suffer from co-morbidities as well as inhalation trauma.
1.2.1.2 Loss of barrier function
The main problem in case of burn injuries consists in the loss of the barrier
function of the skin. As the cells of the immune system, especially the Langerhans
cells, are mainly present in the epidermis, the loss of this barrier function already
plays a role if only the epidermis is affected. In case of extensive and deep
burns, massive infections including sepsis, pneumonia, urinary tract infections
or endocarditis may occur due to the penetration of the body with pathogens,
especially bacteria and fungi [69, chapter 11]. Temperature and water balance
homeostasis are impaired if the dermis is destroyed because many of the blood
vessels regulating, e.g. the temperature, are lacking. Therefore, patients are
endangered by hypothermia, especially if the hypodermis is also affected by the
injuries.
1.2.1.3 Burn disease and other complications
In case of large burn injuries, also the great water loss via vapour from the burned
skin area poses a great threat to the patients. Additionally, due to inflammatory
mediators, the blood vessels become more permeable, leading to so called capil-
lary leakage. Liquid from the blood penetrates the surrounding tissues, resulting
in massive oedemas and a dangerous decrease of blood volume (hypovolemia)
as well as electrolyte imbalance [69, chapter 7]. This, in turn, entails a state of
circulatory shock in the patient, which adds to the life threatening burn disease.
This is further characterised by the leakage of blood plasma (including solved
proteins) into the tissue. Since the blood cells remain in the vessels, the viscosity
of the blood increases drastically. At the same time, the protein loss from the
blood leads to a further liquid deprivation in the vessels. The destroyed tissue
and denatured proteins have toxic effects, which in combination with the afore-
mentioned situation lead to organ failure (e.g. of the kidneys, the lungs or the
liver).
Another complication is represented by circumferential burns of digits, extrem-
ities or the thorax, which may lead to the compartment syndrome. As described
above, burn injuries cause local swelling, which in case of a circumferential burn
may result in a strong compression of nerves, muscles, and blood vessels, the
latter leading to constricted circulation. This, in turn, leads to necrosis of the
tissue due to lack of oxygenation. The compartment syndrome is a life and limb
threatening condition. If the thorax is affected, ventilation may be impaired.
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1.2.2 Possibilities of treatment including clinically used
skin substitutes
1.2.2.1 Small and superficial burn injuries
Depending on the severity of the burn injuries, different treatment measures are
needed. In case of small and superficial burns, quick cooling with lukewarm
low-germ tap water reduces pain and the expansion of the burned area. The
application of ice should be avoided because this may result in frostbite. Sub-
sequent, a sterile wound coverage should be applied and a physician should be
consulted. The wounds will normally heal spontaneously without scarring, helped
by special ointments [128].
1.2.2.2 Large and deep burn injuries - burn centres
In case of a large burned area, cooling may result in drastic temperature loss
of the whole body, which should be avoided. In any case, an emergency call is
necessary. If the patient is unconscious, the recovery position needs to be applied.
For large and deep burns, which may lead to the burn disease, the treatment in
specific burn intensive care units present in burn centres is necessary to provide
an adequate therapy and monitoring of the patients. The monitoring includes
parameters such as blood pressure, pulse rate, temperature, weight, and urine
output. Burn centres provide specifically trained surgeons and nurses as well as
anaesthesiologists, respiratory therapists, rehabilitation therapists, nutritionists,
and psychologists. Also, the availability of an own operation theatre which can
be heated to reach body temperature and other measures like pre-heating the
infusions are important to counteract cooling [69, chapter 12]. To contribute to
infection prevention, each patient is isolated in an own room. These rooms can
also be heated to prevent hypothermia. The daily routine tasks need to be done
in an aseptic manner.
1.2.2.3 Stabilisation of the patients and debridement
During the therapy, the first priority is the stabilisation of the patient’s vital
functions. This already begins directly when the emergency doctor arrives at
the accident location [69, chapter 6]. To counteract the burn disease and hy-
povolemia, infusions with e.g. Ringer’s lactate solution as volume replacement
are one of the first and main elements of the therapy [69, chapters 7 and 8].
However, the choice and amount of infusion solutions depends on age as well as
injury severity, physiological status, associated injuries, and the (non-)existence
of inhalation trauma. Additionally, after reaching the burn centre, the necrotic
and avital tissue needs to be removed quickly and completely by surgical exci-
sion (debridement) during anaesthesia [128], [164]. On one hand, damaged tissue
still contributes to the burn disease by producing toxins and inflammation and
therefore has to be removed. On the other hand, the debridement serves to
avoid infections with bacteria and fungi. If, in spite of this, infections occur,
they are consequently treated with systemically applied antibiotics or antifungals
and topical antiseptic dressings [69, chapter 11]. Additionally, adequate infection
prevention is needed.
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Special care is indicated in case of circumferential burns. Here, the elevation of
the limb may help but in severe cases an escharotomy (a cut through the eschar
and underlying tissue down to the fasciae) is required to release the threatening
pressure and to avoid the compartment syndrome or problems with ventilation.
Special attention is required in case of burned hands, as nerves can easily be
destroyed [128].
Of course, an appropriate analgesic treatment is required in any case, which
reaches from simple analgesics like ibuprofen to narcotics, depending on the pa-
tient’s state. Often, opioids are required. Another major issue is the suitable
nourishment of the patient. This is very important as malnutrition leads to
impaired healing. The nourishment can first be done by infusions (parenteral
nourishment), but this may cause severe compliations. It is advised to switch to
enteral modes of nutrition as soon as possible (nasogastric feeding tube, PEG-
tube). Altogether, burn patients have an elevated basal metabolic rate.
1.2.2.4 Wound coverage - skin equivalents - skin grafts
After the patients are stabilized and the debridement is completed, wound healing
and treatment come to the fore. In case of degree II burns, fresh wounds may be
covered with e.g. hydrocolloid dressings, Suprathel® or Biobrane®. The wound
coverages form a semi permeable protection until wound healing is completed
[128], [165], [69, chapter 4]. Hydrocolloid dressings comprise a gently adherent
inner layer, a methyl cellulose absorbent middle layer, and a semipermeable outer
layer. Thereby, a moist wound environment is created, while wound exudate is
absorbed [69, chapter 15]. Biobrane® consists of knitted nylon threads coated
with porcine collagen with a silicone layer on top. It works especially well in case
of superficial and moderate depth partial thickness burns and can also be applied
subsequent to dermabrasion and skin-graft harvesting. In burn care, it reduces
pain, healing time, and inpatient stay compared to traditional dressings [20],
[169], especially in infants and children [86]. Although Suprathel®, which is a co-
polymer consisting of polylactide, trimethylene carbonate and ε-caprolactone, is
completely synthetic, it behaves like a biological dressing and exhibits properties
of natural epithelium. Since no animal derived components are used, no risk
of infection occurs, and the dressing is acceptable to all religious and ethnic
groups [70]. Suprathel® is often used for partial thickness burns, and can be
applied especially well for children, which often exhibit mixed depth wounds
[70]. It offers a high elasticity, high water permeability, and transparency after
application [106]. Furthermore, pain is greatly reduced and Suprathel® is well
accepted by patients due to easy and painless dressing changes [70], [149].
In contrast, large and deep wounds (degree III and IV) normally require sur-
gical closure with skin derivatives. In this situation, plastic surgery takes effect.
The gold standard of burn injury therapy is the coverage of the wounds with
autologous split-thickness skin grafts, but special types of injuries may require
other kinds of treatment. For example, in case of large electro traumata with
destroyed soft tissue, skin flaps are used to reconstruct and cover the wounds
[164]. The problem with electro traumata is the necrosis of deep mucle layers,
whereas the superficial skin is sometimes less affected. Full-thickness skin grafts
are also possible for small defects and are employed on hands and in the face,
e.g. if eye lids are harmed [164].
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Since in large and deep burns the protection normally given by native skin
is missing during the healing process, a temporary coverage of the wounds is
indicated to prevent infection and water as well as temperature loss. Also, the
temporary coverage protects the wound against mechanical influences [69, chapter
15]. For this, collagen sheets or cadaver allograft like Alloderm® (allogeneic,
decellularised human cryo preserved cadaveric skin, see also table 1.2) is employed
[128]. In the course of wound healing, the Alloderm® is either integrated or
rejected by the body [164]. To minimise the danger of viral disease transmission,
Alloderm® is tested extensively for the potential presence of viruses [69, chapter
15].
Table 1.2: Skin substitutes used in burn treatment.
Alloderm®: Dermal
equivalent consisting of
allogeneic decellularised
human cryo preserved
cadaveric skin
[128], [164]
Integra®: Dermal equivalent
consisting of
glucosaminoglycan mixed
with interwoven bovine
collagen with a silicone layer
on top
[27], [128],
[69], [67]
Matriderm®: Dermal
equivalent consisting of a
freeze dried collagen-elastin
matrix
[65], [164],
[144], [165]
For a successfull grafting and take of the graft, a good vascularisation of the
existing wound bed is very important [128], either consisting of capillarised der-
mal layers (degree II) or muscle fasciae (degree III). If in case of very deep burns
no sufficient dermal parts remain after the debridement, dermal substitutes are
utilised to improve vascularisation of the wound bed. The wound is covered with
Integra®, consisting of glycosaminoglycan (chondroitin-6-sulfate) mixed with in-
terwoven bovine collagen and a silicone layer on top [27] (see also table 1.2). It
is neovascularised from the wound bed prior to wound coverage with autologous
split-thickness skin grafts or cultivated keratinocyte sheets in a second operation
several weeks later (two step approach) [128], [69, chapter 12], [67]. Similarly,
Matriderm® can be used as a dermal substitute, mainly being applied as coverage
over joints [65] due to less scarring and more flexibility than Integra®. It consists
of a collagen-elastin matrix [164] and is mostly used in a single-step operation in
combination with split-thickness skin grafts [144], [165]. However, Matriderm®
and Integra® do not differ with respect to quality of vascularisation, take rate,
and thickness of resulting neodermis in a rat model [147]. Also, Alloderm® can
be used as a dermal substitute [165]. In this case, the dermal substitute still pos-
sesses intact basement membrane proteins (laminin, collagen type IV and VII),
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which might enhance keratinocyte adherence [69, chapter 15]. All of these der-
mal substitutes are gradually degraded and replaced by the patients’ own tissue.
Nevertheless, the time for a successful vascularisation is quite long. Besides, the
high costs represent another drawback.
As just described, split-thickness skin grafts are used to cover the burn wounds.
These grafts are taken from non burned areas, mainly the thighs. The nearer the
donor region and the burned area lie together, the more similar are the skin colour
and texture and the better is the outcome. If the available donor skin areas are
too small, the skin grafts can be expanded by meshing (cutting the skin to reach
a mesh structure after expansion). A further expansion is possible with the
Meek-technique. Here, the donor skin is cut into small squares and attached to a
carrier (e.g. silk) with space inbetween. Since burn injuries treated with meshing
or Meek-technique never heal evenly and have a poor cosmetic appearance, both
techniques are avoided in case of a burned face or hands. Broadly expanded skin
is covered with allogeneic skin to improve healing [69, chapter 12], [165]. In any
case, these techniques require an appropriate wound management at the donor
site to minimise damage there.
To provide an epidermal replacement, autologous keratinocytes are applied. In
this context, two different possibilities exist. In case of e.g. Epicell®, a biopsy
of healthy skin is taken from the patient and keratinocytes are isolated and ex-
panded in special laboratories. Subsequently, the cells are transferred to a special
carrier, with which the wounds are covered. This technique requires the previous
coverage of the wounds with Integra®. The advantage of this method is the use
of autologous cells. The drawbacks are the long time period between the biopsy
and the coverage (up to three weeks) as well as the fragility of the transplanted
skin. Also, this method is quite expensive. Therefore, only patients with very
large burned areas are treated this way [165], [128], [69, chapter 15]. Alterna-
tively, as in case of e.g. ReCell®, epidermal cells (including melanocytes) can
directly be isolated without a cultivation period and subsequently be applied to
the burn wound. The major advantage of this approach is the fact that the cells
can directly be applied to the patient without the need of culturing. Furthermore,
the presence of melanocytes leads to an important improvement of the aesthetic
aspect [165]. Even without melanocytes, keratinocytes applied by spray to face
and neck burn injuries result in good cosmetic outcomes [64].
Regardless which treatment and which skin substitutes are used - either tem-
porary or permanently - they are still highly imperfect [69, chapter 15]. As
long as the deep dermis and possibly the hypodermis are destroyed, no seba-
ceous/perspiratory glands or hair follicles can regrow. This results in a poor cos-
metic and functional outcome, which includes the lack of sweating in the burned
areas. Therefore, a skin substitute containing all of these layers and components
is highly desirable. This, however, is the long term goal of our research.
1.3 Tissue engineering
In surgery - especially in plastic and reconstructive surgery - one of the most
important principles is to replace a special tissue with the same tissue, or if not
available, at least with something as similar as possible. Here, tissue engineering
is employed to artificially create tissues in vitro for their usage in patients, aim-
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ing at the re-establishment, or the replacement, of the damaged tissue. Thereby,
tissue engineering comprises a comprehensive field of disciplines and combina-
tions of many different techniques and principles originating from engineering
and materials sciences as well as life sciences.
As mentioned above in section 1.2.2.4, skin substitutes and autologous ker-
atinocytes play an important role in burn treatment. Autologous cells are always
the best way to replace missing tissue as they are not rejected by the immune
system and do not carry the risk of infectious diseases. Many cell types may be
used for the creation of skin equivalents, including fibroblasts, keratinocytes, and
adipose derived stem cells.
Nevertheless, tissue engineering is not that simple as all cells highly depend on
their immediate surroundings, the so-called microenvironment [75], [174]. The
definition of a biological microenvironment includes the amount and density of
certain cells and their defined 3D position in the tissue. Moreover, soluble factors,
mechanical stimuli, and cell-cell contacts are very important. But also interac-
tions between the cells and the ECM play an important role in the formation
of tissue [4, chapter 19]. Especially stem cells are highly dependent on their
microenvironment [47].
Therefore, specific cell culture methods have to be developed to ensure the
best adapted way of tissue production and culturing. This is often realized by
the use of special bioreactor systems. These provide physical, chemical, and
mechanical stimuli, which are thought to influence the cells in the desired way,
supplying a special biomimetic environment. This, in turn, stimulates the cells
to produce their own needed ECM and cytokines to develop the desired tissue.
In this context, self-assembly and self-organisation of cells are two of the main
components for histogenesis and organogenesis [75].
In tissue engineering, cells are often seeded onto/into special pre-existing scaf-
folds, which vary concerning their substance, porosity, elasticity, stiffness, and
shape, according to their specific uses. Typically, the scaffolds are needed to give
the tissue its desired form and represent spatial templates. This aspect is espe-
cially important in case of bone engineering, as a certain mechanical strength is
needed [142], [52], [96], [167]. However, it is very important that the cells are
distributed evenly in the engineered tissue, provided that this is also the case
in the original organ [75]. Apart from the aforementioned considerations, a very
important factor of an engineered tissue is its integration - including the scaffold -
into the host and the firm connection to the surrounding tissue. However, compli-
cations may arise after transplantation, often due to the scaffold material. These
include a possible inflammatory response in the host, or a mechanical mismatch
of the transplant with the surrounding tissues.
Alternatively, tissue engineering without a rigid scaffold exists, as in case of
flexible tissues like skin. For the production of skin equivalents, often fibrob-
lasts are seeded into a collagen type I gel, which is then kept under submerged
culture conditions until the fibroblasts have contracted the gel. Subsequently,
keratinocytes are seeded on top, which will then develop into a multi-keratinised
epidermis when risen to the air-liquid-interface. This means, that the skin con-
struct is supplied with nutrients and liquid from below, while the air from above
serves as a differentiation stimulus to the keratinocytes. This mimics the natural
physical conditions of skin growth. Furthermore, the culture medium contains
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further supplements to induce differentiation, like hydrocortisone, ascorbic acid
or cholera toxin [79], [168]. Under these conditions, the differentiation of the
skin equivalents normally takes up to three weeks [148]. Additionally, other cell
types than fibroblasts and keratinocytes may be added to the skin equivalents,
to enhance their similarity to physiological skin (see also next section 1.4).
Especially in large tissues immediate and functional vascularisation is needed
after transplantation to supply the tissue with nutrients and oxygen. In this
regard, several approaches are possible, which are delineated in the discussion
(section 4.3.2.1).
1.4 Existing skin equivalents in research
Tissue engineering, as described above, offers the possibility to provide skin equiv-
alents for research, where they are urgently needed [85]. This includes the phar-
macological as well as the cosmetic industry since in vivo animal experiments
should be replaced by in vitro experiments whenever possible. The commonly
used rabbit Draize test to assess the potentially harmful effects of new cosmetic
ingredients does not always prove to be correct [97]. This test, as well as the
also frequently used local lymph node assay (LLNA) in mice (OECD TG 429)
[50], may show false positive or false negative results due to species differences
between the respective animals and humans. Therefore, in vitro test systems
using 3D skin equivalents need to be established and validated against existing
and approved animal tests. The validation process is very extensive and lasts
several years. However, based on the physiological similarity of 3D skin equiva-
lents to natural skin, some equivalents are already accepted as a valid alternative
to animal testing [56].
Many different skin equivalents are being developed continuously, including in-
house skin equivalents of different research groups as well as already commercially
available ones (also see tables 1.3, 1.4 and 1.5). In any case, an organotypic -
meaning 3D - culture of skin cells is important, mimicking the structure of natural
skin and therefore presenting better interactions of the different skin cells than
2D cultures. The equivalents may comprise different kinds of cells, materials,
and structures, some including only the epidermis while others also contain a
dermal part. The skin substitutes comprising a dermal part will resemble natural
skin more, of course. Some equivalents are based on de-epidermised dermis while
others are made of fibroblasts seeded into a collagen gel with keratinocytes placed
on top. Other cell types, like melanocytes or Langerhans cells may be added. In
contrast to simple 2D cell cultures, the skin equivalents possess a keratinized
epidermis and a functional basement membrane. This enables the assessment of
many parameters, e.g. the penetration of different agents through the skin.
In medical research, these manifold skin equivalents serve to answer many
different questions. In the following, different examples of their potential appli-
cations are given.
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Table 1.3: Skin equivalents used in research, based on collagen gel seeded with fibrob-
lasts and keratinocytes.
Basic model
Psoriasis model [83]
Screening of antimycotic
treatment
[123], [101]
Pigmentation disorders [122]
DNA repair deficiency model [15]
Effect of UV irradiation on
keratinocytes
[68]
Testing of sunscreens [116]
Cancer invasion [101]
Continued on the next page
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Irritancy and toxicity testing [101], [56]
Wound healing model [45], [101]
Biofilms in wound healing [32]
As already mentioned before, skin substitutes are used to test the effect of
topically applied drugs or cosmetic products, concentrating on their mode of
penetration into the skin as a measure to assess their potential harm. Note,
that this is only possible due to the presence of a keratinised epidermis. Other
potential impairments of drugs, cosmetic products or nanoparticles with respect
to the skin are the development of inflammations, irritancies or toxic effects,
which can be examined likewise [56], [153], [36], [139], [124], [101].
An important issue for all human beings is the harmful effect of UV irradiation,
causing mutations and resulting in cancer, especially if DNA repair systems are
not functional (as in case of patients suffering from xeroderma pigmentosum). In
order to reduce cancer incidences due to UV irradiation, skin equivalents are used
to test the effect of sunscreens [116] and help to achieve a deeper understanding
of photo aging, photo carcinogenesis, and tissue therapy [15].
In the field of cancer research, skin equivalents are applied to assess the geno-
toxicity of carcinogenic agents [177] as well as the invasion and metastatic po-
tential of cancer cells [38], [78], [101]. Invasion can only be assessed in a 3D skin
equivalent, which represents the normal structure of skin, including the base-
ment membrane. Even the molecular mechanisms of cancer caused by human
papilloma viruses (HPV) can be studied [3].
A further usage of artificial skin is the application of wound repair models,
giving the opportunity to test new wound healing therapies as well as to optimise
dosages [172]. Wounds in 3D skin equivalents are much more similar to real in-
juries than ’wounds’ in 2D cell culture (scratch assays). Among others, the effect
of different growth factors on the re-epithelialisation of wounds can be studied
[45]. Infections are feared in the therapy of wounds, leading to complications in
the healing process, chronicity of wounds or the rejection of skin substitutes in
case of burn patients. In this context, skin equivalents may be used to study the
formation, growth, prevention, and eradication of bacterial biofilms [32]. Also,
they prove capable of assessing the therapeutic efficacies of antifungal drugs in
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the treatment of candidiasis [123], [101] and allow for the measurement of the
according cytokine expression profile [145].
Model skin equivalents are also applied to study pigmentation disorders [122]
and to conduct mechanistic studies concerning melanocytes [159], [16], [66]. In
this context, the construction of a skin equivalent with normal pigmentation is
the aim [91]. Furthermore, skin equivalents are constructed as an in vitro model
of psoriasis [83], [51]. Also in this case, the use of skin equivalents with their
special 3D structure is necessary, since the interaction of the melanocytes and
the other cells is dependent on their location.
Table 1.4: Skin equivalents used in research, based on de-epidermised dermis (DED).
Basic model
Wound healing [172]
Model of cancer caused by
human papilloma viruses
(HPV)
[3]
Cancer invasion [78]
Irritancy testing, penetration
of test substances
[137]
Effect of UV irradiation on
melanocytes
[159], [16]
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Table 1.5: Skin equivalents used in research, based on Matriderm® and excised skin.
Epidermal equivalents used in research.
Burn injury treatment [57]
Basic model
Irritancy testing [56]
Basic model
Model of cutaneous
candidosis
[145]
Irritancy and toxicity testing [56]
1.5 Bioprinting - techniques and possibilities
As mentioned in sections 1.3 and 1.4, the specific 3D spatial positioning of cells
is of utmost importance to create functional engineered tissues. Here, the tech-
niques of bioprinting bear great promise, being able to print small amounts of
biomaterials - containing different cell types - with high accuracy and high reso-
lution in a specific 3D pattern to mimic their position in an organ. The tissue is
printed in a layer by layer approach, transferring the biomaterial on top of each
preceding printed layer. Very important for the successful and economical use of
bioprinting is its computer aided control. This not only comprises the technical
aspect of the transfer process as such, but also includes the possibility to use
images of tissue constructs as a blueprint for the automatic creation of a specific
tissue [7].
In contrast to normal tissue engineering, where cells are seeded onto/into a pre-
existing scaffold, in case of bioprinting no such stiff scaffolds exists. However, as a
certain rigidity is needed to create a 3D structure, hydrogels assume the role of a
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scaffold and are printed together and simultaneously with the cells. As the tissue
is formed layer by layer, different cell types can be printed and included with
high spatial resolution; e.g. endothelial cells to facilitate vascularisation in large
tissue constructs. This is unique to the technique of bioprinting and represents
its major potential.
Bioprinting can be divided into two main approaches: inkjet printing and laser
based printing. For the inkjet printing, most normal deskjet printers can be
modified to print cell solutions instead of normal ink, resulting into low investment
costs [127], [113], [112], [34], [170], [18], [7], [178], [173]. The cells are mixed with
cell culture medium or biocompatible hydrogels, forming the so-called bioink.
This can then be filled into the cartridges of the printer and be used to print
different cell types, even in parallel. Inkjet printing is rapid, versatile, and cheap
[75]. Its major disadvantage, however, is the high shear force at the inkjet nozzle,
leading to cell damage [21], [31]. Also, printer head clogging may appear at high
cell densities [62] and the consistency of the cell concentration may alter during
the printing process [135]. Therefore, only bioink with low viscosity and low cell
density can be printed.
In contrast, laser based bioprinting works nozzle-free, resulting in the possibil-
ity to use bioink with much higher viscosity and cell density [62]. This is especially
important for the creation of tissues containing a very high cell density like skin.
Also in case of laser based bioprinting, hydrogels are of major importance for
the creation of tissue constructs. Different hydrogels used for bioprinting are dis-
cussed in section 4.2. For both approaches, one major requisite is the availability
of pure, non-contaminated cell cultures of the desired cell types.
Applying both bioprinting approaches, different kinds of cells have successfully
been transferred in diverse 2D and 3D patterns [30]. In case of inkjet printing,
alginate is commonly used as hydrogel [7], [112], resulting in the creation of e.g.
a cell containing pyramide, reaching 5 mm in height. Also, a cartilage-like tissue
was formed using human chondrocytes together with a photopolymerized matrix
[34]. Laser based bioprinting has been used to print stem cells with subsequent
differentiation to bone, cartilage [58], or fat [59]. Human osteoprogenitor cells
have also been used to print bone, together with nano-hydroxyapatite as a stabi-
lizing matrix [28]. Additionally - as shown in this PhD thesis - skin tissue could
successfully be printed [81], [103].
1.6 Laser induced forward transfer (LIFT)
LIFT is one form of laser based bioprinting and has originally been used in the
production of construction material. The setup which has been used for this PhD
thesis is described in detail in [82] and [163]. It consists of two coplanar glass slides
(26 x 16 x 1 mm) with a gap in between ranging from 350 to 500µm. The upper
glass (donor slide) is coated underneath with a 60 nm thick light absorbing gold
layer and the cell-matrix solution (bioink) which is intended to be transferred (see
picture 1.5). In order to avoid dripping of the bioink, it has to possess a certain
viscosity. The laser beam is then focused through the donor glass slide into the
gold layer, which absorbs the whole energy and as a result evaporates locally
and expands in all directions. As resistance against expansion is lowest at the
front, a protrusion of the bioink layer develops, which elongates, thereby forming
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Figure 1.5: Process of the laser induced forward transfer (LIFT) In (A) a
schematic overview over the LIFT process is presented (modified after [82]). By focusing
the laser beam through the donor slide into the absorbing gold layer underneath, the
gold absorbs all energy and evaporates. This results in the transfer of the underlying
bioink to the acceptor slide. By moving the glass plates or the laser beam, 2D patterns
can be printed. 3D constructs are formed by a layer-on-layer approach. The different
colours represent different cell types. Part (B) depicts the actual transfer process as
visualised by stroboscopic imaging [163]. After laser application, the hydrogel forms a
jet from the donor slide towards the acceptor slide, onto which the bioink containing
the cells is transferred. Under appropriate laser fluence conditions, the jet possesses
laminar flow characteristics all the time (a), whereas with higher laser fluence turbulent
flow appears in the initial transfer phase (b).
a jet. Via this jet, which - at appropriate laser fluence - exhibits laminar flow
characteristics, the cells are transferred towards the lower glass slide (collector
slide) [163]. During impingement the jet causes droplets with clean boundaries,
spreading in a disk shape. To prevent the cells from dehydration, the collector
slide may be covered with cell medium or some kind of matrix/hydrogel. However,
this is not necessary as long as the bioink contains enough moisture for the cells
to survive.
The applied laser is a Nd:YAG-laser with 1064 nm wavelength, 8 to 9 ns pulse
duration and 20 Hz repetition rate. The laser pulse energy varies between 100
and 190µJ, enabling us to print about 1200 droplets per minute. In our setup,
gold is used as a light absorbing layer, but also titanium [28] or special polymers
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may be used. Gold has the advantage of being relatively cheap and also harmless
towards the cells.
By moving the laser beam, a variety of 2D patterns can be printed easily. If
different cell types need to be used in the same layer, for each cell type one donor
glass slide has to be employed. First, one cell type is printed at its desired posi-
tions, then the donor glass slide is changed and the second cell type is transferred.
Different matrices might need to be used for each cell type (see section 4.2).
During the printing process, the droplet size depends on the laser pulse energy,
the gap distance between the two glass slides, the focused laser spot size, as well
as the thickness of the energy absorbing layer and the matrix (bioink) [82]. The
resolution is correlated to the thickness of the bioink layer, its surface tension and
viscosity, the laser fluence, and also the gap between donor and collector slide
[62]. The higher the viscosity and the thicker the bioink layer, the more energy
needs to be used for the transfer [61].
Different types of cells - including fragile primary cells - have successfully been
transferred by laser based bioprinting. They survive the transfer well, without
showing any difference in morphology or proliferation rate compared to non-
printed control cells [141], [14], [13], [125], [71], [140], [58], [59], [28]. Further,
LIFT does not induce apoptosis, and no signs of DNA-damage can be detected
after the printing process [82]. Moreover, human mesenchymal stem cells (MSC)
maintain their stem cell characteristics [82] and their ability to differentiate [58],
[59]. Likewise, the differentiability of pluripotent murine embryonal carcinoma
cells is preserved after transfer [140]. This shows the suitability of laser based
bioprinting for its application in tissue engineering.
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Major burn injuries pose difficulties with regard to their therapy. As autologous
skin often does not suffice, skin equivalents are used as temporary or permanent
wound coverage. Nevertheless, skin substitutes do not possess hair follicles, se-
baceous or sweat glands, melanocytes or blood vessels. While the lack of hair,
glands, and melanocytes decrease the functional and aesthetic capacity of skin
substitutes, the lack of blood vessels is especially important for a sufficient vascu-
larisation and therefore a good take. The precise positioning of different cell types
in a complex 3D tissue, however, cannot be realized with the hitherto available
methods. Thus, in this thesis laser based bioprinting is used for the creation of a
skin equivalent because it offers the possibility to precisely position different cell
types in a complex 3D mode. The overall aim is the creation of a skin substitute,
which is as similar to native skin as possible. As a prerequisite, this thesis focuses
on the establishment of the bioprinting technique for it’s successful application
in the field of skin tissue engineering. Both, the technical as well as the biological
aspects, need to be considered in this context.
Long-term aim
Creation of a skin substitute as similar to physiological skin as possible.
Short-term aim
Establishment of the LIFT procedure for the production of a skin equivalent.
Workflow
 Establishment of the LIFT technology for the transfer of living cells in
co-operation with the Laser Zentrum Hannover.
 Assessment of transferred living cells for potential damage by LIFT (im-
mediate survival, proliferation behaviour, possible induction of apoptosis,
possible DNA-damage, influence on stem cells).
 Isolation and culturing of primary cells, optimisation of their cell culture
procedures, cultivation of cell lines.
 Printing of 2D patterns with several cell types. Adaptation and optimisa-
tion of the required evaluation methods.
 Assessment of different hydrogels for their suitability in the transfer process
and their compatibility with regard to the cells.
 Printing of 3D cell constructs with several cell types. Adaptation and op-
timisation of the required evaluation methods.
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 Analysis of the 3D skin constructs in vitro (viability, tissue formation, pro-
liferation).
 Establishment of the dorsal skin fold chamber in mice for the assessment
of tissue engineered skin constructs in vivo.
 Evaluation of the printed 3D skin constructs in vivo (viability, tissue for-
mation, keratinocyte differentiation, vascularisation).
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Contributions to publications
Contributions to publications
Our co-operation comprised three research groups with different foci: the techni-
cal aspects of the LIFT, the skin cell research and the stem cell research. In the
Laser Zentrum Hannover the technical aspects of the laser transfer were of main
interest, whereas the biological facets of the printing process and the influences
on the cells were the focus of my work and our co-operation partners in Rostock.
My thesis concentrated on the creation of a skin substitute for burn patients.
For this, I used skin cells, i.e. mainly keratinocytes and fibroblasts. In Rostock
the aim was the generation of cardiac patches for the treatment of myocardial
infarction. This work group mainly used stem cells for their experiments.
The three work groups remained closely connected throughout the project,
often discussing the experimental setups and results inter-disciplinary.
Regarding the experiments, I mainly planned, conducted, and analysed the
experiments concerning the skin constructs and skin cells. This excluded, how-
ever, the counting of the skin cells for the assessment of the proliferation af-
ter LIFT (publication [82], page 36), the comet assay for detection of potential
DNA-damage (publication [82], page 36) and the detection of tissue formation
via immunofluorescence and the scrape loading assay in the in vitro experiments
(publication [81], page 55).
On the other hand, I was involved in some of the experiments regarding the
stem cells, i.e. the preparation and culturing of the stem cells (i.e. adipose-derived
mesenchymal stem cells - ASC) for the fluorescence activated cell sorting (FACS)
analysis to detect stem cell markers after LIFT (publication [82], page 36). Also,
I contributed to the planning of these experiments. Furthermore, I conducted
the ApoOne assay for the detection of possible apoptosis of not only the skin
cells but also the stem cells (i.e. bone marrow derived mesenchymal stem cells -
bmMSC) (publication [82], page 36).
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Laser Printing of Skin Cells and Human Stem Cells
Lothar Koch, Ph.D.,1,* Stefanie Kuhn, Dipl.-Biol.,2,* Heiko Sorg, M.D.,2,3,* Martin Gruene, Dipl.-Ing.,1,*
Sabrina Schlie, Dipl.-Biol., Ph.D.,1 Ralf Gaebel, Dipl.-Biol.,3 Bianca Polchow, Dipl.-Biol.,3
Kerstin Reimers, Ph.D.,2 Stephanie Stoelting, Ph.D.,3 Nan Ma, Ph.D.,3 Peter M. Vogt, M.D.,2
Gustav Steinhoff, M.D.,3 and Boris Chichkov, Ph.D.1
Laser printing based on laser-induced forward transfer (LIFT) is a new biofabrication technique for the ar-
rangement of biological materials or living cells in well-defined patterns. In the current study, skin cell lines
(fibroblasts=keratinocytes) and human mesenchymal stem cells (hMSC) were chosen for laser printing experi-
ments due to their high potential in regeneration of human skin and new application possibilities of stem cell
therapy. To evaluate the influence of LIFT on the cells, their survival rate, their proliferation and apoptotic
activity, and the DNA damages and modifications of their cell surface markers were assessed and statistically
evaluated over several days. The cells survived the transfer procedure with a rate of 98% 1% standard error of
the mean (skin cells) and 90% 10% (hMSC), respectively. All used cell types maintain their ability to proliferate
after LIFT. Further, skin cells and hMSC did not show an increase of apoptosis or DNA fragmentation. In
addition, the hMSC keep their phenotype as proven by fluorescence activated cell sorting (FACS) analysis. This
study demonstrates LIFT as a suitable technique for unharmed computer-controlled positioning of different cell
types and a promising tool for future applications in the ex vivo generation of tissue replacements.
Introduction
Tissue engineering is a rapidly growing scientific fieldwith an extremely high application potential. One im-
portant topic of tissue engineering is the production of skin
substitutes for burn patients.1 Since the possibility of autol-
ogous skin replacement is restricted and many different skin
substitutes have not reached full success in burn regenera-
tion, there is need for a better skin substitute, which fulfils
the distinct criteria of tissue-engineered skin and might re-
pair the respective skin defect without any complications.
Further, the interest in mesenchymal stem cells (MSC) for
research purposes and, in particular, for clinical applications
continuously increased, which is related to the enormous
potential of these cells to repair and support the regeneration
process of specific tissues.2 One major obstacle herein is the
complex composition of very different but highly specific
cells, which are arranged in defined three-dimensional (3D)
structures representing the distinct functionality of the re-
spective tissue or organ. To create such specific tissue, the
different cell types might be arranged layer by layer in suc-
cessive time intervals, so that each cell type can constitute a
living cell sheet before the next cell type is deposited.3 If
more complex structures should be engineered with inte-
grated vessels or glands, very precise deposition of small
volumes of cells and biomaterials is required.
At present, different techniques, based on ink-jet printing
technology4–6 or on laser-induced forward transfer (LIFT),7
also called laser printing, are under investigation to transfer
small amounts of various materials—including living cells—
in preset two-dimensional (2D) or 3D patterns. These tech-
niques offer possibilities to control the process with existing
computer-aided design and computer-aided manufacturing
systems.8 The ink-jet printing approach is the most com-
monly used for printing of biological materials.9–11 The im-
portant benefit of this technique is the low investment
cost, since nearly every ink-jet desktop-printer9 can be re-
assembled for the print of biological materials.12 The main
drawback is the very high shear force at the ink-jet nozzle,
which leads to significant cell impairment.13 Therefore, only
fluids with low viscosity and low cell density can be printed.
Since the laser printing is nozzle free, high viscosity and high
cell density solutions can be printed as well. By combining
cell solutions with materials that can form stable gels14
it would further be possible to print 3D tissues layer-by-
layer. By using the LIFT approach, living cells have been
1Department of Nanotechnology, Laser Zentrum Hannover e. V., Hannover, Germany.
2Department of Plastic, Hand- and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
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transferred in a 2D structure.15–19 Further, Barron et al.20 and
Othon et al.21 transferred single cells also in a 3D structure
using layer-by-layer technique.
In the present study, LIFT with gold as a light absorbing
layer was investigated to transfer skin cells (fibroblasts=
keratinocytes) and human MSCs (hMSC) for the creation of
well-defined patterns. Printing of more than one cell type
and the generation of multicell patterns were demonstrated.
The study was focused on the qualitative as well as quanti-
tative investigation of cell survival, proliferation, apoptosis,
and cell DNA damage of the used cell types as well as on
phenotype changes of the stem cells after LIFT. The dem-
onstrated laser printing of these cells is a promising step
toward the fabrication of living tissue substitutes.
Materials and Methods
Laser printing
The laser printing technique, which is used for defined
deposition of cells, is based on the principle of LIFT, as il-
lustrated in Figure 1. The experimental setup consists of two
coplanar glass slides. The upper, referred to as ‘‘donor-slide,’’
is covered underneath with a light absorbing gold layer and
a layer of the cell containing material to be transferred
(Fig. 1). Laser pulses are focused through the glass slide into
the gold layer, which is evaporated locally. Laser light ab-
sorption in the gold layer generates a high gas pressure that
propels the subjacent cell compound toward the lower glass
slide, referred to as ‘‘collector-slide.’’ A thin layer of hydrogel
or cell medium on the collector-slide provides a humid en-
vironment to prevent the cells from dehydration at longer
processing times and cushions the impact. Note that the cells
survive the impact even without this cushion layer. A hy-
drogel layer additionally keeps the cells positioned. All
transfer experiments in this article are carried out under
normal air conditions.
The achieved droplet size of the transferred cell com-
pound depends on the laser pulse energy, the gap distance,
the focused laser spot size, as well as the thickness of the
energy absorbing layer and the cell compound layer. In our
experiments, printed droplet sizes with a diameter in the
range of 80 to 140 mm are used.
The applied laser is a Nd:YAG-laser (DIVA II; Thales Laser,
Orsay, France) with 1064 nm wavelength, 8–9 ns pulse dura-
tion (FWHM), and 20Hz repetition rate. The laser pulses are
focused with a 60mm achromatic lens, producing an ablation
spot size of 45mm in diameter. Depending on the cell=
hydrogel layer thickness, the laser pulse energy, measured
continuously during the ongoing process, is set between 100
and 190mJ, corresponding to a laser fluence of 3 to 6 J=cm2.
The cell deposition is controlled via a computerized
scanning setup consisting of three high speed translation
stages (M-414.1PD and M413.3PD; PI GmbH, Karlsruhe,
Germany). On the XY-translation stages, two mirrors are
mounted; on the Z-stage holding, the focusing optics as well
as the camera for process visualization are mounted. The
stages are synchronized with laser pulses over a computer-
based real-time system (Adwin-4L-T400; Jaeger Messtechnik,
Lorsch, Germany) to ensure equidistant positioning of the
laser spots. This automated computer-aided manufacturing
controlled stage setup allows the accurate positioning of a
wide variety of patterns with a speed of 1200 printed cell
droplets per minute, which is only limited by the laser rep-
etition rate applied in this study.
The carrier for the donor-slide is structured modularly to
allow quick replacement of the donor-slides coated with
different cell compounds. The collector-slide is assembled on
a Z-stage to provide controlled positioning with respect to
the donor-slide. The gap between the donor- and collector-
slide is set to a value in the range of 350 to 500mm with an
accuracy of 5 mm and is monitored through a camera looking
parallel to the slides (see Fig. 1).
Preparation of donor- and collector-slides
for laser printing experiments
The cultivated cells were trypsinized and centrifuged at
300g. Then the supernatant was removed.
1. For all conducted cell assays, the cell pellet was re-
suspended in the respective cell medium. This cell
suspension was pipetted on the gold-coated donor-
slide. The square glass plates with a size of 26mm and a
thickness of 1mm were coated with a 55 to 60 nm thick
gold layer using plasma-enhanced sputter deposition.
The cell suspension was dispersed on the gold surface
with a blade coater to form a homogenous layer of
approximately 50mm thickness. Then the cell coated
donor-slide was fixed in a metal frame and mounted
upside-down in the setup. To collect the transferred
cells, a sterilized square glass plate (the collector-slide)
was mounted parallel to and under the donor-slide. The
collector-slide was coated with a layer of cell medium
for all the cell assays described here (except for comet
assay). This coating was performed with a t-shape
spreader. Directly after the LIFT experiments, the laser
transferred cells were rinsed from the collector-slide
with additional medium into a tube, counted, and dis-
tributed to the corresponding well plates for further
analysis. The cells that remained on the donor-slide
were also rinsed off and collected as control cells.
2. For the analysis of DNA damage, the collector-slide was
coated with an agarose layer. The cells printed on the
agarose layer were coated with a second layer of aga-
rose and used for the comet assay.
3. For the printing of well-defined cell structures, the cell
pellet was resuspended in a mixture of blood plasma
and alginate hydrogel at a density of 1–2106 cells in
30 mL. The obtained cell suspension was pipetted on
the gold-coated donor-slide and dispersed on the gold
surface with a blade coater to form a homogenous
layer of approximately 50mm thickness. To keep the
printed cells in their position, the collector-slide was
coated with Matrigel (BD Biosciences, Heidelberg,
Germany). Note that the conducted Live=Dead-assays
showed the same results in all studied cases, indepen-
dent on the materials (cell medium, alginate, blood
plasma, Matrigel) used for the preparation of donor-
and collector-slides.
Cell culture of skin cell lines
NIH3T3 fibroblasts were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with high glucose (4.5 g=L) (PAA,
Pasching, Austria) supplemented with 10% fetal bovine
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serum (FBS) (Biochrom, Berlin, Germany), 1% of 100mM
sodium pyruvate (Biochrom), and 1% of 10mg=mL genta-
mycin (Biochrom). HaCaT keratinocytes were grown with
DMEM=Ham’s F12 medium (PAA) supplemented with 10%
FBS and 1% of 10mg=mL gentamycin.
Isolation and culture of hMSC
Bone marrow–derived hMSC. Collections of bone mar-
row (BM) aspirates of 12 patients ranging in the age from 68
to 84 years were obtained from the sternum of patients un-
dergoing cardiac surgery at the Cardiac Surgery Department
of the University of Rostock. The BM aspirates were received
in accordance with the ethical standards of the local ethics
committee. The aspirates were diluted 1:5 with 2mM ethy-
lenediaminetetraacetic acid-phosphate-buffered saline (PBS)
(Merck, Whitehouse Station, NY; Nexell, Baxter, Unter-
schleissheim, Germany). The mononuclear cell fraction was
isolated by density gradient centrifugation using Ficoll-
Hypaque-Plus solution (GE Healthcare BioSciences, Piscat-
away, NJ) and seeded at a density of 1106 cells=cm2 into cell
culture flasks (Greiner Bio-One, Frickenhausen, Germany).
The expansion medium consisted of MSC basal medium
(MSCBM; Lonza, Walkersville, MD). Cells were maintained
in MSCBM until they reached 70% to 90% confluency. Cells
were harvested at subconfluence using Trypsin (PromoCell,
Heidelberg, Germany).
Adipose-derived hMSC. Adipose-derived hMSC (Ad-
hMSC) were yielded from abdominoplastic surgery per-
formed at the Department of Plastic Surgery at Hannover
Medical School with written consent and approval of the
ethics committee. Fat lobules were dissected with sterile
scissors to lobules of approximately 1 cm3 size. They were
washed in equal volumes of sterile Hank’s Balanced Salt
Solution (HBSS) (PAA), and then their extracellular matrix
was digested at 378C for 1 h with 0.075% collagenase (Bio-
chrom) in PBS under permanent shaking. Then, enzyme ac-
tivity was neutralized with Hank’s BSS containing 10% FBS,
centrifuged at 1200g for 10min, and incubated overnight
at 378C=5% CO2 at a density of approximately 150,000=cm
2
in a medium (DMEM=Ham’s F12) containing 10% FBS, 1%
penicillin=streptomycin (Biochrom), and 0.1% ascorbat-2-
phosphate. After incubation, the plates were washed with
PBS to remove residual nonadherent blood cells. Finally, Ad-
hMSC were plated in 150 cm2 cell culture flasks and incu-
bated at 378C=5% CO2 until they reached 60–70% confluence.
Cell staining
For cell staining, carboxy-fluorescein-diacetate (CFDA)
(Invitrogen, Karlsruhe, Germany) and Hoechst 33342 (In-
vitrogen) were used. Cells were incubated for 15min at 378C
and subsequently washed thrice in PBS (PAA).
Analysis of cell survival after LIFT
Survival of fibroblasts (NIH3T3), keratinocytes (HaCaT),
and hMSC was studied directly after LIFT. Fibroblasts and
keratinocytes were shown to be alive or dead after LIFT and
this was attained while using the Trypan Exclusion Assay
with 0.4% Trypan Blue (Invitrogen). Directly after, the LIFT
process cells were rinsed off the collector-slide, counted with
a haemocytometer (Fuchs-Rosenthal; Assistent, Sondheim,
Germany), and compared to nontransferred cells from the
gold layer (control). To evaluate cell membrane integrity of
hMSC, fluorescein diacetate (FDA; Invitrogen) and propi-
dium iodide (PI; Carl Roth, Karlsruhe, Germany) were used
to differentiate between cells with intact membranes (live;
FDA 5.5 mg=mL for 15min) and membrane damaged cells
(dead; PI 50 mg=mL for 15min). After each stain, cells were
washed with PBS, centrifuged, and finally fixed for 10min
with 4% paraformaldehyde for analysis. Live cells were
identified by the presence of intracellular, green FDA stain-
ing. Red cells, stained by PI, were counted as dead cells.
FIG. 1. Schematic sketch of the biological laser printing setup and a perspective figure of the principle of laser-induced cell
transfer between two coplanar slides: The upper slide is coated underneath with an energy absorbing gold layer and
materials to be transferred. Laser pulses are focused through the upper glass slide into the absorbing layer. By evaporating
this layer, the material to be transferred is propelled toward the lower glass slide.
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Analysis of cell proliferation after LIFT
Proliferation of NIH3T3, HaCaT, and hMSC was analyzed
using different methods. Proliferation of fibroblasts and
keratinocytes was studied using the CellTiter-Blue Kit (Pro-
mega, Madison, WI). The test was carried out according to
the description of the manufacturer in five replicates per
LIFT process. Cells were distributed in a 96-well plate,
starting with 500 viable cells in each well and measured with
a Genios2 Tecan Reader (Tecan, Gro¨dig, Austria). Prolifera-
tion was additionally measured by distributing 1000 trans-
ferred vital NIH3T3 cells as well as 860 HaCaT, respectively,
in each well of 24-well plates. Over 6 days, every 24 h, 24
chosen samples were trypsinized and stained with Trypan
Blue (0.4%) and vital cells were counted separately for each
well. Nontransferred cells were used as controls.
To evaluate the influence of LIFT on hMSC prolifera-
tion, we assessed the proliferative activity using water-
soluble tetrazolium salt (WST-1) assay (Roche Diagnostics,
Mannheim, Germany). The WST-1 assay is a colorimetric
method in which the dye intensity is proportional to the
number of viable cells. HMSC were seeded into 96-well mi-
crotiter plates directly after LIFT at a concentration of 2103
cells=well. Cells were then cultured in medium (MSCBM).
After incubation of 24 h to 96 h, the cell proliferation reagent
WST-1 was added with cell culture medium followed by
incubation for 4 h. Sample absorbance was analyzed using a
bichromatic enzyme-linked immunosorbent assay reader
(Microplate Reader, Model 680; BioRad, Munich, Germany)
at 450 nm.
Analysis of apoptosis after LIFT
For determination of apoptosis, fibroblasts, keratino-
cytes, and hMSC were lysed in ApoOne Buffer (Promega),
and N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin
(Sigma-Aldrich, Munich, Germany) was added as a substrate
for caspases 3=7. Fluorescence was detected with a Genios2
Tecan Reader. As a positive control, HaCaTs treated for 7 h
with 0,525 mM staurosporine (Merck, Darmstadt, Germany)
were used.
Analysis of DNA damage through LIFT
To determine whether the LIFT procedure induces geno-
toxicity effects, a comet assay experiment was performed
with fibroblasts (NIH3T3), keratinocytes (HaCaT), and
hMSC right after the cell transfer and under control condi-
tions, as previously described.22 Genotoxicity can be studied
by analyzing DNA damages, which are detected with the
comet assay method according to single and double DNA
strand breaks via a single-cell-gel electrophoresis. These
DNA damage effects can be quantitatively described by the
parameter tailmoment that characterizes the amount of
damaged DNA.
Analysis of hMSC phenotype after LIFT
For characterization of changes in hMSC phenotype, which
might be induced by LIFT, cell surface antigen phenotyping of
Ad-hMSC was performed 4 days after the laser transfer using
flow cytometry. The following cell-surface epitopes were
marked with anti-human antibodies: CD90-PE-Cy5 (Becton
Dickinson, Heidelberg, Germany), CD29-APC, CD44-FITC
(Beckman Coulter, Krefeld, Germany), and CD105-PE (Im-
munokontakt; AMS Biotechnology, Wiesbaden, Germany).
Mouse isotype antibodies served as controls (Becton Dick-
inson, Beckman Coulter). About 10,000 labeled cells were
acquired and analyzed using an FACScan flow cytometer
running with CellQuest-Software (Becton Dickinson).
Statistical analysis
To analyze, if a difference between the mean values of
corresponding sets of measured values of laser printed cells
and controls were real and not only due to statistical varia-
tions, Student’s t-test (a¼ 0.05) was performed with the
program Origin 8 (Origin Lab, Northampton, MA).
In the case of the used skin cell lines, the ‘‘n’’ refers to the
amount of samples in each experiment. The used skin cell
lines have always been one strain (e.g., NIH3T3 and HaCaT),
as these cells are commercially available cell lines. For the
experiments using MSC, the ‘‘n’’ refers to the number of
samples used out of 12 patients (1 sample¼ 1 patient).
Results
Printing of cells
All cells (fibroblasts, keratinocytes, and hMSC) used in
this study were transferred successfully by LIFT. A local
transfer efficiency of over 90% could be reached, considering
the cells in the area wherein laser transfer was performed. In
contrast, the overall efficiency also includes cell losses at the
blade coater and considers coated areas at the edges of the
donor-slide, which are not used for transfer on purpose.
Therefore, the overall efficiency is lower than the local
transfer efficiency.
Different 2D patterns consisting of one or more cell types
were generated. Figure 2 shows a representative immuno-
FIG. 2. Representative immunofluorescence microscopic
image of fibroblasts (NIH3T3; green, stained with carboxy-
fluorescein-diacetate (CFDA)) and keratinocytes (HaCaT; blue,
Hoechst33342) arranged in a chess board pattern by LIFT.
LIFT, laser-induced forward transfer.
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fluorescence microscopic image of fibroblasts (NIH3T3;
green, stained with CFDA) and keratinocytes (HaCaT; blue,
Hoechst33342) arranged in a chess board pattern by LIFT.
The chess board pattern with a total size of 9.69.6mm
consists of four lines per square with a line width of 70mm
and a line spacing of 200 mm. This image (Fig. 2) shows the
possibility of creating specific patterns consisting of two or
even more different cell types, which could precisely be ar-
ranged by LIFT.
Cell survival after LIFT
Survival of cells was determined directly after the transfer.
Compared to nontransferred control cells, 98% 1% (stan-
dard error of the mean [SEM]) of the skin cell lines survived
the transfer. The Live=Dead staining of BM–derived hMSC
(Bm-hMSC) immediately after transfer showed a survival
rate of 90% 10% (SEM) versus control.
Cell proliferation after LIFT
To assess the effect of LIFT on cell growth, we analyzed
the proliferation of the transferred cells in comparison to the
respective control cells over a time period of several days.
Proliferation was measured by two different methods. First,
fibroblasts and keratinocytes were directly counted using a
haemocytometer. Applying this method (with n¼ 24 sam-
ples each date), we could not detect any major differences in
their ability to proliferate after LIFT. Skin cells showed ex-
ponential growth starting on day 1 and continuing up to day
6 with no significant differences compared with the control
cells (Fig. 3a, b). Second, proliferation was tested by mea-
surement of the metabolic activity, which is proportional to
the amount of cells. Using the Celltiter-Blue method for fi-
broblasts and keratinocytes (each n¼ 20), transferred skin
cells also showed nearly exponential cell proliferation
(Fig. 3c), which could already be detected 24 h after LIFT.
Albeit significant differences between transferred and control
cells were measured at day 1 (fibroblasts, keratinocytes) and
two (fibroblasts), the ongoing analysis presented similar
curve gradients without statistical significant difference;
thus, the difference at the beginning seems to be negligible
from the biological point of view.
The proliferation of Bm-hMSC, analyzed by WST-1-assay
(n¼ 7), showed a continuously increasing proliferation
a b
c d
FIG. 3. (a–d) Assessment of proliferation of HaCaT keratinocytes (a, c), NIH3T3 fibroblasts (b, c), and human mesenchymal
stem cells (hMSC) (d), which were printed by LIFT versus nontransferred cells (Control). Proliferation was assessed by cell
counting in a haemocytometer (a, b) and metabolic activity with CellTiter-Blue (c). The water-soluble tetrazolium salt-1 assay
(d) is a colorimetric method in which the dye intensity is proportional to the number of viable cells. Values are given as
means standard error of the mean.
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without significant difference between transferred and non-
transferred hMSC (Fig. 3d) until day 4 after LIFT.
Apoptosis of cells after LIFT
Transferred cells were tested for apoptosis as a parameter
of possible cell death caused by LIFT. Fibroblasts, keratino-
cytes, and Bm-hMSC showed no significant differences in the
fluorescence signal in the analysis of caspase 3=7 activity
between the transferred cells and their respective controls
(Fig. 4, each n¼ 9). This applies for the whole observation
period from 12 h up to 48 h after laser transfer.
DNA damage through LIFT
Genotoxicity was investigated using the comet assay
method. The parameter tailmoment characterizes the
amount of damaged DNA. The results are given as mean of
tailmoment SEM (n¼ 4). At least 1000 cells per treatment
were evaluated. For fibroblasts, keratinocytes, and Bm-
hMSC, it could be shown that the LIFT procedure did not
significantly increase the incidence of DNA damages. As can
be seen in Table 1, the tailmoments of all treatments were
comparable with their controls.
HMSC phenotype
For phenotype characterization of hMSC, surface protein
expression of Ad-hMSC from five donors at passage 2 was
examined by flow cytometry, 4 days after the laser transfer.
Ad-hMSC, similarly to nontransferred control Ad-hMSC,
expressed the typical stem cell marker proteins CD44,
CD105, CD29, and CD90 without statistical significant dif-
ference (Fig. 5). This indicates that LIFT did neither change
the immunophenotype of hMSC nor start the initiation of
differentiation of stem cells after laser transfer.
FIG. 4. Assessment of apoptosis of
fibroblasts (NIH3T3), keratinocytes
(HaCaT), and hMSC, which were printed
by LIFT versus nontransferred cells
(Control). Apoptosis was assessed by
measurement of the activity of caspases
3=7. Values are given as means standard
error of the mean.
Table 1. Analysis of DNA Damage Effects
After Laser-Induced Forward Transfer
of Fibroblasts (NIH3T3), Keratinocytes (HaCaT),
and Human Mesenchymal Stem Cells Demonstrated
by Comet Assay (each n¼ 4)
Control LIFT
NIH3T3 1.81 0.33 1.72 0.43
HaCaT 2.41 0.38 2.31 0.25
HMSC 1.27 0.28 1.32 0.28
At least 1000 cells per treatment were evaluated. The results are
given as average of tailmoment as a marker of DNA damages
standard error of the mean.
LIFT, laser-induced forward transfer; hMSC, human mesenchymal
stem cell.
FIG. 5. Flow cytometric analysis of the phenotype of
hMSC. The hMSC expressed the typical MSC-marker pro-
teins CD44, CD105, CD29, and CD90. No significant differ-
ence in the ratio of expression between transferred cells
and control cells was detected (mean values of %-positive
cells standard error to the total number of cells analyzed).
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Discussion
In the last few years, the ability to print biological material
offered a revolutionary new technique for tissue engineering
and functional genomics. With these printing techniques,
it became possible to create multicellular constructs of arbi-
trary size with micrometer accuracy. The present study
demonstrates LIFT of skin cells as well as hMSC to be a new
promising printing method in tissue engineering. The fol-
lowing major findings have been obtained: (i) LIFT is a fast
and reliable technique for printing living cells in predefined
patterns; (ii) printed cells do not present major differences in
survival, proliferation, apoptosis, and DNA-damage com-
pared with respective control cells; and (iii) LIFT does not
change the phenotype of the transferred hMSC, thus keeping
their high potential for tissue regeneration.
As tissue engineering emerged, it provided many new
therapeutic options in regenerative medicine. Besides all the
advantages, major problems still exist with the preparation
of pure and noncontaminated cells as well as the production
of stable 3D-constructs. For this purpose, LIFT might offer
the technical precondition for the production of complex 3D
tissue-engineered constructs of multiple cell types with high
precision, that is, skin or cardiovascular tissue.
In this context, many different skin substitutes have been
created, varying in their utilization time (temporary, perma-
nent) and composition (dermal, epidermal, both, with or
without cells).23–25 These are already available for clinical use
(e.g., Biobrane, Bertek Pharmaceuticals, Morgantown, WV;
Integra, Integra Life Science, Plainsboro, NJ; Matriderm,
Dr. Suwelack Skin & Health Care, Billerbeck, Germany;
Apligraf, Organogenesis, Canton,MA), offer decreasedheal-
ing time and less pain, and result in an improved cosmetic
outcome.26–28 Regardless, current research still pursues fur-
ther approaches to improve the quality of skin substitutes.
Therefore, LIFT might offer a new procedure for the fast, pre-
cise, and reliable production of a ready-to-use skin equivalent.
The laser printing of fibroblasts, keratinocytes, and hMSC
demonstrated high survival rates as one of the most impor-
tant preconditions of this technique. Additionally, the as-
sessment of cellular proliferation by two different methods
and the possible induction of apoptosis studied by ApoOne
did not present any biological significant changes compared
with the respective control cells, which have not been
transferred by LIFT.
Similarly to the used skin cells, laser transfer of hMSC also
was studied and evaluated for the same parameters. MSC
are found in many adult tissues and represent an attrac-
tive stem cell pool due to their self renewing ability, high
differentiation capacity, and mesodermal differentiation po-
tential.29 Therefore, MSC are thought to regenerate many
human tissues like bone, cartilage, adipose tissue, skin, car-
diomyocytes, and even insulin producing tissue.30 The print-
ing of hMSC with a high survival rate demonstrates LIFT to
be a very promising method for stem cell therapy. We could
also not detect any differences in proliferation and apoptosis
for hMSC. In addition, flow cytometric analysis demon-
strated that LIFT does not induce differentiation of hMSC so
that stem cells could be transferred safely.
In conclusion, the present study proved LIFT to be a
reliable and safe technique for the unharmed computer-
controlled positioning of different cell types. The stan-
dardized and statistical evaluation, as shown here, is an
important precondition for the ongoing research in laser
printed tissue-engineered constructs. Therefore, LIFT is a
promising tool for future applications in the ex vivo genera-
tion of tissue replacements. The 3D printing of skin equiva-
lents for burn patients or the production of cardiac tissue or
even cardiac valves might be potential areas of application.
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ABSTRACT: For the aim of ex vivo engineering of functional
tissue substitutes, Laser-assisted BioPrinting (LaBP) is under
investigation for the arrangement of living cells in prede-
ﬁned patterns. So far three-dimensional (3D) arrangements
of single or two-dimensional (2D) patterning of different
cell types have been presented. It has been shown that cells
are not harmed by the printing procedure. We now dem-
onstrate for the ﬁrst time the 3D arrangement of vital cells by
LaBP as multicellular grafts analogous to native archetype
and the formation of tissue by these cells. For this purpose,
ﬁbroblasts and keratinocytes embedded in collagen were
printed in 3D as a simple example for skin tissue. To study
cell functions and tissue formation process in 3D, different
characteristics, such as cell localisation and proliferation
were investigated. We further analysed the formation of
adhering and gap junctions, which are fundamental for
tissue morphogenesis and cohesion. In this study, it was
demonstrated that LaBP is an outstanding tool for the
generation of multicellular 3D constructs mimicking tissue
functions. These ﬁndings are promising for the realisation of
3D in vitro models and tissue substitutes for many applica-
tions in tissue engineering.
Biotechnol. Bioeng. 2012;109: 1855–1863.
 2012 Wiley Periodicals, Inc.
KEYWORDS: cell printing; bioprinting; laser; 3D tissue
generation; skin
Introduction
One major goal of regenerative medicine is manufacturing
autologous replacement tissue by arranging vital cells in
three-dimensional (3D) patterns mimicking the structure,
characteristics and functionality of natural tissue. Such 3D
cell patterns could also bridge the gap between common cell
culture conditions and animal models, since two-dimen-
sional (2D) cell culture models have signiﬁcant limitations.
It has become obvious (Cukierman et al., 2001, 2002;
Edelman and Keefer, 2005) that cell behaviour differs
dramatically in 3D. This is reﬂected in the complexity and
architecture of the 3D-microenvironment in vivo, consisting
of the extracellular matrix (ECM) and different cell types
arranged in correlation to their speciﬁc function in tissue.
Innovative 3D cell models could provide new insights in
understanding of cell behaviour, tissue functions and
regeneration. These facts point out that reproducible,
controllable and well-deﬁned 3D cell models are a key
challenge for future progress in tissue engineering.
Therefore, the ability to precisely position different cells
in complex 3D patterns is of essential importance.
For this purpose, different techniques are under
investigation (Hon et al., 2008). Since these techniques
are related to printing technology, the terms ‘bioprinting’ or
‘cell printing’ are used. A detailed description of these
techniques has been given by Ringeisen et al. (2006). From
the biological and technical point of view, all these
techniques have to fulﬁll several speciﬁcations: (a) achieve
a high resolution similar to the heterogeneity of natural
tissue (100mm), (b) printing of any desired cell density
and (c) variable viscosities of cell suspensions, (d) controlled
cell patterning and (e) the cell behaviour shall not be
negatively affected by the printing procedure.
Modiﬁed ink-jet printers are used for ejecting small
droplets of a biological material through a small nozzle
(Alper, 2004). Printing of bacteria (Xu et al., 2004), DNA
arrays (Okamoto et al., 2000), protein patterns (Phillippi
et al., 2008) and living cells (Nakamura et al., 2005; Saunders
et al., 2008) has been demonstrated. However, ink-jet
printers are capable to handle cell suspensions only with low
viscosities and low cell densities to avoid shear stress at the
oriﬁce or cell clogging (Born et al., 1992). To overcome these
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cell density limitations, printing of cell aggregates (Mironov
et al., 2009) is now under investigation.
Microdispensing as another approach uses extrusion
mechanisms (Khalil et al., 2005; Lee et al., 2009). The
material is extruded under pressure out of a nozzle with
about 50–1,000mm diameter continuously or in droplets by
switching a microvalve with a suitable frequency. With
larger extrusion nozzle diameters, the disadvantages of the
ink-jet printers (clogging and shear stress) can be avoided
at the expense of resolution (Chang et al., 2008). However,
all these techniques still have the potential for further
development and it is still not sure, which technique will
prevail.
In this study, Laser-assisted BioPrinting (LaBP) by laser-
induced forward transfer is used to arrange cells in 3D
structures, which also has been used for previous studies
(Gruene et al., 2011a,b,c,d; Koch et al., 2010). LaBP is
capable of positioning small volumes (down to a few
hundred femtoliters) of cell suspensions with high resolu-
tion (Barron et al., 2005; Gruene et al., 2011a). Furthermore,
high cell densities (up to 108 cells/mL; Ringeisen et al., 2006)
and hydrogel precursors with any desired viscosity can
be printed. An overview of the different realisations and
denominations of this technique are given by Schiele et al.
(2010).
It has been shown that cells are not harmed by the
printing procedure (Barron et al., 2005; Hopp et al., 2005;
Koch et al., 2010; Othon et al., 2008; Raof et al., 2011). Our
own group has recently demonstrated that the differentia-
tion potential of mesenchymal stem cells printed in grafts
is not inﬂuenced with respect to osteogenic, chondrogenic
(Gruene et al., 2011b) and adipogenic (Gruene et al., 2011c)
differentiation.
Up to now, studies have concentrated on 3D arrange-
ments (Barron et al., 2004; Gruene et al., 2011b; Othon et al.,
2008) of single or 2D patterning of different cell types
(Guillemot et al., 2010; Raof et al., 2011; Schiele et al., 2009).
More complex multicellular 3D constructs generated via
laser printing have not been described in literature. To serve
as tissue substitutes or 3D cell models in the future, vital and
functioning 3D cell constructs are required, which mimic
natural tissue with respect to cell density and distribution of
different cell types and wherein the cells form similar tissue.
Whether LaBP can be used to build multicellular 3D
patterns in natural matrix and whether the generated
constructs are functioning and forming tissue, are the main
focuses of our study.
Tissue formation is guided by intercellular junctions (Ko
et al., 2000). Speciﬁc junctions can be found as cell–cell and
cell–matrix connections in all kinds of tissue, abundantly
in epithelium like the epidermis. Intercellular adherens
junctions (Gumbiner, 1996; Niessen, 2007) are fundamental
for tissue morphogenesis and cohesion. They are composed
mainly of cadherins (calcium-dependent adherent pro-
teins). Gap junctions (Mese et al., 2007; Simon and
Goodenough, 1998) allow intercellular communication by
chemical signals passing through these cell–cell channels.
Gap junctions, consisting of connexins (Cx; Richard, 2000),
are known to play a fundamental role in differentiation, cell
cycle progression and cell survival (Fitzgerald et al., 1994;
Schlie et al., 2010).
Thus, cadherin and Cx localisation followed by gap
junction coupling are good parameters to study tissue
properties. In this work, tissue formation of LaBP-generated
3D constructs was investigated with a focus on cadherins
and Cx-43 (Cx43), which is the main Cx in human skin
(Fitzgerald et al., 1994; Wiszniewski et al., 2000). The
functionality of cell–cell communication via gap junction
coupling was assessed with a dye-transfer, so-called scrape-
loading method (Begandt et al., 2010).
In this study, ﬁbroblasts (murine cell line NIH-3T3) and
keratinocytes (cell line HaCaT from adult human skin)
embedded in collagen were printed layer-by-layer in a 3D
pattern as a simple example for skin tissue. Previously,
we demonstrated that these cell types are not harmed by
the printing procedure (Koch et al., 2010). These well-
established cell lines were also combined in other studies
(Bigelow et al., 2005; Delehedde et al., 2001). In the
cultivation of keratinocytes 3T3 ﬁbroblast cells are widely
used, because they are secreting growth factors favorable
for keratinocytes (Boehnke et al., 2007; Linge, 2004; Schoop
et al., 1999). Collagen was employed as hydrogel, since
it is the main component of ECM in skin, in order to
approximate native skin as far as possible (Wisser and
Steffes, 2003).
Our main focus was the arrangement of these skin cells
under conditions (3D cell pattern, cell density, matrix
material) comparable to native skin tissue for studying the
tissue formation process. Therefore, the printed 3D cell
constructs were analysed after different cultivation times
by histological and immunohistological methods. The
existence of cell–cell channels as an indication of tissue
formation was investigated in vital 3D cell constructs.
Materials and Methods
Materials
Cell culture media and supplements were obtained from
Lonza (Basel, Switzerland). Cell culture ﬂasks and plates
were purchased from TPP-Techno Plastic Products AG
(Trasadingen, Switzerland). Chemicals and antibodies were
purchased from Sigma–Aldrich (Deisenhofen, Germany),
unless otherwise noted.
Cell Lines and Cell Culture
3D tissue formation experiments were performed with
mouse NIH-3T3 Swiss albino ﬁbroblasts (DSMZ
Braunschweig, Germany) and the human immortalised
keratinocyte cell line, HaCaT (DKFZ, Heidelberg,
Germany). NIH-3T3 ﬁbroblasts were cultured in
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Dulbecco’s modiﬁed Eagle’s medium (DMEM) with high
glucose (4.5 g/L) supplemented with 10% foetal bovine
serum (FBS) and 1% antibiotic solution (100U/mL
penicillin, 100mg/mL streptomycin). HaCaT keratinocytes
were expanded in DMEM/Ham’s F12 medium supplemen-
ted with 10% FBS and 1% antibiotic solution. The cells were
cultured in a 378C, 5% CO2 humidiﬁed incubator and fed
every 3 days. Cell passaging was performed with 0.05%
trypsin/0.02% EDTA when the cells were at approximately
80% conﬂuence.
Lentiviral Transduction
HaCaT human keratinocytes were transduced with lentiviral
(pRRL.PPT.SF.FP.pre) or gammaretroviral (pSRS11.SF.FP.
pre) expressing the ﬂuorescent proteins (FP) green
ﬂuorescent protein (GFP) or mCherry. The lentiviral and
gammaretroviral backbones have been previously described
(Schambach et al., 2006a,b). Gammaretroviral and lentiviral
supernatant production was performed as described
in Schambach et al. (2006c). In brief, 293T cells were
transfected with gammaretroviral/lentiviral vector, a gag/pol
helper plasmid, a vesicular stomatitis virus glycoprotein
(VSVg) expression plasmid and a Rev expression plasmid
(the latter only for lentiviral production). 293T cells were
maintained in DMEM supplemented with 10% foetal calf
serum (FCS), 1% antibiotic solution and 2mmol/L
glutamine. Viral titers determined on HT1080 and SC-1
cells by ﬂow cytometry were in the range of 107 IU/ml.
HaCaT and NIH3T3 were transduced using an MOI of 3 to
obtain nearly 100% positive cells containing the ﬂuorescent
marker gene. Transduced cells were used for Figures 1, 2c
and 3f and g.
Laser Printing of Cells
Cells were arranged in 3D patterns via LaBP based on the
principle of laser-induced forward transfer, using the setup
described by Koch et al. (2010). Brieﬂy, the experimental
setup consists of two coplanar glass slides (Fig. 1, top). The
upper one is covered underneath with a laser absorbing
layer (here a 60 nm thin gold layer) and a layer of the cell
containing material to be transferred (here cells embedded
in collagen gel or a mixture of blood plasma and alginate).
Laser pulses are focused through the glass slide into the
absorption layer which is evaporated locally. This generates a
high pressure that propels the subjacent cell compound
towards the lower glass slide. A material sheet, scaffold or a
layer of gel can be positioned on the lower glass slide to print
cells onto or into it. In this study, a sheet of MatridermTM
Figure 1. Top: Sketch of the laser printing setup. The cell–hydrogel compound is propelled forward as a jet by the pressure of a laser-induced vapour bubble. Layer-by-layer a
3D cell pattern is generated. A printed grid structure (top view) of ﬁbroblasts (green) and keratinocytes (red) demonstrates micropatterning capabilities of the laser printing
technique. Bottom: Seven alternating colour-layers of red and green keratinocytes (left; detail right). Each colour-layer consists of four printed sublayers. A histological section was
prepared 18 h after printing. The whole structure has a height of about 2mm and a base area of 10mm 10mm. Scale bars are 500mm. [Color ﬁgure can be seen in the online
version of this article, available at http://wileyonlinelibrary.com/bit]
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Figure 2. Skin mimicking bi-layered construct: 20 layers of murine ﬁbroblasts (NIH-3T3) and 20 layers of human keratinocytes (HaCaT) embedded in collagen were printed
subsequently on a sheet of MatridermTM. Cryostat sections were prepared 10 days after printing, except (c). All scale bars are 50mm. Haematoxylin and eosin staining (a) show all
printed cells in a tissue-like pattern. Immunoperoxidase staining of cytokeratin 14 in reddish-brown (b) depicts keratinocytes in the bi-layered structure while all cell nuclei
(ﬁbroblasts and keratinocytes) are counterstained in light blue with haematoxylin. Image (c) shows a section through the laser printed structure, prepared directly after the printing
procedure, with transduced ﬁbroblasts (red) and keratinocytes (green). In picture (d) the ﬁbroblasts are stained in red (pan-reticular ﬁbroblast), keratinocytes are stained in green
(cytokeratin 14) and cell nuclei are stained in blue (Hoechst 33342). Especially the keratinocytes formed a compact cell organisation. In picture (e) all cell nuclei are stained with
Hoechst 33342 (blue), the proliferating cell nuclei are stained with Ki-67 (red) and ﬁbroblasts are stained in green. Fibroblasts and the keratinocytes above are still vital and
proliferating. Image (f) depicts an anti-laminin staining in green and all cell nuclei in blue (Hoechst 33342). Laminin is a major constituent of the basement membrane in skin.
Figure 3. Qualitative analysis of adherens and gap junction formation essential for tissue function. Fluorescence microscopic images of 3D printed ﬁbroblasts and
keratinocytes: (a) pan-cadherin-staining depicts the adherens junctions consisting of cadherins, which are located between the membranes of neighbouring cells; (b) pan-
cadherin-staining (green) and cell nuclei staining with Hoechst 33342 (blue); (c,d) connexin-43 (Cx43) staining (green) and Hoechst 33342 nuclei staining (blue), connexins are the
constituents of the gap junctions; Picture d shows Cx43 distributed in a scattered, punctate fashion, which is a sign for the formation of gap junctions; (e–g) gap junction coupling
visualised in green with lucifer yellow (e,g) after scrape-loading procedure, the keratinocytes, transfected with mCherry, are depicted in red (f,g). All scale bars are 50mm.
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(Dr. Suwelack Skin & Health Care, Billerbeck, Germany)
was used (Golinski et al., 2009), which is porous and
permeable for cell culture media.
The cell–gel compound is transferred as a jet (Duocastella
et al., 2009; Unger et al., 2011). The transferred volume
depends on the laser absorbing layer and the cell–gel layer as
well as the laser pulse energy and the focused laser spot size.
Volumes in the range of 0.1–1 nL were transferred in this
study.
A Nd:YAG-laser (DIVA II; Thales Laser, Orsay, France)
with 1,064 nm wavelength, approximately 10-ns pulse
duration (FWHM) and 20-Hz repetition rate was applied.
A 60mm achromatic lens focussed the laser pulses into a 45-
mm diameter ablation spot size. Depending on the cell–gel
layer thickness (approx. 60mm) and viscosity, the laser pulse
energy was set between 30 and 60mJ, corresponding to laser
ﬂuences between 1 and 2 J/cm2. In Figure 1, a grid pattern
consisting of green ﬁbroblasts and red keratinocytes
demonstrating the capability of the laser printing technique
is shown.
Generating 3D Cell Structures With Layers of Green and
Red Keratinocytes
To prove the ability of 3D cell arrangement, alternating
layers of HaCaT keratinocytes labelled with GFP (green) and
mCherry (red) were printed. For the printing process
1.5 106 cells were resuspended in 45mL of a hydrogel
composed of 50% 4 (wt.%) alginate and 50% ethylenedia-
minetetraacetic acid (EDTA) human blood plasma.
Subsequently, this cell containing hydrogel was dispersed
on the absorption layer on the upper glass slide with a blade-
coater to form a homogenous layer of approximately 60mm
thickness. Then, the cell-coated glass slide was ﬁxed in a
metal frame and mounted upside-down in the setup for
printing.
The lower glass plate was covered with an initial 60mm
layer of a mixture of 25% 4 (wt.%) alginate and 75% blood
plasma and subsequently wetted with a 0.1M CaCl2 solution
for gelation. Alternating layers of red and green keratino-
cytes were printed onto the lower glass plate. Each colour
layer of cells consisted of four printed sublayers. When the
colour layer was ﬁnished, it was cross-linked with the CaCl2
solution. Altogether seven colour layers with 28 sublayers
were printed. After cultivation submerged for 18 h, vertical
sections were prepared with a scalpel and analysed by
ﬂuorescence microscopy, using an AxioImager A1.m micro-
scope (Carl Zeiss Microimaging, Go¨ttingen, Germany),
equipped with AxioCam ICc1 camera and AxioVision Rel.
4.8 software.
3D Bi-Layered Tissue Formation Experiments With
Collagen Hydrogel
For the transfer of cells by LaBP, type I collagen was isolated
from rat tail tendons as described by Dunn et al. (1991) by a
modiﬁed procedure of Elsdale and Bard (1972). For each
cell–collagen layer a mixture consisting of collagen (3mg/
mL: 66.5% of the total volume), 10 DMEM/Ham’s F12
(10% of the total volume), sodium hydrogencarbonate
(NaHCO3 7.5% for neutralisation and geliﬁcation, 1% of
the total volume) and 1.5 106 cells resuspended in 1
DMEM/Ham’s F12 medium (22.5% of the total volume)
was used. Subsequently, 45mL of the cell containing collagen
gel was dispersed on the absorption layer on the upper glass
slide with a blade-coater to form a homogenous layer of
approximately 60mm thickness. Then the cell-coated glass
slide was ﬁxed in a metal frame and mounted upside-down
in the setup for printing. To create 3D bi-layered cell
constructs composed of ﬁbroblasts and keratinocytes,
20 cell–collagen sublayers of NIH-3T3 ﬁbroblasts were
ﬁrst printed onto a sheet of MatridermTM followed by
20 cell–collagen sublayers of HaCaT keratinocytes. The 3D
cell constructs were further cultivated submerged in
DMEM:Ham’s F12 (3:1, v/v) supplemented with 10%
FBS and 1% antibiotic solution at 378C in a humidiﬁed
atmosphere containing 5% CO2 for 10 days. At the end of
the experiment, the 3D bi-layered cell constructs were
embedded in Tissue-Tek OCT (Science Services, Mu¨nchen,
Germany) and snap frozen in liquid nitrogen and stored
at 808C.
Immunohistochemistry of 3D Bi-Layered Cell Constructs
Immunohistochemical and immunoﬂuorescence staining
of frozen sections (7–10mm) was performed by a two-step
indirect method. Brieﬂy, sections were ﬁxed in 4%
paraformaldehyde for 10min. After blocking with 5%
normal goat serum, sections were incubated overnight at
48C with primary antibodies against keratin 14 (mouse
monoclonal antibody, clone RCK 107, diluted 1:50; Acris
Antibodies, Herford, Germany), ﬁbroblasts (Pan Reticular;
rat monoclonal antibody, clone ER-TR7, diluted 1:100;
Acris Antibodies), Cx43 (rabbit polyclonal antibody, diluted
1:1,000), pan-cadherin (rabbit polyclonal antibody, diluted
1:250), laminin (rabbit polyclonal antibody, diluted 1:250)
and Ki-67 (rabbit polyclonal antibody, diluted 1:50; Acris
Antibodies). Following washing with Dulbecco´s phosphate-
buffered saline (DPBS), sections were incubated for 1 h
at 378C with peroxidase-conjugated or ﬂuorescence-
conjugated secondary antibodies at an appropriate dilution
[horseradish peroxidase-conjugated goat anti-mouse IgG
(Hþ L), diluted 1:100; Dianova, Hamburg, Germany] or
for ﬂuorescence staining with Alexa Fluor
1
488/Alexa Fluor
1
555 F (ab’) 2 fragment goat anti-mouse, anti-rat or anti-
rabbit IgG (Hþ L), diluted 1:500; Invitrogen, Karlsruhe,
Germany). After that, sections were washed and cell nuclei
in the immunoﬂuorescence samples were stained with
10mg/mL Hoechst 33342 (blue ﬂuorescence staining).
Immunostaining with horseradish peroxidase was devel-
oped by incubation with 3-amino-9-ethyl-carbazole sub-
strate in sodium acetate puffer (0.1mol/L, pH 5.2),
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containing hydrogen peroxide, for 30min. Cell nuclei were
counterstained with haematoxylin. Following washing,
sections were mounted in glycergel and analysed by
microscopy. As negative control, primary antibody was
replaced with an irrelevant primary antibody at the same
concentration and of the same isotype. No signiﬁcant
staining was observed in the negative controls. For
histological analysis, cryosections (10mm) were stained
with haematoxylin and eosin (H&E) following standard
protocols.
Analysis of Gap Junction Coupling
Gap junction coupling, as a sign for tissue functions with
respect to intercellular communication, can be estimated
via scrape-loading method (Begandt et al., 2010). The
conﬂuently grown 3D printed cells were scratched and by
this means, the added dye lucifer yellow (LY) could
penetrate into the destroyed cells. As gap junctions are
permeable for LY, the diffusion distance over channel-
connected neighbouring cells correlating with gap junction
coupling can be analysed. Twenty layers of keratinocytes
embedded in collagen were printed on a glass slide and
cultivated for 10 days at 378C (5% CO2). After washing with
PBS, the slides were transferred into a DPBS solution
including 0.25% LY. With the help of a razor blade one
scratch along the whole sample was set. Following 5-min
incubation time, the slides were washed four times with
DPBS for 5min each. At last the cells were ﬁxed by 10-min
incubation in DPBS containing 4% paraformaldehyde
and conserved in DPBS. The diffusion distance of LY was
documented via ﬂuorescence microscopy.
Results
Generation of 3D Structures Consisting of Layers of
Green and Red Keratinocytes
Seven alternating layers of red and green ﬂuorescence
labeled keratinocytes with four sublayers each (28 layers
altogether) can be seen in the histologic cryo-section in
Figure 1. The whole structure has a height of about 2mm
and base area of 10mm 10mm. The red and green layers
can be distinguished clearly; the individual layers do not
intermix with each other.
Fibroblasts and Keratinocytes as a Simple Bi-Layered
3D Skin Structure
On a sheet of MatridermTM 20 layers of NIH-3T3 ﬁbroblast
and subsequently 20 layers of HaCaT keratinocytes were
printed to generate simple 3D skin equivalents with dermis-
and epidermis-like structure. Collagen was used as the
matrix material. After printing, cell structures were
cultivated for 10 days. In Figure 2a, a H&E staining of a
histological section depicts the cells on the MatridermTM
sheet. Cytokeratin 14 staining was used to distinguish the
keratinocytes from the ﬁbroblasts since the former have an
abundant source of keratin, while the latter lacks the
presence of keratin. Also a ﬁbroblast pan-redicular red
ﬂuorescence staining combined with a cytokeratin 14 green
ﬂuorescence staining depicts the printed bi-layered struc-
ture. It can be seen that the ﬁbroblast–collagen compound
penetrates into the pores of the MatridermTM sheet.
However, the cell layers keep strictly separated over the
whole observation period (Fig. 2b and d). The thickness of
the printed structure decreases from 500 to 250mm during
the cultivation time as can be seen by comparing
Figure 2c, taken directly after printing and 2b and d taken
after 10 days in culture. This shrinkage of collagen gel by
cultured ﬁbroblasts is well known in literature (Bellows
et al., 1982).
Post-Printing Cell Proliferation
To examine the vitality in the bi-layered 3D cell structures,
the proliferation of the cells was studied in histologic
sections prepared 10 days after printing. In Figure 2e, a Ki-
67 staining shows the fraction of proliferating cells. The Ki-
67 protein is present in cells during their active cell cycle
phases, but it is absent in resting cells. In all regions
proliferating cells can be found which veriﬁes the vitality of
the printed cells 10 days after printing.
Development of a Basement Membrane
Figure 2f illustrates the formation of a laminin layer between
the ﬁbroblasts and keratinocytes. Outside this layer, the
laminin concentration is very low. Laminins are major
proteins of the basal lamina, which is part of the basement
membrane between epidermis and dermis in natural skin.
Analysis of Adherens Junctions
For tissue morphogenesis and maintenance adherens
junctions mediated by cadherins are crucial, since they
are connecting cells and their cytoskeleton mechanically
with neighbouring cells and the ECM (Niessen, 2007).
Immunostaining with pan-cadherin depicts in Figure 3a
cadherin expression localised in the cell membrane 10 days
after LaBP in all cells. In Figure 3b cadherin and the cell
nuclei of keratinocytes are shown. While adherens junctions
consisting of cadherins are formed extensively between the
keratinocytes they are less between the ﬁbroblasts.
Analysis of Gap Junctions
Tissue functions require intercellular communication over
gap junctions consisting of Cx. Immunostaining of Cx43,
the main Cx in human skin, pointed out that it is expressed
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in all cells and localised within the cell membrane 10 days
after LaBP procedure (Fig. 3c and d). It can be seen in
Figure 3d that Cx43 is distributed in a scattered, punctate
fashion, which is a sign for the formation of gap junctions
(Morritt et al., 2007). Furthermore, the scrape-loading
method proved that the gap junction channels generated by
the cells are functional. The LY dye penetrated from the
destroyed keratinocyte cells into neighbouring cells and
further cells, which is only possible through functional gap
junctions (Fig. 3e–g). The LY in the cells located furthest
away from the scratch went through about 10 cells.
Discussion
Since more than 10 years different printing techniques are
under investigation for applications in tissue engineering. By
means of laser printing it has been shown that vital cells can
be printed unharmed and that stem cells are not affected in
their differentiation potential (Barron et al., 2005; Gruene
et al., 2011b; Hopp et al., 2005; Koch et al., 2010; Othon
et al., 2008; Raof et al., 2011). First 3D patterns have
been presented (Barron et al., 2004; Gruene et al., 2011d;
Othon et al., 2008). However, no printed tissue has been
demonstrated so far.
This study is focused on the generation of 3D multi-
cellular constructs resembling simple skin tissue as their
native archetype. Vital skin cells were printed in 3D patterns,
their vitality and tissue-formation behaviour was examined.
The alternating layers of red and green keratinocytes in
Figure 1, printed with a blood–plasma/alginate mixture,
demonstrate the ability to print 3D cell structures layer-by-
layer, whereby the individual layers do not intermix with
each other. Also, the ﬁbroblasts and keratinocytes in
Figure 2, printed with collagen (the main component of
ECM in skin), did not intermix even after 10 days in culture.
The cells remain in the printed pattern.
We have previously shown that the cells are not harmed
by our printing procedure (Gruene et al., 2011b; Koch et al.,
2010). Here, it was investigated if the printed cells kept their
vitality also in the 3D structure. Therefore, proliferation
after 10 days under 3D culture conditions was visualised by
immunohistology. The Ki-67 staining and the Hoechst
33342 staining in Figure 2e showed that cells—ﬁbroblasts
and keratinocytes—in all areas of the printed construct
proliferated and were vital.
The build-up of a basal lamina shown in Figure 2f is
already a sign of the formation of skin tissue. To substantiate
the tissue formation by laser printed cells, existence of cell–
cell junctions was investigated. Adherens junctions assure
the cohesion of tissue while gap junctions allow cell–cell
communication (Ko et al., 2000). Therefore, the existence of
these junctions and the functionality of the gap junctions
were studied.
Tissue formation requires the adherence of cells to other
cells and the ECM. Therefore, intercellular adhesion
mediated by cadherin is an appropriate ﬁrst measure for
the tissue formation process. Figure 3a and b depict the
extensive formation of intercellular adherens junctions
between keratinocytes and their minor formation between
ﬁbroblasts. This difference is expected, since keratinocytes
form the dermal epithelium (epidermis), where typically a
higher level of junctions can be found (Niessen, 2007).
Since gap junction channels enable the direct exchange of
metabolites, hormones, electric signals and second messen-
gers needed for physiological activities (Mese et al., 2007),
they are good candidates for analysis of tissue formation and
its functionality. Gap junctions are associated hemi-
channels built out of tissue-speciﬁc Cx located within the
cell membrane of neighbouring cells. To get a ﬁrst insight
whether gap junction channels are formed, analysis of Cx
localisation (Morritt et al., 2007) is the primary step—hence
a deﬁcit of Cx localisation indicates a loss of function of gap
junctions. Figure 3c and d reveal that Cx43, the main Cx in
human skin, is still expressed in the membrane of the 3D
printed cells. This result indicates that LaBP procedure and
3D cell arrangement does not affect Cx43 localisation
providing gap junction formation. The Cx43 distribution in
a scattered, punctate fashion is thereby a sign for the
formation of gap junctions (Morritt et al., 2007).
In a second step, gap junction coupling via dye-transfer
following scrape-loading method was documented. As the
used dye LY can only diffuse via gap junctions, it cannot only
be analysed whether the channels are formed in general, but
also whether they are functional. In Figure 3e–g it is shown
that the dye penetrated into parallel and vertical directions,
meaning that the neighbouring cells in 3D setups build
the channels and are connected in all 3D. Therefore, it can be
concluded that the 3D printed skin grafts mimic tissue-
speciﬁc functions with respect to gap junctions. Here, future
research could concentrate on molecular procedure to
quantify more detailed Cx expression levels or electrophys-
iological analysis with focus on gap junction conductance
and second messenger exchange.
We demonstrated the 3D arrangement of vital cells by
laser-printing as multicellular grafts analogous to native skin
archetype. It could also be shown that these printed skin cells
evolve intercellular adhesion and communication via
adherens and gap junctions, which proves the tissue
formation. To the best of our knowledge, these results are
unique and have never been demonstrated so far.
The aim of the present study was to demonstrate that
the laser printed cells are capable to generate real tissue.
The applied tissue model, skin, has a layered conﬁguration
(dermis and epidermis), which was reproduced by printing
ﬁbroblasts and keratinocytes. This is an important step for
future experiments where by integration of additional cell
types, the printed cell construct complexity will be increased.
For example, by printing endothelial cells we plan to
generate capillaries inside the 3D structures. To illustrate
further potential of our technique, a printed grid structure is
shown in Figure 1.
The presented skin tissue constructs can serve as 3D cell-
based models to study ex vivo cell and tissue functions or
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milieu-/disease-dependent mechanisms. By integrating
further cell types (e.g. melanocytes, Schwann cells, hair
follicle cells) into the printed cell construct, the behaviour of
these cells in a 3D in vitro microenvironment similar to their
natural one can be analysed. Additionally, the generated
tissue constructs might be used for in vivo testing by
implanting them into animal models. The MatridermTM
substrates possess the required mechanical strength for
suturing.
The tissue formation process needs also to be studied with
different printed ECM and cell types to mimic other tissues,
since our ﬁndings are demonstrated only for skin cells so far.
Furthermore, with additional printing of endothelial cells
also microvascularisation processes might be investigated.
The here generated skin tissue with the collagen matrix is
thin enough to supply the cells with oxygen and nutrients by
diffusion, but the integration of a vascular network is crucial
for printing bigger tissue grafts to assure the survival of the
printed cells.
The LaBP technique offers promising potential for the
future generation of different tissue engineered autologous
grafts including skin substitutes. To cope with the challenge
of producing tissue with an integrated vascular network, the
LaBP technique might even enable the long-term goal of
printing complete organs.
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1. Introduction
The therapy of burns still displays a complex and challenging
field due to the many difficulties arising from large and deep
burns, i.e. the high risk of infections, the destruction of both
epidermis and dermis and the only limited availability of
autologous split-thickness skin grafts and keratinocytes for
wound coverage. This leads to the need of skin substitutes for
temporary or permanent wound closure. Several skin sub-
stitutes have already been used for years in the clinical
application [1–3] but full success in burn regeneration has not
been achieved yet. Although the available skin substitutes
fulfil their very important goal of wound coverage, none is able
to substitute all of the physiological functions of native skin on
the functional and the aesthetic level.
Here, tissue engineered skin might be of a great benefit to
these patients and many approaches are being followed to
improve tissue engineered skin substitutes, e.g. by adding
different cell types or growth factors. Nevertheless, following
in vitro analysis, these skin constructs need to be tested in vivo
before using them in humans. For this purpose the mouse
displays one of the most ideal animal models due to several
advantages, i.e. the easy and cheap breeding in large numbers,
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plastic surgery. The outcome is generally not satisfactory, neither from the functional nor
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of skin substitutes in vivo. Dermal skin constructs consisting of matriderm1 covered with a
collagen type I gel were inserted into full thickness skin wounds in the skin fold chambers.
The skin substitutes integrated well into the adjacent skin and got epithelialized from the
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gain split thickness skin grafts. Further advantage of the chambers is the lack of wound
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the known genetic background and the availability of different
knock-out strains. For testing of new skin substitutes, the
constructs can be inserted into full thickness skin wounds,
mostly on the back of mice. This animal model can be
performed on a standardized manner and already showed to
be valid in the analysis of cells cultured in a bioreactor in
contrast to cells cultured in normal cell culture [4,5], to
examine the vascularization of transplants [6,7], to test the
effect of mesenchymal cells and growth factors in addition to
the skin constructs [8], to analyse constructs enriched with
Schwann cells to enhance nerve migration [9] or constructs
containing sweat gland cells [10], to assess constructs
containing bone marrow mesenchymal stem cells [11], or to
establish a humanized mouse model for psoriasis [12].
A disadvantage of the above-mentioned method, however,
is the contraction of the wound due to the healing mechanism
of rodents [13]. A solution may be the use of the dorsal skin fold
chamber. In this case, the skin is fixed in a titanium frame
avoiding tissue contraction [14]. Also, in the skin fold chamber
the skin constructs can be monitored continuously without
potential disturbances by wound dressing changes.
Here, we adapted the dorsal skin fold chamber for analysis
of a tissue engineered skin construct. Therefore, we chose to
insert a construct comprising a collagen type I gel on top of a
matriderm1 layer into a full thickness skin wound inside the
skin fold chamber and analysed it for 11 days. Macroscopic
changes were easily be assessed throughout the duration of
the experiments with the chambers. Additionally, the in-
growth of the constructs as well as the migration of cells and
possible neovascularization are parameters which can simply
be analysed after the completion of the experiments.
2. Material und methods
2.1. Production of the transplant
Small round pieces of matriderm1 sheet (Dr. Suwelack Skin &
Health Care AG, Billerbeck, Germany), a collagen elastin matrix,
were generated by using a biopsy punch of 6 mm diameter. After
disinfection with isopropanol and washing with PBS, collagen
type I gel was added on top of the matriderm1 which was
isolated from the tails of Sprague-Dawley rats (source: local
animal care facility) as follows: The tails were washed with soap,
cleaned with ethanol and each time four tendon bundles were
prepared. The tendons were washed with NaCl 1% (J.T. Baker,
Deventer, The Netherlands) and distilled water and subse-
quently incubated with acetic acid 3% (v/v) (J.T. Baker) at 4 8C
over night. The solution was filtered through sterile gauze and
centrifuged at 10,000  g at 4 8C for 2 h. The supernatant was
mixed dropwise with NaCl 30% (w/v) and centrifuged at 3300  g
at 4 8C for 30 min. The supernatant was discarded and the
obtained pellet was resuspended in 5% (w/v) NaCl plus 0.6%
acetic acid and centrifuged at 3300  g for 10 min. The
supernatant was discarded and the pellet resuspended in NaCl
5% (w/v) plus 0.6% acetic acid (v/v). This step was repeated with a
final volume of 250 ml. The solution was dialysed against 5 l
hydrochloric acid (pH 3, Roth, Karlsruhe, Germany) at 4 8C for
8 h, repeating the dialysis step five times. The solution
was sterilized by addition and evaporation of chloroform
(Sigma–Aldrich, Steinheim, Germany). The concentration of
the obtained collagen was determined with absorbance spec-
troscopy at 280 nm with the mass extinction coefficient
em = 0.9 ml mg
1 cm1. The purity of the collagen was deter-
mined by electrophoretic separation with SDS-PAGE. To
produce gels for testing the skin fold chamber, a mixture
consisting of the collagen (66.5% of the total volume), 10
DMEM/Ham’s F12 (10% of the total volume), sodium-hydro-
gencarbonate (NaHCO3 7.5% for neutralization and gelification,
1% of the total volume) and 1 DMEM/Ham’s F12 medium (22.5%
of the total volume) was used and gelified at 37 8C for 30 min.
2.2. Skin fold chamber
The dorsal skin fold chamber was used as a model for wound
healing, according to Sorg et al. [14,15]. During anaesthesia with
isoflurane the dorsal skin chamber was implanted, resulting in
an extended double layer of back skin between the two titanium
frames. A full thickness wound was created after marking a
circle of 6 mm diameter by removing the complete skin inside
the circle, down to the panniculus carnosus. The opposite side
remained intact, still comprising the epidermis, dermis and the
panniculus carnosus (Fig. 1). The respective skin constructs of
6 mm diameter were transferred into the wound with forceps
and the wound area was covered with a glass coverslip,
integrated into one of the frames (Figs. 1 and 2). After 11 days the
mice were sacrificed. The constructs surrounded by normal
skin were removed and saved for histological analyses (Fig. 1).
2.3. Animals
All animal experiments were evaluated and approved by the
standinglocal animal care committee and theHannoverMedical
School. The animals (5 male BALB/c-Nude mice, 8 weeks) were
purchased from Charles River and kept in the local animal care
facility with a day-night cycle of 12 h each, according to the
institution guidelines. They received standardized food and
water ad libitum. Animals were used for the experiments when
they were at least 12 weeks old and weighed at least 25 g.
2.4. Histology
After fixation of the samples in 4% paraformaldehyde and
subsequent embedding in paraffin, sections of 5 mm thickness
were cut and haematoxylin/eosin and Masson’s trichrome
stainings were carried out following standard procedures. In
the Masson’s trichrome staining muscles are stained in red,
connective tissue (containing collagen) appears green and cell
nuclei are marked in black whereas cell nuclei appear dark
blue in the haematoxylin/eosin staining, accompanied by pink
cytoplasm.
2.5. Immunofluorescence
In order to detect blood vessels, deparaffinised and rehydrated
paraffin sections were stained with anti actin smooth
muscle (1:100, Millipore, Schwalbach, Germany) as first
antibody followed by Alexa Fluor 488 chicken anti mouse
(1:1000, Invitrogen, Darmstadt, Germany) as secondary anti-
body following standard protocols. After removing the
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paraffin, the sections were treated with 0.1% Triton X 100
(Roth) in PBS (PAA, Pasching, Austria) for 4 min and subse-
quently blocked with 2% FBS (Biochrom, Berlin, Germany) in
PBS for 30 min at room temperature. Both antibodies were
incubated for 1 hour at 37 8C using 1% FBS in PBS. Signals were
detected with a fluorescent microscope (Zeiss) equipped with
the appropriate barrier filters.
3. Results
3.1. Surgery of the mice
In order to establish skin fold chambers as a means for
investigation of tissue engineered skin constructs, we
implanted skin fold chambers onto five mice. All of them
survived the procedure and no problems occurred during the
surgical procedure. The mice tolerated the chambers well and
showed no signs of discomfort or changes in sleeping or
feeding habits.
Constructs consisting of matriderm1 with collagen type I
gel on top were inserted into full thickness wounds in one half
of the skin fold held by the skin fold chambers, while the
opposite skin remained intact (for details see material and
methods and Fig. 1). After introducing the constructs into the
wounds, the borders of the constructs and the surrounding
skin laid adjacent to each other (Fig. 2, left). We chose to
analyse the described constructs because matriderm1 plays
an important role in burn or other wound treatment. Here, it
serves as a carrier matrix to support the collagen, and in the
long term may also support different cells types.
3.2. Macroscopic observations
Constructs were observed daily over a time period of 11 days.
The transplants approximately kept their round form and at the
Fig. 1 – Cross section of the employed dorsal skin fold chamber in mice. The back skin of the mouse is pulled up and fixed by
the chambers forming a sandwich like structure. In one side, a round full thickness wound is prepared into the skin and
filled with a construct comprising collagen gel type I on top of matridermW. The chamber is closed with a cover glass.
Fig. 2 – Pictures of a construct inserted into the wound directly after the operation (left) and on day 11 (right). The constructs
contain collagen type I on top of matridermW and fill the whole full thickness skin wounds.
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end of the observation period the borders of the constructs
seemed to be connected to the skin of the mice (Fig. 2, right).
Meanwhile, the surface of the constructs tarnished increasingly
during the course of time. After 11 days the tissue surrounding
the skin substitute was still alive showing no inflammatory or
necrotic processes. No contraction of the wounds could be
detected (Fig. 2).
3.3. Histological observations
To assess the processes involved in the integration of the
constructs, histological stainings were conducted (haematox-
ylin/eosin, Masson’s trichrome). All constructs were well
received in the wound beds and no gaps could be observed
between the constructs and the surrounding skin (Fig. 3a and
4c). On the contrary, at the borders of the constructs, cells from
the mouse skin started to grow onto the constructs. Single cells
were also observed in the matriderm1 layer and in the collagen.
On the surface of the matriderm1 keratinocytes migrated from
the wound edges towards the middle of the constructs (Fig. 3b),
but the centre of the surface remained free of cells (Figs. 3 and 4).
There was no complete epidermis present on the matriderm1.
In contrast, the inner part of the matriderm1 was completely
colonized by fibroblasts (Figs. 3 and 4).
After 11 days, the trichrome staining clearly showed
collagen present on the surface of the matriderm1 (Fig. 4b
and d), leading to the conclusion that the collagen gel placed
onto the matriderm1 remained stable over the full observa-
tion period and was not degraded.
Also, on the histological level no contractions of the wound
beds could be observed (Figs. 3 and 4). The intact skin opposite
the wounds remained relaxed and showed all characteristics
of normal skin.
To assess the formation of new blood vessels, the
histological sections were stained with anti alpha smooth
muscle actin antibody (Fig. 5). Several small and large blood
vessels were present in the normal mouse skin and especially
between the constructs and the opposite normal skin (Fig. 4a
and 5). In contrast, in the matriderm1 erythrocytes could be
observed, but no blood vessels. This is probably due to
bleeding during the surgical process.
4. Discussion
In our study we concentrated on the establishment of the
dorsal skin fold chamber for the investigation of tissue
engineered skin constructs. The skin fold chamber has already
been used for many different purposes, e.g. in wound healing,
angiogenesis, cancer, trauma research [14–21] and the
evaluation of revascularization and angiogenesis of skin
grafts [22,23]. But to our knowledge it has not been used for
the testing of tissue engineered skin substitutes before.
A very important advantage of the skin fold chamber is the
lack of wound contraction. In the chambers, the skin is safely
secured by stitches to the frames and is therefore not able to
close a wound by contraction via myofibroblasts [14] or the
panniculus carnosus. A contraction leads to the reduction of
the wound area and as such to an undesired sideward
pressure onto the tissue engineered construct. Many skin
substitutes have been tested by their integration into a normal
full thickness wound onto the dorso-lateral region of the
mouse [24–27], where a contraction can be seen. The
avoidance of contraction is very important for the evaluation
of the skin substitute as a major contraction of the wound is
very typical for rodents but not for humans.
Additionally, in experiments with the chambers no need
for wound dressings arise. This makes the experiments very
easy to be carried out and reduces the failure rate of
experiments due to problems with wound dressings and the
respective dressing changes. This comprises the possible
exsiccation of the wounds as well as the destruction or loss of
Fig. 3 – Histological cross sections stained with haematoxylin/eosin. An overview of a construct embedded in the
surrounding skin is shown (A) as well as a detailed view of the keratinocytes (asterisks) migrating from the border regions
onto the construct (B).
b u r n s 3 9 ( 2 0 1 3 ) 8 2 – 8 8 85
59
Author's personal copy
wound dressings due to the manipulation and removal by the
mice themselves. Also, fixing the wound dressing neither too
loosely, and as such risking the loss of the dressing, needs a lot
of experience and care. The same holds true for fixing the
dressings too tight, which could result in restriction of
breathing as well as increased abdominal pressure.
In our experiments, the constructs were well received in
the mice and fibroblasts migrated into the matriderm1 from
below. Additionally, keratinocytes started to migrate from the
edges of the skin over the matriderm1, but did not suffice to
form a complete epithelium within the chosen time frame of
11 days. This shows the integration of the skin substitute into
the mouse skin, which is necessary for a skin substitute.
Nevertheless, the time period was too short to form a new
epidermis. Therefore, the next step would be to test a skin
substitute already containing layers of fibroblasts and kera-
tinocytes embedded in collagen on top of the matriderm1.
Furthermore, the fact that no necrosis could be detected
is an additional sign for the acceptance of the construct by
the mouse. However, no new vessel formation could be seen
after 11 days. In studies comparing the vascularization rates
of matriderm1 and integra1, both kinds of matrices showed
CD31 staining throughout the depth of the matrix after
2 and 3 weeks, respectively, in a rat model [28,29], but no
shorter time points were described. In contrast, at least
the border zones of matriderm1 were vascularised after
10 days in a mouse model assessing the effect of low-
pressure plasma treatment on the neovascularization of
matriderm1 [30].
In our study we show that the dorsal skin fold chamber is
an appropriate tool to assess the behaviour of tissue
engineered skin substitutes in vivo. The presented model
is suited for cell-free and cell-seeded constructs, which is
important for the testing of tissue engineered biomaterial. It
offers the possibility to analyse and evaluate the skin
constructs macroscopically as well as on the microscopic
level [15,14]. Due to the transparent glass slide, the skin
constructs can be monitored continuously without the need
to change wound dressings [31]. The latter is especially
advantageous for the animals as the animal stress response
is massively reduced. On basis of the histological specimen,
the integration of the skin constructs and the distribution of
the cells in and on a matriderm1 carrier can be shown by
histological stainings. Also, the presence of collagen depo-
sition can be determined by Masson’s trichrome staining.
This is important because collagen type I is a major
Fig. 4 – Histological cross sections stained with Masson’s trichrome. The detailed view (A) shows one large and several small
blood vessels (arrows) between the construct and the opposite skin. Many cells are seen in the matridermW (m), but only
few cells are present in the normal skin (n). In the border regions, the constructs and the adjacent normal skin are firmly
connected (C) and some keratinocytes (filled asterisk) of the skin start to migrate onto the matridermW. The collagen gel
(empty asterisks) is still present after 11 days (B and D).
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component of the dermis. Additionally, immunofluores-
cence offers the possibility to detect any blood vessels in the
constructs. If available, also intravital microscopy can be
applied to assess the vascularization of the skin constructs
by time.
A skin substitute for burn patients needs to fulfil several
criteria, among others the easy handling of the construct, the
presence of a stable epithelium and the successful vasculari-
zation of the skin substitute. The first criterion is met by the
use of matriderm1 as a carrier matrix, which is already widely
used in clinical applications. The other two criteria will be
subject of further research and the here presented technique
is as further contribution to the successful assessment of
newly developed skin substitutes.
The second criterion can be met by the integration of
keratinocytes into the skin substitute as a second step. Even
further cells, such as fibroblasts or endothelial cells (to meet
the third criterion) can be integrated and analysed. The long-
term goal of many research groups is the development of a
skin substitute for burn patients, which exhibits a structure
close to real skin. This includes the presence of e.g.
melanocytes and hair follicles for cosmetic improvement or
the inclusion of perspiratory glands for the ability to control
body temperature via sweat. Still, we have not reached our
goal yet, but the here presented technique is a further
contribution to the successful assessment of newly developed
skin substitutes.
5. Conclusion
The use of the dorsal skin fold chamber in mice offers many
possibilities in research. During the observation period the
transplanted matriderm1/collagen skin construct integrated
well into the surrounding tissue and no harmful effects
occurred. Infiltration of single host cells indicates that the
constructs are well-received in the wound bed while interfer-
ence of transplanted cells with host cells has not to be feared.
Due to the fact that the chamber avoids contraction of the
wound area, it is a good model for wound research in rodents.
Also, it helps to prevent difficulties connected to wound
dressings. Therefore, it is an adequate and useful tool for the
analysis of tissue engineered skin substitutes.
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Abstract
Tissue engineering plays an important role in the production of skin equivalents for the therapy of chronic and especially
burn wounds. Actually, there exists no (cellularized) skin equivalent which might be able to satisfactorily mimic native skin.
Here, we utilized a laser-assisted bioprinting (LaBP) technique to create a fully cellularized skin substitute. The unique
feature of LaBP is the possibility to position different cell types in an exact three-dimensional (3D) spatial pattern. For the
creation of the skin substitutes, we positioned fibroblasts and keratinocytes on top of a stabilizing matrix (MatridermH).
These skin constructs were subsequently tested in vivo, employing the dorsal skin fold chamber in nude mice. The
transplants were placed into full-thickness skin wounds and were fully connected to the surrounding tissue when explanted
after 11 days. The printed keratinocytes formed a multi-layered epidermis with beginning differentiation and stratum
corneum. Proliferation of the keratinocytes was mainly detected in the suprabasal layers. In vitro controls, which were
cultivated at the air-liquid-interface, also exhibited proliferative cells, but they were rather located in the whole epidermis. E-
cadherin as a hint for adherens junctions and therefore tissue formation could be found in the epidermis in vivo as well as
in vitro. In both conditions, the printed fibroblasts partly stayed on top of the underlying MatridermH where they produced
collagen, while part of them migrated into the MatridermH. In the mice, some blood vessels could be found to grow from
the wound bed and the wound edges in direction of the printed cells. In conclusion, we could show the successful 3D
printing of a cell construct via LaBP and the subsequent tissue formation in vivo. These findings represent the prerequisite
for the creation of a complex tissue like skin, consisting of different cell types in an intricate 3D pattern.
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Introduction
Major burn injuries often prove difficult in therapy due to their
complexity, the high risk of infection, the large area which might
be affected and the potential destruction of deeper skin layers
including the dermis. Often, the availability of autologous split-
thickness skin grafts and keratinocytes for wound coverage is
limited, especially in case of large burned areas. Therefore, the
need of skin substitutes for temporary or permanent wound
coverage is high. Several skin substitutes like IntegraH and
MatridermH are already employed in the clinical application,
being complemented by the use of autologous split-thickness skin
grafts [1–3]. While IntegraH serves to prepare the wound bed in
preparation for transplantation with autologous split-thickness skin
three weeks later, MatridermH is used in a single step procedure
and must be covered immediately. Nevertheless, full success in
burn wound regeneration has not been reached yet, neither under
functional nor under aesthetic aspects. In nearly every case of
treating large and deep burn injuries discolouring or scarring
remains, the latter leading to undesirable contractions. Also,
neither hair follicles nor sebaceous and perspiratory glands can be
regenerated.
Tissue engineering promises to have high potential in the
production of new skin. In this context, it remains a challenge to
create a precise and complex new tissue comprising several cell
types which are arranged in a specific 3D pattern. Furthermore,
the different tissue functions strongly depend on its specific
structure and on the cells which are influenced by their distinct
microenvironment [4]. For example, the formation of vessels in a
skin equivalent cultivated in vitro is thought to be dependent on the
direct interaction of endothelial cells with fibroblasts and their
secreted extracellular matrix proteins and growth factors [5].
Bioreactors are used for the in vitro cultivation of complex tissues
offering the possibility to mimic and control the desired
microenvironment [6].
One solution for the problem of creating complex 3D tissues
might be the use of LaBP. It offers the possibility to produce
specific high resolution two-dimensional (2D) as well as 3D
patterns, incorporating different cell types like human osteosarco-
ma and mouse endothelial cells [7], human osteoprogenitor cells
[8], rodent olfactory ensheathing cells [9], human endothelial cells
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[10] and human adipose derived mesenchymal stem cells which
can subsequently be differentiated to fat [11] as well as bone and
cartilage [12]. Cells – including rat Schwann and astroglial cells,
pig lens epithelial cells [13], Chinese hamster ovarian cells, human
osteoblasts [14], murine embryonal carcinoma cells [15], and
fibroblasts and kerationcytes [16] – survive the transfer without
damage and alteration of cell phenotype. This represents a major
prerequisite for the use of LaBP in tissue engineering. Commonly,
also the terms cell printing or simply bioprinting are used. In
advance of the in vivo testing of the here produced skin substitutes
we could already show tissue formation and functional cell-cell
contacts in corresponding 3D tissue constructs in vitro [17].
In this study, via the use of LaBP, we created a multi-layered,
fully cellularized skin equivalent for the future treatment of burn
patients. The transplanted skin equivalent was tested in vivo for its
ability to form tissue as well as cellular behaviour of the printed
cells, the differentiation of the keratinocytes and potential
neovascularisation using the dorsal skin fold chamber in mice. In
vitro controls supplemented the in vivo experiments.
Materials and Methods
Cell Culture
NIH3T3 fibroblasts (DSMZ, Braunschweig, Germany) and
HaCaT keratinocytes (DKFZ, Heidelberg, Germany) have previ-
ously been labelled by stable transduction with lentiviral or
gammaretroviral vectors encoding for either eGFP or mCherry
[17]. In the following the four resulting cell lines are named
accordingly: NIH3T3-eGFP, NIH3T3-mCherry, HaCaT-eGFP
and HaCaT-mCherry. Fibroblasts were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) with high glucose (4.5 g/L)
(PAA, Pasching, Austria) supplemented with 10% fetal bovine
serum (FBS) (Biochrom, Berlin, Germany), 1% of 100 mM sodium
pyruvate (Biochrom), and 1% of penicillin/streptomycin (Bio-
chrom) whereas keratinocytes were grown with DMEM/Ham’s
F12 medium (PAA) supplemented with 10% FBS and 1% of
penicillin/streptomycin.
Cell Transfer and Production of the Transplant
Cells were arranged in 3D skin constructs using LaBP (as
previously described in [16] [18–19]). Briefly, the setup consists of
two co-planar glass slides. The upper one is coated with a thin
layer of laser absorbing material (here 60 nm of gold) and a layer
of biomaterial to be transferred (here 60 mm of cell containing
collagen). This glass slide is mounted upside-down above a second
(receiver) glass slide. The laser pulses are focused through the
upper glass slide into the laser absorbing layer, which is evaporated
locally. The vapor pressure propels a small amount of the
subjacent biomaterial towards the receiver glass slide. By moving
the glass slides relative to each other, arbitrary patterns of
biomaterial can be produced. By repeating this procedure layer-
by-layer also 3D patterns can be generated.
For the here presented skin substitutes the cells were trypsinized
and centrifuged at 400 g. A pellet containing 1.5 million cells was
resuspended in a mixture of 37 ml collagen (Collagen Type I, Rat
Tail, BD Biosciences, Bedford, MA, USA), 5 ml phosphate
buffered saline (106 PBS, Biochrom) and 0.8560.5 ml sodium
hydroxide (1N NaOH, Sigma-Aldrich) for neutralization
(pH=7.160.3) prior to the transfer. For the skin substitutes 20
layers of fibroblast-containing collagen and 20 layers of keratino-
cyte-containing collagen were printed subsequently onto a sheet of
MatridermH (2.3 cm62.3 cm, Dr. Suwelack Skin & Health Care,
Billerbeck, Germay), used as a stabilization matrix.
The printed cells were kept in the incubator under submerged
conditions over night. The next day (defined as day 0), nine round
pieces (diameter 6.0 mm) were removed from the large construct
with a biopsy punch, three of which were implanted into the skin
fold chambers in vivo (one per mouse). As four independent
printing processes were conducted, altogether 12 animals were
used. The remaining six pieces of each printing process served as
in vitro controls. Two of them were directly fixed on day 0 to depict
the situation at the beginning of the experiments, whereas the
remaining four pieces were raised to the air-liquid-interface. In vitro
controls were then fixed on days 5 and 11 (duplicates per time
point) and in vivo specimen on day 11.
Cultivation of Constructs in vitro
Constructs were raised to the air-liquid-interface and cultivated
with differentiation medium on top of plastic platforms. The latter
consisted of cell strainers (BD Biosciences, Bedford, MA, USA)
turned upside down. The medium was composed of DMEM high
glucose medium (PAA) mixed with the same amount of DMEM/
Figure 1. Scheme of the utilised dorsal skin fold chambers in mice. The chambers are attached to the back skin of the mice. The printed skin
construct consisting of 20 layers of fibroblasts and 20 layers of keratinocytes on top of MatridermH is placed into a round full-thickness wound in the
mouse skin, while the opposite side remains intact. To close the chamber a cover glass is used.
doi:10.1371/journal.pone.0057741.g001
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Ham’s F12 medium (PAA), supplemented with 1% FBS, 1%
penicillin/streptomycin, 1027 mM isoprenaline hydrochloride
(Sigma-Aldrich, Steinheim, Germany), 1027 mM hydrocortisone
(Sigma-Aldrich) and 1027 mM insulin (insulin bovine pancreas,
Sigma-Aldrich). The resulting calcium chloride concentration of
the culture medium is 158.3 mg/L.
Animals and Ethics Statement
All animal experiments were evaluated and approved by the
responsible animal care committee (Nds. Landesamt fu¨r Ver-
braucherschutz und Lebensmittelsicherheit) and the Hannover
Medical School (Institut fu¨r Versuchstierkunde). The animals
(male BALB/c-Nude mice, 8 weeks) were purchased from Charles
River and kept in the local animal care facility according to the
institution guidelines. They received standardized food and water,
living with a day-night cycle of 12 hours each. Animals were used
for the experiments when they were at least 12 weeks old.
Skin Fold Chamber
The dorsal skin fold chamber was used for the evaluation of
tissue engineered skin in vivo as published previously [20]. The skin
constructs were placed into full-thickness wounds, while the skin
on the other side of the chamber remained intact. All surgery was
performed under isoflurane anesthesia, and all efforts were made
to minimize suffering. The mice were sacrificed on day 11 after
implantation, preparing the constructs surrounded by normal skin
for histological analyses (Figure 1). Analogous constructs - without
cells - have already been assessed in vivo [20] and are used as a
comparison in this study.
Histology
Samples were fixed in 4% paraformaldehyde, embedded in
paraffin and subsequently cut to sections of 5 mm thickness.
Masson’s trichrome stainings were conducted following standard
procedures.
Immunohistochemistry
In order to detect the presence of e-cadherin, collagen IV,
cytokeratin 14 and Ki67, immunohistochemistry was carried out.
For Ki67 (Thermo Fisher, RM9106_S0, 1:200) and e-cadherin
staining (Santa Cruz, SC 7870, 1:300) the deparaffinised and
rehydrated paraffin sections were incubated in a 99uC heated
water bath for 25 min (Ki67) and 15 min (e-cadherin), respec-
tively, before blocking. For cytokeratin 14 (Biozol, DBB-DB099-1,
1:300) and collagen IV (Abcam, Ab6586, 1:2000) stainings the
sections were incubated in a 37uC warm water bath for 10 min,
using 100 ml 0.2 N HCl solution with 100 mg pepsin. All sections
were blocked with 2% FBS in PBS at room temperature for
30 min, followed by incubation with first antibody in 1% FBS in
PBS at 4uC over night. After washing with PBS for all but the
collagen IV staining a goat anti rabbit secondary antibody (Sigma-
Aldrich, A3687, 1:1000) coupled to an alkaline phosphatase was
employed. The samples were incubated at 37uC for 1 h. As a
substrate nitro-blue tetrazolium-5-bromo-4-chloro-3’-indolypho-
sphate (Roche, Mannheim, Germany) was used. In case of the
collagen IV primary antibody, a biotin coupled secondary anti
rabbit antibody (Dako, E0432, 1:400) was used for 90 min at room
temperature. Subsequently, the Vectastain ABC Kit (Vector
Laboratories, Peroxidase Standard PK-4000) was employed for
60 min at room temperature to enhance the signal. The latter was
then visualised with diaminobenzidine tetrahydro chloride
(ICN98068). Staining of all antibodies was detected with a light
microscope (Olympus).
Results
Operations and Macroscopic Evaluation
To evaluate skin constructs in vivo generated via LaBP, we
printed 20 layers of a keratinocyte cell line (HaCaT) on top of 20
layers of a fibroblast cell line (NIH3T3) by an established laser-
assisted bioprinting procedure. Using stable transduction, cell lines
were labelled with genes encoding for green or red fluorescent
proteins, respectively: NIH3T3-eGFP, NIH3T3-mCherry, Ha-
CaT-eGFP and HaCaT-mCherry. MatridermH was used as a
carrier matrix to enhance stability of the constructs for transplan-
tation (Figure 1). The skin constructs were placed into full-
thickness skin wounds in the dorsal skin fold chamber preparation
in mice in such a way that the constructs and the surrounding skin
laid in close contact to each other. Uninjured skin from the
opposite side of the back fold served as a control for all
experiments. Analogous constructs without the cells [20] serve as
a comparison to this study.
All animals survived the surgical intervention and implantation
procedure and tolerated the chambers well, showing no signs of
discomfort or changes in sleeping and feeding habits. After 11
Figure 2. Tissue engineered skin construct in the dorsal skin fold chamber in nude mice. The pictures show a skin construct inserted into
the wound directly after the implantation (left) and on day 11 (right). The implanted constructs were created via LaBP, consisting of 20 layers of
fibroblasts and 20 layers of keratinocytes on top of MatridermH. They fill the full-thickness wound completely.
doi:10.1371/journal.pone.0057741.g002
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days, the borders of the skin constructs and the surrounding mouse
skin were tightly grown together so that no sharp linings were
visible between the two tissue types any more (Figure 2). During
the course of time, the previously shining surface of the constructs
became matt. Neither inflammatory/necrotic processes nor
contraction of the wounds could be detected.
Formation of Skin-like Tissue in vivo by Printed Skin
Constructs
First of all, the survival and tissue formation of the printed skin
cells was of particular interest. On top of the fibroblasts and the
MatridermH, the keratinocytes (HaCaT-eGFP) developed a dense
stratified tissue (Figure 3E), similar to normal epidermis as can be
Figure 3. Histological sections of the tissue engineered skin constructs in vivo. Skin constructs were implanted in dorsal skin fold chambers
in mice for 11 days. Sections were stained with Masson’s trichrome (A–D) or analyzed with fluorescence microscopy (E), respectively. (A) illustrates an
overview with the junction between the inserted skin construct (m=MatridermH) and native mouse skin (n) at the wound edge after 11 days in the
dorsal skin fold chamber in mice. The intact mouse skin opposite of the skin construct can be seen in the lower part of the picture (n) (see also
Figure 1). The skin construct and the intact skin part in the sandwiched skin are separated by the panniculus carnosus (pc). Both in native mouse skin
(B) and the printed skin construct (C) a dense epidermis (empty asterisks) and a corneal layer can be observed. In case of the skin construct, the
epidermis is formed by the printed keratinocytes (E). This can clearly be seen by the green fluorescence emitted by the used HaCaT-eGFP cells. The
fibroblasts (NIH3T3-mCherry) partly migrated into the MatridermH (yellowish fibres). The fibroblasts, which stayed on top of the MatridermH, display
an outstretched morphology (C), being accompanied by collagen deposition (filled asterisks). Blood vessels (arrows) can be detected in the skin
constructs (D). Scale bars depict 200 mm (A, D, E) and 100 mm (B, C).
doi:10.1371/journal.pone.0057741.g003
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seen in the Masson’s trichrome staining (Figure 3A, C). In some
samples, this was followed by a corneal layer (Figure 3A, C).
However, the epidermis in the skin constructs was less thick than
in native mouse skin. Besides, no rete ridges could be found in the
skin constructs. After 11 days the tissue developed by the printed
cells was connected to the surrounding native mouse skin tissue at
the wound edges. Neither an interruption of the epidermis nor a
gap between the dermis and the MatridermH could be observed at
the junction between the skin constructs and the mouse skin
(Figure 3A, Figure 4). In this context, two different situations could
be observed: In some cases, the normal mouse epidermis started to
grow on top of the MatridermH, becoming connected to the
epidermis which was formed by the printed keratinocytes
(Figure 4A). In other cases, the epidermis formed by the printed
keratinocytes ended simultaneously with the printed fibroblasts
(NIH3T3-mCherry), directly at the border of the MatridermH.
Partly, the keratinocytes even grew on top of the normal mouse
epidermis (Figure 4B, C).
Furthermore, the migration pattern of the printed fibroblasts
was assessed. As can be seen in the histological sections, the
fibroblasts partly migrated into the MatridermH, closely following
the fibres of the latter (Figure 3E, Figure 4). Some fibroblasts
remained on top of the MatridermH, composing a multi-layer
sheet of tissue (Figure 3C) and secreting collagen as can be seen in
the trichrome staining. As such, the printed skin cells survived well
and formed a multi-layer, keratinized skin equivalent.
One important issue in respect of the use of skin substitutes is
their vascularisation. Here, small blood vessels could be found in
the skin constructs which seem to grow in from the depth of the
wound bed as well as from wound edges into the MatridermH in
the direction of the printed cell layers (Figures 3D and 5).
Figure 4. Fluorescent pictures of the tissue engineered skin constructs in vivo. Skin constructs were implanted in dorsal skin fold chambers
in mice for 11. The sections show an overview of the junction between the inserted skin construct (m=MatridermH) and native mouse skin (n) with
either fluorescence microscopy (A, C) or transmitted light microscopy (B). Two different situations concerning the epidermis were observed during
analysis of the junction zones: In some cases, as depicted in (A), the normal mouse epidermis (ne) started to grow on top of the MatridermH, where it
connected to the epidermis formed by the printed keratinocytes (pk). The latter were labelled in green by stable transduction (HaCaT-eGFP). In other
cases, as depicted in (B) and (C), the epidermis formed by the printed keratinocytes ended at the border of the MatridermH, synchronous to the
presence of the printed fibroblasts (pf) labelled in red (NIH3T3-mCherry). As can be seen by comparing (B) and (C) - which depict the same location -
the keratinocytes even partly grew on top of the normal mouse epidermis. In both cases, the printed fibroblasts formed a multi-layer tissue
underneath the printed keratinocytes. Partly, they also migrated into the MatridermH. All scale bars depict 200 mm.
doi:10.1371/journal.pone.0057741.g004
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Adherens junctions – containing especially e-cadherin - are
essential for stable cell-cell contact and can abundantly be found in
epithelia like skin. Therefore, e-cadherin can be used as a hint for
epithelia formation and consequently for tissue development. By
means of immunostaining, e-cadherin could be detected between
the keratinocytes of the skin constructs inserted into the wounds.
Here, the pattern of the e-cadherin localisation is the same as in
native skin and can be found in the whole epidermis (Figure 6).
One important characteristic of an epidermis is the differenti-
ation of the keratinocytes. Cytokeratin 14 is a marker for
undifferentiated keratinocytes. The corresponding immunostain-
ing revealed the presence of cytokeratin 14 in the whole epidermis
of the skin constructs (Figure 7A–C). In native skin cytokeratin 14
staining could be found in only the suprabasal layers.
In contrast, Ki67 as a proliferation marker, showed a signal
mainly in the suprabasal layer of the skin constructs (Figure 7D–F),
indicating that only those keratinocytes maintained their prolifer-
ating state. Note that in the skin constructs only a few cells showed
a positive signal for Ki67 whereas in the normal mouse skin nearly
all suprabasal cells were stained. Fibroblasts in the dermis showed
proliferation in the skin constructs as well as in the native mouse
skin.
In vitro Controls of Printed Skin Constructs
As a control, printed skin constructs were also cultivated in vitro
with the addition of differentiation medium. Samples were taken
for histology on day 0-at the same time point as the corresponding
transplants were inserted into the chambers of the mice – to
demonstrate the starting conditions of the experiments. Further
on, samples were also secured on day 11, corresponding to the end
of the in vivo experiments and in between (on day 5).
On day 0 the two multi-layers of different cell types on top of
the MatridermH could clearly be seen (Figure 8A, D, G). The
keratinocytes were still round and embedded in the collagen gel
without contact to each other and with quite large spacing
between the cells. In contrast, the fibroblasts already began to
stretch out and to migrate into the MatridermH. While the
keratinocytes formed a dense tissue during the course of time, part
of the fibroblasts migrated into the MatridermH, following the
Figure 5. Blood vessel detection via immunohistochemistry in skin constructs cultivated in vivo for 11 days. Skin constructs were
cultivated in vivo for 11 days in the dorsal skin fold chamber in mice. Collagen IV expression (brown) – indicating blood vessels/capillaries – can be
detected in the MatridermH as small tubes reaching from the wound bed in the direction of the cells (A). Small and large blood vessels are present in
the normal mouse skin (B). MatridermH (C) and normal mouse skin (D) without first antibody serve as the respective negative controls. Scale bars
depict 200 mm each.
doi:10.1371/journal.pone.0057741.g005
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fibres closely (Figure 8, brown cells beside green MatridermH
fibres, especially clear in Figure 8H and I).
A thickening of the epidermis-like tissue formed by the
keratinocytes could be observed comparing day 11 to day 5
(Figure 8). Surprisingly, trichrome staining revealed the presence
of a horizontal line of collagen in the lower part of the epidermis-
like tissue and some globular collagen accumulations in the upper
part. These probably are the remnants of the collagen used for the
printing process.
Also in the in vitro cultures, immunostaining was carried out.
The presence of e-cadherin increased during time from none on
day 0 to its detection in the whole epidermis-like tissue on day 11,
(Figure 9A–C). This is in accordance with the trichrome stainings,
where a dense tissue can be observed on days 5 and 11 (Figure 8).
Also in vitro, cytokeratin 14 could be detected evenly distributed
throughout all layers of the epidermis-like tissue (Figure 9D–F).
This indicates a lack of differentiation. Proliferation could be
found in all examined stages of the in vitro cultures (Figure 9G–I).
While nearly all of the just printed cells showed proliferation on
day 0, only some of the cells did so on days 5 and 11. But in
contrast to the in vivo situation, the proliferating cells were found in
the whole epidermis-like structure, more or less evenly distributed.
No special spatial pattern could be observed.
Discussion
The development of newly generated skin substitutes for burn
therapy is very important. Here, we present the in vivo assessment
of a simple skin equivalent created via LaBP. The printed cells
form a tissue which is quite similar to native skin, including
collagen producing fibroblasts and presumably differentiating
keratinocytes, forming a dense epidermis. Although 11 days of
cultivation is too short for a complete differentiation of keratino-
cytes, the distribution of Ki67 (as a marker for proliferation)
mainly in the suprabasal layers hints at the beginning differenti-
ation of the keratinocytes. In native skin, only the keratinocytes in
the stratum basale maintain proliferation, whereas the differentiating
keratinocytes in the other skin layers cease proliferating. Further-
more, the MatridermH carrier becomes populated by the printed
fibroblasts (presented in this work) as well as murine host
fibroblasts (presented in previous work [20]). This leads to the
integration and ingrowth of the skin construct into the wound.
However, the absence of rete ridges and the thinner epidermis in
the skin constructs may result in less stability of the constructs
compared to native mouse skin. This may be solved by printing
rete ridges and a thicker epidermis in future experiments, though.
As skin is a complex organ consisting of different cell types and
substructures arranged in defined spatial patterns, LaBP is suited
Figure 6. E-cadherin detection via immunohistochemistry in skin constructs cultivated in vivo for 11 days. Skin constructs were
cultivated in vivo for 11 days in the dorsal skin fold chamber in mice. E-cadherin expression (dark brown) can be found throughout the epidermis in
both normal mouse skin (A) and the skin constructs (B). Normal mouse skin without first antibody serves as a negative control (C). All scale bars depict
100 mm.
doi:10.1371/journal.pone.0057741.g006
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for the production of tissue engineered skin substitutes. It offers
many possibilities and is a very promising technique for the
fabrication of other kinds of tissues as e.g. bone or cartilage [8]
[10]. [12]. Different levels of tissue generation have been
investigated using bioprinting techniques. As we have previously
shown in vitro, printed epidermal cells develop a dense epidermis
including the expression of adherens and gap junctions [17]. In
this manuscript, the next step has been carried out and tissue
formation also in vivo could be documented. In a different setting, a
pie-shaped multi-layered construct produced by inkjet printing (see
below) and consisting of different cell types (stem cells, smooth
muscle cells, endothelial cells) has already been analysed in vivo as a
technical prerequisite to develop vascularised bone tissue in the
future. The implanted cells could be detected several weeks after
implantation indicating good survival rates. Interestingly, the used
stem cells were able to differentiate into bone in vivo and
endothelial cells formed a network of blood vessels in the implants
after six weeks [21].
Concerning maintenance of cellular phenotype, human chon-
drocytes were found to express cartilage specific genes after being
printed into cartilage lesions by inkjet printing and being
cultivated ex vivo. They maintained their deposited positions due
to simultaneous photopolymerization of a surrounding biomaterial
scaffold, and attached firmly to the enclosing cartilage tissue [22].
These findings are in accordance with our own experiences [16]
and that of others [7] [9] [13–14] as LaBP does not seem to impair
cellular phenotype and behaviour. Even the differentiability of
transferred mesenchymal stem cells [11–12] and pluripotent
murine embryonal carcinoma cells [15] is maintained.
In the in vitro samples, a horizontal stripe of collagen without
cells could be observed in the lower part of the epidermis-like
structure. Obviously, the fibroblasts did not degrade the circum-
jacent collagen - which has been used as a hydrogel during the
printing process - but started to migrate into the MatridermH right
away. During the printing, the cells are mixed with a hydrogel (in
general called printing matrix) to serve four different purposes.
Firstly, the matrix is necessary to achieve a uniform coverage of
the donor glass slide with the biomaterial to be transferred. This is
important as only then a consistency and uniformity of the printing
process is possible. Secondly, the matrix helps the cells to survive,
providing a moist environment preventing drying. Thirdly, it
presents a specific surrounding for the printed cells and thereby
acts as a biomimetic gel to create the desired micro-environment.
In our case, collagen is already present in physiological skin and
therefore is very suited as a printing matrix. Fourthly, a matrix like
collagen enables the formation of a 3D construct due to its gelling
effect. While in the in vitro controls the collagen is left by the
fibroblasts, in the in vivo situation outstretched fibroblasts can be
found in the collagen, probably also expressing and producing
collagen by themselves. As this is similar to the situation in
physiological skin, this process is much desired.
Very important for the take of a grafted skin or skin substitute is
its fast vascularisation. It is a major prerequisite for the successful
clinical use of a skin substitute. In our experiments, blood vessels
could be found to start growing into the MatridermH from the
wound bed and the wound edge mostly in the direction of the
transplanted cells. In a previous study, in skin constructs consisting
of MatridermH covered with collagen type I but without cells [20]
no vessels could be detected growing into the MatridermH. This
suggests that the neovascularisation might be induced or supported
by the printed cells on top of the MatridermH. Actually,
keratinocytes were found to produce vascular endothelium growth
factor (VEGF) [23], the expression of which is regulated by several
growth factors and cytokines [24] as well as by insulin in a diabetic
mouse model [25]. Furthermore, keratinocytes in a tissue
engineered skin substitute regulate the size of newly growing
Figure 7. Detection of cytokeratin 14 and proliferation via immunohistochemistry in skin constructs cultivated in vivo. Skin constructs
were cultivated in vivo in the dorsal skin fold chamber in mice for 11 days. The left column shows normal mouse skin, the middle column the skin
construct and the right column the respective negative controls (normal mouse skin without first antibody) of the immunohistochemistry stainings.
Cytokeratin 14 expression is limited to the suprabasal layers of the epidermis in mouse skin (A) but present in the whole epidermis in the skin
constructs (B). Proliferation via Ki67 can be detected in the suprabasal layers of the epidermis and in the dermis in both normal mouse skin and skin
constructs (D, E). Scale bars depict 200 mm (A–C) and 100 mm (D–F).
doi:10.1371/journal.pone.0057741.g007
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vessels in the dermis in vitro, resulting in small vessels similar to
capillaries present in the skin’s microcirculation [26]. The same
effect could be observed in the absence of keratinocytes when
adding keratinocyte-conditioned medium or VEGF. Therefore,
we assume that the printed keratinocytes in our skin substitutes
might enhance vessel formation by VEGF production.
In our experiments no complete vascularisation of the printed
skin equivalents could be achieved under the current conditions.
Probably, the period was too short for complete vascularisation of
the skin equivalent. Following the idea of improving graft
vascularisation, Black et al. integrated human umbilical vein
endothelial cells (HUVEC) into tissue engineered skin equivalents
containing fibroblasts and keratinocytes in combination with a
collagen chitosan scaffold [5] [27]. According to their study, the
HUVEC were shown to form capillary-like tubules in the dermis
in vitro. In a similar approach, skin equivalents constructed by
seeding acellular dermis with keratinocytes and Bcl-2-transduced
HUVEC showed perfusion through HUVEC-lined microvessels
two weeks after implantation into mice [28]. This highlights the
necessity but also the probable success to incorporate endothelial
cells into our printed constructs as a next step.
In contrast to the in vivo situation, our in vitro controls formed a
multi-layered tissue with collagen producing fibroblasts, but did
not show any differentiation of the keratinocytes (HaCaT). This
might be due to the culturing method in vitro. Although
differentiation aiding supplements were added to the culture
medium and the skin constructs were raised to the air-liquid-
interface, this might not have been appropriate enough to trigger
the differentiation. Also, the culturing period of 11 days is quite
short and induction of differentiation in vitro might have been
observed at a later time point. However, the beginning differen-
tiation of the keratinocytes in vivo could be due to the growth
factors present in mice but absent in vitro.
Summing up, LaBP offers the possibility to place cells of a
specific type wherever in the tissue they are needed. This is a
unique feature of bioprinting techniques and it may be used to
print skin supplemented with endothelial cells, hair follicle cells,
peripheral nerve cells, Schwann cells, melanocytes or cells present
Figure 8. Histological sections of the tissue engineered skin constructs in vitro. Skin constructs were cultivated at the air-liquid-interface
with differentiation medium for 11 days. Sections show cells using fluorescent microscopy and Masson’s trichrome staining, respectively. The time
points indicated in A–C are valid for the whole respective columns. The skin constructs were cultivated at the air-liquid-interface. The keratinocytes
(HaCaT-mCherry) exhibit red fluorescence while the fibroblasts (NIH3T3-eGFP) appear in green (A–C). Masson’s trichrome staining reveals the
connective tissue containing collagen (green) and the cells (reddish) (D–I). The fibroblasts already start to grow into the MatridermH underneath one
day after printing (A, D, G). The keratinocytes, which still are rounded and are not connected to each other on day 0 (A, D, G), already form a dense
tissue on day 5 (B, E, H). The thereby formed epidermis increases in height until day 11 (C, F, I). Scale bars depict 200 mm (A–F) and 100 mm (G–I).
doi:10.1371/journal.pone.0057741.g008
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in perspiratory and sebaceous glands. Therefore, we hope to be
able to produce a much more similar skin construct to native skin
compared to other current approaches. This is especially
important for the future patients as they gain a much more
functional and aesthetic skin substitute. This in turn would lead to
a major increase of their quality of life, on the physical as well as
on the mental level.
As an alternative to LaBP, a similar technique called inkjet
printing is available, which has already been used to print 2D
protein arrays [29], endothelial cells, smooth muscle cells [29–30],
a 3D construct containing HeLa cells [31], or a 3D composite
construct containing muscle cells, endothelial cells and stem cells
[21]. Also, inkjet printing can be used to create antimicrobial
assays [32] or to transfect cells with relatively large molecules [33].
The major disadvantage of this technique, however, is the high
shear force of the nozzle, leading to severe cell impairment [34].
With LaBP – which is nozzle free – cells can be printed with a
much higher density [10]. This is very important for the printing
Figure 9. Sections of immunohistochemically stained skin constructs cultivated in vitro. Skin constructs were cultivated in vitro at the air-
liquid-interface with differentiation medium for 11 days. The indicated time points in A–C are valid for the whole respective column. E-cadherin
expression is absent on day 0 but can be detected on days 5 and 11 (A–C) while cytokeratin 14 expression is clearly visible at all time points in the
whole epidermis (D–F). While nearly all cells exhibit Ki67 staining on day 0, only few cells do so at days 5 and 11 (G–I). The corresponding negative
controls of the stainings (skin constructs without first antibody) are shown below (K – e-cadherin, L – cytokeratin 14, M – Ki67). All scale bars depict
100 mm.
doi:10.1371/journal.pone.0057741.g009
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of skin, which is a tissue with a very high density of cells present.
Therefore, for our purposes, LaBP remains the technique of
choice.
To further improve the use of LaBP for the creation of (skin)
tissue, an adaptation to automation would be of advantage. Our
setup is not suited for the high throughput production of skin
substitutes yet, but in principal an automation of the whole process
- including the printing process as such as well as the cultivation of
the skin substitutes - is conceivable.
We used the dorsal skin fold chamber in mice for the assessment
of the tissue engineered skin constructs. This approach exhibits
different advantages as well as drawbacks. The common approach
of dorso-lateral full-thickness wounds without a chamber allows for
the cultivation of a tissue engineered skin constructs for a long
period of time. While two to eight weeks are the most frequently
used time intervals [35–38], animals can be kept up to six months
[39]. Using the chambers and the small nude mice, the
observation period is quite limited as the mice would not be able
to bear the weight of the chambers for several weeks. In our study,
we demonstrated that skin constructs produced by LaBP are viable
in vivo, forming a tissue similar to simple skin within the time frame
of 11 days. As a further limitation, compared to the common
approach of simple full-thickness wounds in the dorso-lateral
region of mice with an area of 2 cm62 cm to 2 cm63 cm [35]
[38–40], the wound area in the chambers is very small (round hole
with 6 mm diameter). This, however, is partly compensated by the
lack of wound contraction. The latter is the major way of wound
healing in rodents [41], opposed to the main mechanisms in
human wound healing, i.e. granulation tissue formation and
subsequent reepithelialisation [3] [42]. In the chambers, the skin
constructs are safely secured in the wound by the glass slide while
the surrounding and opposite skin is firmly attached to the
titanium frames [20]. Therefore, no contraction of the wound area
occurs. This is very important since we aim at assessing the
situation in humans and not in rodents. A further advantage of the
skin fold chamber is the lack of customary wound dressings.
Thereby, no changes of the dressings are necessary, which reduces
the stress for the animals considerably [20]. Furthermore, the
transparent glass slide allows for a continuous observation of the
wound closure, without any stress for the animals due to the
removal of wound dressings [43].
In conclusion, we could show LaBP to be an adequate
technique for the creation and in vivo formation of a 3D tissue
like skin. Therefore, LaBP represents a major promise for the
improvement of burn therapy and thus for a raised quality of life
for the patients.
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4 Discussion
4.1 General aspects of LIFT in skin tissue
printing
The establishment of the LIFT process for the creation of a skin substitute for
burn patients - which is the aim of this thesis - comprised several steps. First,
the LIFT setup was planned and arranged according to the needed parameters.
Subsequently, the basics of the transfer were tested with hydrogels alone and in
combination with living cells. In this context, the creation of different 2D pat-
terns was successfully conducted. One impressive example is a high resolution
chessboard pattern, consisting of keratinocytes and fibroblasts. Having mastered
the mechanical and physical aspects of the transfer, the influence of LIFT on
the cells was of central interest, as only unimpaired cells are of use in tissue
engineering. Our investigations showed no harmful effects of LIFT on different
cell types. Neither morphological nor behavioural changes occured. Therefore,
the necessary prerequisites for the application of LIFT in the field of tissue en-
gineered were fulfilled. All the above described experiments are part of the first
publication [82] (page 36).
After all aspects of the 2D printing were successfully established, the 3D print-
ing of tissue, i.e. skin tissue, became the next step. In this context, the choice
of a suitable printing matrix (hydrogel) was a big challenge. Our studies demon-
strated, that neither alginate nor fibrinogen/thrombin - which are very adequate
for the printing process as such - were suitable for the printing of skin tissue.
Finally, using collagen as a matrix, skin equivalents consisting of 20 layers of
fibroblasts followed by 20 layers of keratinocytes were printed via LIFT and cul-
tured in vitro. Histological analysis showed tissue formation by the printed cells,
which was confirmed by the detection of adherens junctions and functional gap
junctions. To be able to track the printed cells in vitro, as well as in vivo, skin
cell lines were marked with fluorescent proteins by stable transduction of the
according genes. All of these data can be found in the second publication [81]
(page 45).
Following the assessment of the printed skin constructs in vitro, as the next
logical step the in vivo evaluation took place. As a preparation, the use of the
dorsal skin fold chamber in mice was adapted to this purpose and shown to be a
suitable and sophisticated tool. The use of the skin fold chambers offers several
advantages: no contraction of the wound developes, the skin constructs can be
observed during the whole cultivation period without the need to change wound
dressings, and after the end of the experiment the specimen can easily be taken
for histological analysis, being surrounded by native skin as a control. These
findings are described in the third publication [104] (page 55).
The in vivo experiments showed the tight connection between the skin con-
structs and the surrounding native skin as well as the development of tissue by
the printed cells. The tissue formation was observed by histological analysis and
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even more evident by the direct detection of the fluorescently labelled printed
cells. The presence of adherens junctions could be identified in the epidermis.
Moreover, a beginning differentiation of the keratinocytes occured. Also, the
presence of capillaries sprouting from the host tissue towards the printed cells
could be detected. This is especially important with respect to the successful
integration of even larger skin equivalents in clinical applications. All of these
results are the content of the fourth publication [103] (page 63).
Thus, the four publications which are part of this thesis describe the different
steps to achieve the generation of a skin substitute by laser based bioprinting.
While at first the technical aspects of the LIFT setup and the transfer of the cell
were the central aspects, in the course of time the biological considerations came
to the fore. Altogether, the inter-disciplinary approach towards tissue engineering
used in this thesis proved to be very successful.
4.2 Scaffold-free bioprinting - possibilities and
problems
As explained in section 1.5, bioprinting is an example of scaffold-free tissue engi-
neering. While this is not the common approach, it displays a major advantage.
Normally, it is difficult to seed scaffolds with cells in exactly the desired location.
Although they tend to migrate through present pores, the creation of a defined
seeding pattern would be very difficult - even if chemokinces would be used -
since the migration of cells is influenced by a complex set of parameters. An un-
oriented distribution of cells, however, is especially undesired in complex tissues
like the skin. Here, different cell types reside close to each other in a defined 3D
distribution to achieve functional cell structures. As one example, a network of
endothelial cells preparing blood vessels can be created by bioprinting but never
be pipetted into a simple collagen gel following the hitherto existing approaches.
In the process of laser based bioprinting, hydrogels are needed to realise
scaffold-free tissue engineering. They serve mainly three different purposes: First,
the hydrogels enable an even coating of the donor glass slide with the cell-matrix-
solution (bioink). This is a major prerequisite for the uniform transfer of the cells
as the needed laser energy is directly dependent on the thickness of the bioink
layer (see section 1.6). Second, the hydrogels serve as a protection for the cells
against dehydration by providing a highly hydrated protective surrounding. This
is especially important if the printed constructs are large, because then the print-
ing process is quite time consuming. Third, a 3D construct can only be printed
if the employed hydrogel forms a stable network, providing the needed rigidity to
stably print layer on top of layer. Even so, in case of a skin substitute, the formed
gel needs to be flexible enough to provide the elasticity found in physiological skin.
Many different hydrogels exist and are being used in tissue engineering and bio-
printing, either naturally occurring substances or chemically designed polymers.
They have to allow for the desired mechanical support as well as for sufficient
transport of nutrients, an appropriate degradation, and a good biocompatibility
[48], [87]. Furthermore, the chosen hydrogel must be suitable for the required cell
type(s). This means, that the desired interactions of the cells with the hydrogel
must be possible, i.e. support of growth, adhesion, migration, proliferation, and
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differentiation. For this purpose, hydrogels complemented with growth factors,
biomimetic alterations or appropriate ECM molecules can be used. Thereby, dif-
ferent desired and specific cellular responses may be elicited [48], [151]. This is
the fourth purpose a chosen hydrogel may serve in bioprinting, apart from the
other three basic ones.
Several different matrices may be used to achieve the printing of various cell
types in different situations. Nevertheless, each hydrogel has its advantages and
drawbacks, either concerning the printing process or the needs of the cells. Those
do not have to be congruent, though. Each newly printed cell type may require
a different gel, which has to be found by the according experiments. In any
case, cell vitality and behaviour of the cells need to be assessed and the selected
hydrogels should maintain, or induce, the desired functions of the included cells
as well as exhibit the needed mechanical properties [30], [48]. In the end, the
used matrix must be suitable for the printing process as well as for the specific
cell type. To find the appropriate hydrogel, sometimes elaborate experiments are
needed, as e.g. in case of the skin cells (see the next section 4.2.1).
4.2.1 Matrices used for skin tissue printing - occurring
problems and challenges
In the process of printing skin tissue, several different hydrogels and stabilising
agents were tested. Three of them were the most promising: alginate, fibrino-
gen/thrombin, and collagen type I. In the following, the respective results are
discussed.
4.2.1.1 Alginate
Alginate is a polysaccharide originating from algae and bacteria. Sodium-alginate
gels in the presence of bivalent cations like calcium chloride and forms an ionic
network (ionic cross-linking) [48]. It has been used for drug delivery [158] and cell
encapsulation [160], [162], [76] as well as for tissue engineering [94], [87], treat-
ment of vesicoureteral reflux [9] or myocardial infarction [161]. Furthermore, it is
employed as wound dressing [5], [43] and as an impression material in dentistry
[114], [6].
The major advantage of alginate with regard to bioprinting is the fact that
its viscosity is very easily adapted and controlled, which is especially important
for the even coverage of the donor glass slide and thereby an optimal and uni-
form LIFT process. Moreover, alginate can easily be gelled and hardened after
transfer by the addition of simple calcium chloride solution. This, in turn, leads
to the simple creation of stable 3D constructs. Furthermore, it displays high
biocompatibility, low toxicity, and very low cost and is already used in clinical
applications.
Mainly we used it for the transfer of ASC, which were subsequently differ-
entiated to bone, cartilage, and fat tissue [58], [59]. Furthermore, alginate has
been used to study the influence of parameters like viscosity, cell density, printing
speed, and laser energy in case of laser based bioprinting [62]. In case of inkjet
printing, alginate has been employed to successfully arrange a variety of different
cell types [119], [112] including HeLa cells [7] in diverse 2D and 3D patterns.
Therefore, it seems to be a promising hydrogel with respect to bioprinting.
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Nevertheless, it is not suitable for the production of tissue using skin cells.
A large 3D construct consisting of different fluorescently labelled keratinocytes
arranged in several layers was successfully created (see figure 1 on page 48) to
show the possibility of 3D printing by LIFT. Unfortunately, skin cells (fibroblasts
and keratinocytes) were not able to degrade the alginate gel, maintaining a round
appearance even after two weeks of cultivation and as such failing to form a
normal tissue (see picture A.1 in appendix A). As can be seen in the live dead
staining, the cells remained viable in the alginate, though (see picture A.2 in
appendix A). Similar results were obtained when fibroblasts were treated with an
alginate solution in the sol phase. Proliferation was strongly reduced, adherence
was impaired, but cytotoxicity was very low [110].
Different concentrations of alginate were tested to see if lower concentrations
were more compatible with the cells (see picture A.3 in appendix A). Neverthe-
less, this did not result in success, as even in very low concentrations (0.5 %), the
cells remained rounded. This, however, is of no use in the context of skin tissue
generation. In contrast, the deposition of stem cells with alginate and the subse-
quent differentiation to bone and cartilage proved to be successful [58], which is
probably due to the fact that the stem cells did not need to form a dense tissue
with cell-cell-contacts, but just produced their specific ECM at their deposited
position.
As has been shown before, protein adsorption and therefore adherence of the
cells to alginate is low due to its hydrophilic properties [87]. Therefore, as a rem-
edy for the above described situation, one solution might be to chemically alter
the alginate and introduce respective signalling peptides. This might be possible,
since modification of alginate has been shown before [87], [157]. Indeed, when
GRGDY peptides were covalently coupled to alginate, myoblasts were able to ad-
here to and spread on disk-shaped alginate gels in vitro. The cells subsequently
proliferated and formed myofibrils. Controls, which consisted of non-modified
alginate, showed neither cell attachment nor proliferation [143]. However, this
would probably not solve our problem since when printing skin tissue, the cells
are encapsulated in the alginate gel. Even if they were able to adhere, they would
probably not be able to degrade the alginate to stretch out and proliferate. We
suppose that mammalian skin cells lack the necessary enzyme to degrade the al-
ginate (alginate lyase). In the literature, only algae, fungi, marine invertebrates,
and microorganisms are described to produce alginate lyases [171]. Moreover,
a search for alginate lyase in the human genome did not produce any hits (nu-
cleotide database of NCBI). Nevertheless, alginate is often described as a bio-
compatible and biodegradable hydrogel. Its degradation in mammals is realised
by the leakage of the bivalent Ca2+ ions from the alginate gel, which ultimately
leads to its dissolution [118]. In our experiments, this leakage was apparently not
strong enough to dissolve the alginate.
4.2.1.2 Fibrinogen and thrombin
Another very useful hydrogel is the combination of fibrinogen and thrombin.
Fibrinogen-like proteins are already present in gastropodes [175] and fibrinogen
and thrombin are both involved in blood coagulation in the mammalian body.
In this context, fibrin is formed by enzyme-catalyzed crosslinking of fibrinogen in
the presence of thrombin, calcium chloride, and factor XIIIa [48].
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Fibrin has already been used for different purposes in vitro and in vivo: In
research, human umbilical cord stem cells were encapsulated into fibrin for myo-
genic differentiation, with the goal of achieving tissue engineered muscles [92].
Fibrin in combination with collagen and chitosan was also used for the creation
of a specific ECM microenvironment within a dermal wound healing model [115].
Furthermore, a fibrin-chitosan composite substrate was developed for the in vitro
culture of chondrocytes [54].
In clinical surroundings, fibrin is often applied as a biocompatible sealant [87].
This comprises the use of fibrin for the sutureless wound healing of inner organs
after operations [100], its application as a sealant for pneumothorax [74] as well
as its usage in inguinal hernia repair with meshes [117]. Furthermore, fibrin
glue is employed in facelifts [154] and was tested for its ability to improve graft
adherence in a porcine burn wound model [22]. Similarly, its use resulted in an
increase of skin graft take in patients with diabetes mellitus type II or smoking
history [136].
A major advantage of this hydrogel is the possibility of using autologous fibrin
from the patients [87]. This in turn, drastically reduces the risk of infection and
the rejection connected to allogeneic material. Moreover, no toxic degradation
or inflammatory reactions are to be expected. The major disadvantage of the
fibrinogen/thrombin approach is the short storage life of both substances.
In general, cells can easily and evenly be deposited with this hydrogel, forming
very stable 3D constructs. The cells are mixed with fibrinogen and hyaluronic
acid before transfer, while stiffening of the printed 3D construct is effected by
the addition of a thrombin and calcium chloride containing solution. This results
in a very precise positioning of the printed cells and the accurate formation of
a 3D pattern. Precisely this characteristic was appreciated and utilized by our
group when creating a 3D migration assay. MSC and endothelial colony forming
cells (ECFCs) were printed as a spot array in several layers above each other [60].
Thereby, cell-cell and cell-environment interactions could easily be assessed.
When used for the production of a skin equivalent by LIFT, transfer of skin cells
resulted in the specific deposition of fibroblasts forming a multi layer dermal part
and keratinocytes residing in a multi layer epidermal part on top of the fibroblasts,
which was very promising. However, after a few days the keratinocytes started
to migrate into the dermal part (see picture A.4 in appendix A). In some cases,
a continuous epidermis was formed, but in other cases mushroom-like formations
were produced by the keratinocytes. This is not unexpected as keratinocytes
are initiated by e.g. fibrin to migrate during wound healing from the wound
edges towards the wound to conduct reepithelialisation [55], [42]. Therefore, this
hydrogel is not suitable for the creation of a skin substitute.
4.2.1.3 Collagen
As a major constituent of skin, collagen type I has finally been used by us for the
bioprinting of skin equivalents [81], [103]. It is a major constituent of connective
tissue [4, chapter 19] and can already be found in simple life forms like sponges
[108]. Collagen serves as a structural protein in the ECM and gives cells structural
support from the outside [87]. In skin, it plays an important role not only for
the flexibility of the tissue but also for the survival of endothelial cells and vessel
formation [17].
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Being a fibrous protein, collagen contains a triple-helix structure which is sta-
bilised by hydrogen bonds. Connected via covalent bonds, these helices form
elongated fibrils which are found in fibrous tissues like tendon, ligament, fascia,
and skin, but also in cornea, cartilage, bone, blood vessels, the gut, and interver-
tebral discs. Collagen is mainly synthesised by fibroblasts and exhibits a great
tensile strength. Being located in the dermis, in co-operation with elastin and
other molecules, collagen type I is responsible for skin strength and elasticity,
while collagen types IV and VII are part of the basement membrane. Ligament
and tendon comprise collagen types I and III, whereas cartilage mainly contains
collagen type II. Also in bone collagen type I can be found, being the main com-
ponent of the organic part [19], [4, chapter 19]. Collagen type V is present on
cell surfaces, in hair, and the placenta.
The major advantage of the application of collagen in tissue engineering is its
natural occurrence in the human body. Therefore, collagen is very biocompatible
and biodegradable and does not elicit a rejection reaction. However, collagen also
possesses some disadvantages. Although collagen is a natural hydrogel it cannot -
like fibrin - be used as an autologous biomaterial from the patients. Therefore, the
risk of infection and rejection remains. Normally, collagen isolated from bovine
skin or rat tails is used.
In tissue engineering, collagen type I forms a thermally reversible gel, provid-
ing good cell adhesion [48]. It can often be found as an ingredient of compound
matrices comprising a natural occurring and an artificially created polymer. For
instance, poly ethylene glycol (PEG) can be mixed with collagen to produce a
hydrogel system which can be used as a scaffold for viscoelastic tissue engineer-
ing [29]. While the PEG is mainly responsible for the mechanical properties, the
collagen enables the bioactiveness of the matrix, i.e. the interaction with the cells
and biological molecules. Another example of a compound matrix is the combi-
nation of collagen with amphiphile nanofibres and bone morphogenetic protein
2 (BMP-2) with the aim to enhance bone regeneration [89]. Moreover, collagen
sponges were used to provide a scaffold for cartilage regeneration in combination
with MSC and stromal cell-derived factor-1 (SDF-1) [176].
Collagen is often used in skin tissue engineering (see sections 1.3 and 1.4).
It can be degraded by cells [87] and resulting gels are contracted by fibroblasts
[4, chapter 19]. In the field of bioprinting - apart from skin tissue formation -
collagen has also been used to transfer endothelial cells and smooth muscle cells
[170], [18].
Regarding the printing process, the inconsistency of different batches is a major
drawback [87] (and our own experiences). This is especially problematic for the
printing process as with every new batch the printing parameters need to be
tested anew. This is very time consuming and according to our own experiences
not all batches work well for printing if they work at all. In this context, we
tried many different collagens from different companies, complemented by rat
tail collagen isolated ourselves, until we found a feasible commercial collagen.
A further disadvantage of collagen is the inconsistency of the printing. The
gelification of collagen is difficult to control and uneven gelification will negatively
affect the spatial accuracy of the printing process [75] (and our own experiences).
To compensate for the inconsistency of the printing process, I tried a combination
of alginate and collagen to create a 3D cell construct, thereby making use of the
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advantages of both hydrogels. These experiments were only conducted in vitro
by pipetting, without the use of LIFT. The idea was to first utilize the alginate
to achieve a stable and accurate 3D gel very quickly, while the collagen needs
more time to gel. Then, as a second step, the alginate should have been dissolved
enzymatically by alginate lyase, leaving the stable collagen with the cells behind
to form a skin-like tissue without the inhibiting alginate. Unfortunately, this
approach did not work as either both hydrogels dissolved at the same time or the
cells were damaged by the used solutions.
As no other hydrogel worked for the printing of the skin cells and since collagen
type I is present in normal skin, we chose to use collagen for the creation of the
skin substitutes by bioprinting. To further improve skin tissue generation and
to mimic physiological skin even closer, we may add elastin to our bioprinted
skin constructs to enhance elasticity. Nevertheless, this would need appropriate
testing systems and probably it is not necessary as the printed fibroblasts quickly
start to synthesize their own ECM.
4.2.2 Further matrices used for bioprinting
Apart from the above mentioned matrices, further hydrogels were used for bio-
printing of different tissues/constructs by other groups. Subsequently, some of
these hydrogels and their applications are discussed.
For instance, Pluronic F127 was employed to print a 3D hollow diamond shape.
Pluronic F127 is a poloxamer, consisting of hydrophilic poly(ethylene oxide) and
hydrophobic poly(propylene oxide) [41]. It has already been applied in different
situations, e.g. for bone [73] or cartilage [77] tissue engineering or for cardiovas-
cular applications. Advantages are its biocompatibility, reversible temperature-
sensitive gelling, adhesion to surfaces, and broad range of viscosities at room
temperature [30]. Furthermore, Pluronic F127 has been approved by the Food
and Drug Administration (FDA) of the USA [48]. From the biological/medical
viewpoint, especially its biocompatibility and its approval by the FDA are ma-
jor assets for its application in tissue engineering. Its easy and adaptive gelling
characteristics, on the other hand, are very suitable for the printing process. Al-
though tissues with characteristics of bone and cartilage were successfully formed
by cells seeded into Pluronic F127, the development of skin tissue might be more
difficult due to similar reasons as in case of alginate. Pluronic molecules are not
degraded by the body [10], but instead are cleared after intravenous administra-
tion by renal and biliary excretion in a rat model [166]. Therefore, it is doubtful
that a dense epithelium would be able to form in case of skin tissue engineering.
Matrigel® is a hydrogel which is often used in the context of endothelial cells
as it stimulates complex cell behaviour and formation of networks on Matrigel®
by endothelial cells [111]. When endothelial cells were printed into a layer of
Matrigel® as a specific 2D pattern they remained viable after printing [170].
Nevertheless, Matrigel® does not seem to be the optimal hydrogel to use (re-
gardless of the cell type) due to its very heterogeneous composition, which also
varies from batch to batch. This hydrogel is gained from the basement mem-
brane of a mouse sarcoma and contains among others laminin, collagen type IV,
entactin, heparin sulphate proteoglycans and a variety of growth factors which
occur naturally in this tumour and may promote differentiation and proliferation
of many cell types [48]. The use of such a matrix is surely not optimal for tissue
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engineering, as material and growth factors derived from a tumour might not be
safe to use in humans (or animals) since induction of cancer growth in the tissue
engineered or the surrounding host cells cannot be excluded.
In a different approach, agarose was used for the printing process. It is a thermo
sensitive polysaccharide originating from red algae and gels via hydrogen bond
formation [48]. Apart from its gelatinous properties, which are utilised in the
food industry, it is also employed for gel electrophoresis and as an ingredient for
agar in laboratories. Here, it was used as a stabilizing matrix for the production
of vasculature by printing multiple cell types to form vessels [75], [120]. Even
a branched vessel construct could successfully be printed as well as a double-
layered vascular tube containing smooth muscle cells and fibroblasts. In this
context, agarose proved to be an inert and biocompatible hydrogel which the
cells neither invaded nor rearranged. This was important, since only due to the
inertness of the agarose, the cells were forced to stay in the printed place and
to form the desired vessel structure. After the cells were grown together, the
excessive agarose was removed to free the vessel lumen of the now superfluous
hydrogel. The biocompatibility and natural occurrence of agarose certainly are
advantageous. Nevertheless, if used for skin tissue creation, its stability and
inertness are not expedient since the skin cells need to form a dense tissue and
would probably not be able to do so when encapsulated by agarose.
For the creation of bone or cartilage, a much harder scaffold is needed than
for the production of skin or blood vessels. Bone tissue engineering was e.g. re-
alised by the transfer of osteoprogenitor cells along with nano-hydroxyapatite [28].
Thereby, a 3D construct was created, which remained stable and contained cells
expressing osteoblastic phenotype markers. A similar approach was used to trans-
fer chondrocytes together with poly(ethylene glycol) dimethacrylate (PEGDMA)
for the production of cartilage [34]. This resulted in the creation of a cartilage-
like construct with the printed cells remaining at their deposited positions due to
simultaneous photopolymerization of the PEGDMA. When this tissue engineered
’cartilage’ was directly printed into a real cartilage defect, the printed construct
bound firmly to native cartilage tissue. This especially emphasises the necessity
to adapt the chosen hydrogel to the tissue, which should be engineered. In this
context, both approaches seemed to be successful under biological and technical
aspects. Moreover, the described approach for the creation of cartilage utilised
two major advantages of the bioprinting: the defined and even distribution of the
printed cells and the defined and accurate shaping of the cartilage construct.
Further hydrogels used for bioprinting are reviewed in [48]. They include the
above described gels as well as starch, dextran, gelatin, methylcellulose, and
chitosan and are used for different approaches.
4.2.3 Final conclusions about matrices used for
bioprinting
Both, the section about skin tissue printing as well as the overview of different
hydrogels used for bioprinting of other tissues, emphasise the same conclusions,
i.e. that the selection of the adequate matrix for the printing of different cell
types and tissues is of utmost importance. While one matrix might be suited
for one specific aim, it might not be appropriate for another purpose. Moreover,
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even if one matrix is suitable from the technical point of view it is not necessarily
optimal concerning the biological aspects and vice versa. This is especially true
for the printing of skin tissue, since only collagen allowed good tissue formation
by the printed skin cells. On the other hand, collagen is disadvantageous for the
printing process.
4.3 Clinical applicability
4.3.1 Challenges and solutions for tissue engineering of
skin for clinical application
One major challenge is posed by the step from research to clinical application, the
step from bench to bedside. In this case, several issues need to be considered. The
first issue is the scale-up from printing a few small pieces of skin for research to the
serial production of large skin constructs for clinical use in e.g. burn patients (see
also section 5). The second concern is the functional and aesthetical enhancement
of the tissue engineered skin by addition of different supplemental cell types.
Bioprinting - specifically laser based bioprinting like LIFT - is able to successfully
solve this quest. The possibility of transferring special types of cells to exactly
the desired 3D position in a (skin) tissue is the unique feature of bioprinting and
as such its major strength. As we [81], [58], [60] and others [14], [125], [30], [34],
[7], [28] could show, already now 3D constructs and 3D patterns of different cell
types can be printed by laser or inkjet printing. Still, the printing process and
the selection of the appropriate matrix need to be optimized for the different cell
types until their inclusion is possible (see also section 4.2).
4.3.2 Alternative cell sources for tissue engineered skin
4.3.2.1 Vascularisation of tissue engineered skin
When thinking about clinical applications of LIFT, among others the question
about the source of all the above described cell types needs to be considered.
In case of extensive burn injuries, autologous cells for biopsies to produce skin
sheets or similar are very scarce. Nevertheless, autologous cells are the best
source of cells for transplantation or the production of skin substitutes as they
are not rejected by the immune system of the patient and do not bear the risk of
infectious diseases. Also, the use of genetically modified cells for the treatment
of humans still is a controversial issue. Therefore, other cell sources are being
searched for by researchers and clinicians. In this context, the use of stem cells
may represent a solution. They can be found in nearly every organ as tissue
must be capable of self-renewal [102]. Adult stem cells can be found e.g. in bone
marrow, adipose tissue, blood, and skin and may be used according to the desired
differentiated cell type. Especially ASC may prove to be of major advantage as
they are of bountiful occurrence in humans.
Since fast vascularisation is one of the most important prerequisite for the
take of a graft, major research has been focusing on the quick vascularisation
of tissue engineered skin or other organs (see also section 1.3). In this context,
ASC from lipoaspirates could be amplified to obtain endothelial progenitor cells,
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which were then differentiated into endothelial cells. A skin equivalent was con-
structed in vitro by seeding a collagen-glycosaminoglycan-chitosan scaffold with
those differentiated endothelial cells, also adding fibroblasts and keratinocytes.
In this setting, the endothelial cells formed capillary-like tubular structures. In
contrast, in skin constructs seeded with endothelial progenitor cells instead of
already differentiated cells no tubular structures were formed [12]. Also another
group demonstrated the possibility of differentiating MSC to endothelial cells us-
ing endothelial growth medium supplemented with vascular endothelial growth
factor (VEGF) [129]. These cells may be used to create a vascularised tisse en-
gineered skin equivalent. While these approaches might be feasible regarding
the clinical aspects, the fact still remains that a long time for the differentiation
of stem cells to endothelial cells is needed. However, in burn injuries a quick
coverage of the burned skin is essential. Therefore, a temporary coverage with
allogeneic cadaveric skin - as is already common in the clinic - could be used to
bridge the time until the skin equivalent would be ready for use. This is also true
for the further described approaches.
Sweat gland derived stem cells represent another cell source, displaying the
feature of being quite abundant in the human body. They can be isolated easily
and exhibit a high proliferation rate in vitro as well as in vivo. When seeded
onto Integra® (an acellular dermal substitute consisting of collagen and gly-
cosaminoglycan) and cultured in vitro, the cells released molecules involved in
angiogenesis, immune response and tissue remodelling. After seeding the stem
cells onto Matrigel® they formed capillary-like structures. In vivo they signifi-
cantly enhanced vascularisation during dermal regeneration in a full skin defect
model in mice. The exact mechanism is not known yet, but the stem cells might
differentiate into endothelial cells or they might act as mediators to create a pro-
regenerative microenvironment in the wound area [37]. Although - according to
the authors of this publication - these stem cells are plentiful in the body, the
question remains if enough of them can be isolated and cultured to print a skin
equivalent for burn patients.
Apart from stem cells, endothelial cells can be used. In one approach, trans-
duced human umbilical vein endothelial cells (HUVEC) overexpressing Bcl-2 were
seeded onto human acellular dermis grafts. Upon subcutaneous implantation in
immunodeficient mice the transduced grafts contained a significantly higher den-
sity of perfused HUVEC-lined microvessels than the controls (unseeded human
acellular dermis) after one month. Following this approach, a skin equivalent was
produced by seeding the apical surface of the acellular dermis with keratinocytes
and the basal surface with Bcl-2-transduced HUVEC. Already two weeks after
implantation into a full-thickness skin wound, perfusion through HUVEC-lined
microvessels could be detected. The vessels showed signs of progressive matura-
tion and increased the speed of graft vascularisation. In contrast, murine vessels
could only be detected at the edges of the implants. The latter was also true
for unseeded controls. Therefore, the very quick successful vascularisation by
the human endothelial cells already present in the grafts is of major importance.
Inosculation of the human vessels with the murine ones also occurred quickly.
Even after six weeks, the human vessels could still be detected [146]. Despite
these promising results, this approach has two drawbacks concerning its clinial
application. First, HUVEC are allogenic cells, which bear the risk of infection
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and may elicit rejection. Second, the use of genetically modified cells in human
therapy may be risky.
Another approach to seed Integra® or Matriderm® with cells as a dermal skin
substitute utilizes ECFCs derived from cord or adult blood. The idea is to estab-
lish pre-formed vessel networks in the dermal substitutes prior to implantation.
Thereby, the vascularisation time decreases from two weeks (in case of the scaf-
fold without cells) to only five days (in case of the scaffold already containing
a vessel network). Using an in vitro vasculogenesis assay, the cells originating
from cord blood were found to form more vessels than the cells originating from
adult blood. Further, bmMSC as well as fibroblasts could enhance vessel forma-
tion of the ECFCs derived cells. To test the same parameters in a 3D model,
ECFCs were seeded together with either bmMSC or fibroblasts on Integra® or
Matriderm® scaffolds and cultured in vitro for 14 days. Here, also vessel forma-
tion could be detected, after the cells migrated into the scaffolds. The vessels
contained lumens, were lined with endothelial cells connected with tight junc-
tions, and showed typical capillary walls. No differences with respect to the cell
type or the scaffold could be found [11]. The idea to use autologous cells from
adult blood seems feasible and sensible for the clinical application. Neverthe-
less, proliferation and propagation of those cells and the subsequent creation of
pre-formed vessel networks in vitro before implantation still needs time. This,
however, is scarce for burn patients. Therefore, as mentioned before, coverage
with a temporal skin substitute like cadaveric allogeneic skin may be a solution.
As a further alternative cell source, fibroblasts were used and transformed
into endothelial cells by genetic reprogramming. The reprogrammed fibroblasts
showed endothelial cell (EC) morphology and expressed endothelial markers in
vitro, confirming their transformation. Moreover, when seeded onto decellularized
aortic grafts and cultured in a bioreactor, the grafts displayed normal vessel mor-
phology while the cells expressed EC markers. Furthermore, the reprogrammed
cells expressed VE-cadherin and improved neovascularization and blood flow re-
covery in a hindlimb ischemic model in mice. Thereby, they formed a typical
vascular architecture. Concerning their safety, the reprogrammed cells did not
induce tumour formation in vivo after subcutaneous injection into SCID mice
[98]. Since no hint for their tumourigenesis is present and fibroblasts are quite
abundant, they might represent a feasible and good cell source for tissue engineer-
ing of artificial skin. Nevertheless, genetically modified cells are still considered
as problematic regarding their application in human therapies.
An even more feasible way to enhance vascularisation may be the use of the
stromal vascular fraction (SVF), which contains heterogeneous cells of the adi-
pose tissue, including ASC, endothelial progenitor cells (EPCs), hematopoietic
progenitors, T cells, and anti-inflammatory cells. The major advantages are the
abundance of adipose tissue in the human body as well as the quick access to the
SVF during the operation and the lack of cultivation time of cells in vitro. To
compare the ability of SVF to promote vascularisation to that of bone marrow
derived mononuclear cells (BM-MNCs), both were used in a skin flap model in
rats. BM-MNCs were already shown to promote neovascularisation of random
skin flaps. Two days prior to lifting the flaps, either SVF or BM-MNCs were
injected subcutaneously in the area of the flap. Seven days after the flap surgery,
in both treated groups blood perfusion and capillary density were higher than
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in the control group (injection of PBS without cells) and VEGF and basic fi-
broblast growth factor (bFGF) expression was increased. Altogether, the SVF
acted similar to the BM-MNCs. Therefore, in case of flap surgery, the use of SVF
seems to be a feasible and quick manner to achieve increased vascularisation and
increased flap survival [150]. Whether this technique represents a possibility in
burn therapy still needs to be assessed.
In summary it can be said that several approaches are being followed to enhance
vascularisation of tissue engineered skin constructs and that many different cell
types were proposed to achieve this goal. Some seem to be more feasible in the
clinical applications than others due to their abundant/scarce availability and
their autologous/allogeneic origin.
4.3.2.2 Skin equivalents and wound healing
Many research groups propose to use stem cells, originating from different tis-
sues in the body. They seem to be abundant enough to be used as autologous
cells and display hope inspiring behaviour with respect to tissue engineered or-
gans. Especially in case of skin regeneration and chronic wounds, MSC were
shown to improve wound healing [109]. Cutaneous wound repair comprises a
well-coordinated interaction of inflammation, neovascularisation, ECM forma-
tion, and epithelialisation. In chronic wounds, however, the cells are thought to
be intrinsically impaired and therefore no physiological skin regeneration occurs.
Treatment with bone marrow derived MSC showed promising results in animal
studies as well as in humans. In mice and rat models, it led to an accelerated
wound closure, being accompanied by an increase in the inflammatory response,
granulation tissue, angiogenesis, collagen composition, and wound burst strength
[109]. Note that these experiments also included diabetic animal strains. This is
especially important since they represent circumstances in which chronic wounds
are likely to appear. Also in human trails containing chronic wounds, the ad-
ministration of MSC resulted in an increased inflammatory response, increased
angiogenesis and decreased wound size if not complete wound closure. This, in
turn, led to an improvement of life quality for the patients, as e.g. in an increased
pain-free walking distance [109]. A similar approach utilized EPCs originating
from BM-MNCs, which were topically applied to full-thickness skin wounds in
diabetic mice. Wound healing and wound vascularity were increased compared
to wounds treated with BM-MNCs or PBS alone (controls). The seeded EPCs
were shown to express VEGF and basic fibroblast growth factor [8].
Apart from MSC originating from bone marrow or adipose tissue, amniotic
mesenchymal stem cells (AMM) were shown to enhance cutaneous wound heal-
ing in a diabetic mouse model [80]. The AMM integrated into the forming tissue
and partly differentiated towards a keratinocyte-like phenotype. Already in vitro
wound closure induced by AMM conditioned medium was enhanced compared to
closure rates due to ASC conditioned medium. Also in vitro AMM showed a sig-
nificantly higher expression of angiogenic cytokines like insulin-like growth factor
1 (IGF-1), epidermal growth factor (EGF), and interleukin 8 (IL-8) compared to
ASC. While EGF plays a role in keratinocyte migration and angiogenesis, IL-8
promotes skin re-epithelialisation.
In a burn wound model in pigs, tissue engineered skin consisting of collagen-
GAG scaffolds seeded with porcine bmMSC resulted in a better healing, better
87
4.3 Clinical applicability
keratinisation, less wound contraction, and more vascularisation compared to
controls (scaffolds without cells). To be able to track the seeded cells, they were
stained with a fluorescent dye. Since single fluorescent signals were detected
throughout the whole wound area after four weeks, the bmMSC were thought to
accelerate wound healing and to contribute to the formation of the new dermis
and epidermis of the wound area [95]. Nevertheless, no information was given
concerning the question how exactly the seeded cells contributed to the wound
healing. They might have differentiated to e.g. keratinocytes, they might have
hybridised with host cells, or/and they might have provided special chemokines
or the like.
The way of action of the MSC still has to be studied in more detail, but
paracrine effects on keratinocytes and fibroblasts could be detected in vitro.
ASC conditioned medium increased proliferation of HaCaT cells as well as pri-
mary human fibroblasts. Furthermore, in vitro wound healing of HaCaT was
improved and contraction of a fibroblast-seeded collagen lattice was increased,
while the transcription of the type I procollagen alpha 1 chain was upregulated
[88]. Paracrine factors also stimulated migration of inflammatory cells, endothe-
lial cells and keratinocytes as well as the secretion of collagen from dermal fibrob-
lasts. They include among others VEGF, EGF, and erythropoietin [109]. In vivo
experiments also hint at the incorporation of ASC into the new skin tissue, when
scaffolds seeded with MSC were implanted into wounds in a rat model [152].
In search for still another, abundant cell source, human amniotic mesenchymal
stem cells and human amniotic epithelial cells were suggested [90]. They possess
properties of stem cells and are easy to isolate, at the same time exhibiting a huge
availability. The cells were used to create a tissue engineered skin construct,
by seeding the cells into/onto a collagen type I matrix and culturing them at
the air-liquid-interface for 2 weeks. No cornified layers could be detected but a
stratified epidermis developed. Proliferation of the cells as well as the secretion of
collagen type I could be perceived. In vivo, the skin constructs could successfully
repair full-thickness skin defects in a mouse model. They exhibited a morphology
similar to normal skin with a stratified epidermis and an underlying dermis after
18 days. Here, amniotic cells were present in the epidermis as well as the dermis.
As feasible as this approach might be due to the large availability of the cells,
their allogeneic origin might pose severe problems in case of transplantation.
For the function of skin not only a stratified and cornified epidermis and a suf-
ficient vascularisation are needed, but also the innervation of the skin equivalent
is necessary. In a porcine model it could be shown that vascularisation precedes
innervation and that the development of nerves is dependent on the nutritional
and trophic factors supplied by the vascular network [49]. Therefore, a quick
vascularisation by the addition of appropriate cells and growth factors in the bio-
printed skin substitutes might also lead to a faster and better innervation of the
skin equivalent.
4.3.2.3 Possible dangers concerning the use of stem cells
In spite of those promising results, the use of stem cells might also pose danger to
the patients. These cells might differentiate into very many other (unwanted) cell
types or may secrete factors which enhance the formation or growth of other cells
like cancer cells. The risk of tumour formation is dependent on the origin of the
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cells, the extent ex vivo expansion, the induced differentiation, and the site/route
of administration. Large differences exist between embryonic stem cells, which
are pluripotent, and adult/somatic stem cells (e.g. MSC), which are multipotent
[46]. Also, the interaction between the tumour cells and their microenvironment
is very important concerning tumour development and prognosis. Corresponding
examples will be presented in the following:
In e.g. pancreatic tumours so-called cancer stem cells (CSC) were found. These
cells play a major role in the malignancy of tumours due to contributing to the
resistance of tumours towards chemotherapeutics as well as to the establishment
of metastasis and tumour growth/proliferation [63]. CSC have been shown to
be partially independent from their stem cell niche, adding to their migration
and metastatic activity. Moreover, cancer cells interact with surrounding cells,
stromal cells, and MSC, resulting in the establishment of a suitable microenvi-
ronment for their survival and growth. In this context, MSC were found to be
recruited to and accumulate in the tumours from the bone marrow, therefore
adding to the protective role of CSC towards tumour development. Furthermore,
they contribute to the angiogenesis and desmoplasia of the tumours and suppress
anti-tumour immune responses [35]. The immunosuppressive role of MSC and
its dangerous consequences have also been indicated by the fact that only in the
presence of coinjected MSC, B16 melanoma cells led to tumour growth in an
allogeneic mouse model [40].
Further evidence along similar lines indicates that cancer cells are able to induce
malignant transformation of MSC in vitro by paracrine effects. In a co culture
experiment of rat bmMSC and malignant rat glioma cells without direct cell-cell
contact, MSC became phenotypically malignant cells after seven days [93]. They
showed a decreased wildtype p53 expression while increasing the expression of
a mutant p53, being accompanied by an aneuploid karyotpye. Therefore, the
exposure of MSC to a tumour microenvironment resulted in the conversion of
normal MSC to tumour-promoting, malignant cells. Furthermore, MSC were
found to be transformed into carcinoma-associated fibroblasts-like cells in vitro
by exposing them to tumour-conditioned medium over a period of 30 days [105].
The resulting cells showed the ability to promote tumour growth in vitro as well
as in vivo in a co implantation model. Carcinoma-associated fibroblasts (CAF)
were shown to enhance tumour growth, angiogenesis, and metastasis in epithelial
solid tumours. Thus, also by transformation to CAF, MSC are thought to be
involved in the formation and maintenance of tumours.
Taking the above mentioned into account, the selection of suitable cells for
tissue engineering needs to be made with utmost prudence and care. While MSC
may be transformed to malignant cells in the context of tumours, they may also
be of immense value in the formation of tissue engineered skin. Therefore, for
each combination of application and cell type, the benefits and drawbacks as well
as potential dangers have to be assessed.
4.3.3 From bench to bedside - legal framework and use of
Matriderm®
Since tissue engineered skin substitutes contain living cells and are destined for
use in humans, they have to be produced, processed, and applied according to
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the corresponding legal requirements. In case of Germany, European (EU) law in
form of different directives and regulations is in effect, which is then implemented
in according German laws.
Regulation (EC) 726/2004 specifies procedures for the authorisation and su-
pervision of medicinal products for human and veterinary use on the Community
level (meaning on the EU level). Furthermore, to provide Community institutions
and Member States with the best possible scientific knowledge, the European
Medicines Agency (EMA) is established [134]. Medicinal products comprising
gene therapy, somatic-cell therapy, or Tissue Engineering are subsumed under the
term ’advanced therapies medicinal products’ (ATMP). ATMP may contain bio-
logical materials (e.g. tissues or cells), chemical structures (e.g. metal implants),
or polymer scaffolds [99]. For the evaluation of ATMP and the according coun-
sel, a special committee within the EMA is present, the Committee for Advanced
Therapies (CTA). The CTA centres the highest available expertise concerning
the advanced therapies, with the aim to ensure the highest quality of the medici-
nal products and the highest safety of the patients (Regulation (EC) 1394/2007).
This regulation specifies particular rules concerning authorisation, supervision
and pharmacovigilance of ATMP. This includes for example the free movement
and facilitation of access to the EU market by the Member States [133]. Special
attention to the application of stem cells in human treatment and corresponding
advanced therapies is given by the EMA and the CTA, due to potential harmful
risks. The risk depends on the origin of the stem cells (e.g. embryonal or adult
stem cell) as well as the status of differentiation (e.g. proliferation or terminally
differentiated). In this context, undifferentiated and proliferative stem cells pos-
sess a relatively high potential risk of tumour formation. New regulations need
to be developed for the assessment of risk factors concerning stem cells [46].
Further considerations comprise the donation, procurement, testing, process-
ing, preservation, storage, and distribution of human tissue and cells. The accord-
ing standards of quality and safety to ensure a high protection of human health are
laid down in Regulation 2004/23/EC [130]. This regulation is amended and aug-
mented by Commission Directives 2006/17/EC and 2006/86/EC, which describe
the implementation of e.g. the technical requirements with the aim of preventing
disease transmission, and the technical aspects of traceability and notification of
serious adverse reactions [131], [132].
On the national level - in Germany - the EU regulations and directives are im-
plemented mainly by four laws: the Transplantationsgesetz (TPG), the Transfu-
sionsgesetz (TFG), the Arzneimittelgesetz (AMG), and the Gewebegesetz (Gewe-
beG). In the TPG, mainly organ donation is regulated [26]. The TFG aims at
providing the population with blood and blood products, but also states the reg-
ulations concerning the acquisition and processing of blood and blood products
[25]. The AMG is responsible for the provision of the human population and
animals with pharmaceuticals and drugs, and to ensure the quality, efficacy, and
harmlessness of the pharmaceuticals [23]. The GewebeG is a law which amends
and alters the other three laws insofar, as these laws are also valid for tissues and
cells [24].
Following the mentioned regulations, appropriate premises, equipment, labo-
ratories, personnel, and administration is needed to be able to use ATMP for
the treatment of patients. This is only possible in appropriately equipped and
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certified clinics/centres. To establish such structures, vast monetary resources
are needed. This might be especially difficult for clinics, since they are not able
to operate as profit-oriented as companies.
Another aspect is, that these regulations are also valid for the use of autologous
cells of a patient, when his/her cells are not used in the same operation again,
but have to be stored and/or amplified. Even the simple act of saving healthy
tissue/cells for later use when debriding a burn patient, cannot be conducted
without having to follow the regulations. This limits the possible ways of treat-
ment considerably, especially in small hospitals, which cannot meet the technical
and administrational requirements. Therefore, simplified regulations would be
desirable. Regardless, the safety of the patients needs to be ensured.
In every case, the principles and guidelines of good manufacturing practice
(GMP) need to be followed, which is explicitly stated in the EU regulations. EU
wide GMP principles are laid down in Commission Directive 2003/94/EC, but
also in other countries similar regulations are present. The guidelines include
an adequate quality management and quality control (including self-inspection),
appropriately trained personnel, suitable premises and equipment, and an exten-
sive documentation of all steps of the manufacture, storage and distribution of
the products [39], [121]. Therefore, concerning our printing setup, vast technical
adaptations need to be implemented to reach GMP standard. This includes e.g.
the encapsulation of the printing area into a laminar flow hood to ensure sterility.
Also, as many of the components used in the printing process and the cell culture
as possible should be disposable to minimise contamination [30].
A further issue concerns the components of our skin constructs. In our project,
Matriderm® was used as a carrier matrix. A carrier was needed to stabilise the
printed skin constructs as they only comprised 40 cell layers in height and there-
fore were very fragile. Without a carrier matrix underneath, the skin constructs
could not have been moved from the printing setup to the culture plates, nor could
they have been placed into the skin wounds of the mice. In this context, the use
of Matriderm® was due to two important facts. First, it is already used in clinical
applications as a dermal substitute in connection with autologous split-thickness
skin grafts. As such, no new trials and applications concerning the biosafety and
biocompatibility are needed. This, in turn, may lead to a quick introduction of
tissue engineered skin substitutes by LIFT in the clinic. Second, Matriderm® acts
as a dermal substitute, consisting of freeze dried collagen and elastin. The cells
are able to migrate into this scaffold easily and vascular networks can be formed
[103], [104] (see also the previous section 4.3.2). Additionally, Matriderm® can
easily be stored, handled, and sutured. Therefore, it represents a feasible and
very suitable stabilisation matrix for our tissue engineered skin constructs. Also,
others have already used Matriderm® to create skin substitutes [57].
4.4 Further applications of LIFT
Apart from tissue engineering as such, bioprinting can also be used for other
biological or biomedical applications. Here, laser based as well as inkjet printing
prove useful. In research often assays with very small amounts of volumes are
needed (e.g. in case of DNA or protein assays) to achieve a high throughput
and save samples. Bioprinting allows for the deposition of small volumes of
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biomolecules with a high spatial resolution and as such is the optimal choice to
produce such assays. Two different complementary DNAs (cDNAs) were printed
by laser based bioprinting onto a coated glass slide to create a microarray [33].
The cDNAs transferred with bioprinting were equivalent to those created by pin
microspotting, microspotting being the common way to produce microarrays.
Signal intensity and gene discrimination capacity were similar and the laser pulse
did not cause damage to the transferred DNA. Due to the fact that bioprinting
is easily automatised, it might represent a feasible and promising alternative to
hitherto used methods of producing microarrays. The costs of each method,
however, need to be assessed and compared.
In a similar way proteins were transferred with laser based as well as inkjet
bioprinting to form microarrays. With laser based bioprinting the volume of each
transferred drop is dependent on the used energy and can range from nanolitres to
femtolitres [14]. A great uniformity and symmetry of the printed protein droplets
could be reached while printing biotinylated bovine serum albumin (BSA) onto
a coated glass slide [141]. After incubation with Cy5-labelled streptavidin the
transferred BSA could be detected by fluorescence. Similar results could be ob-
tained by inkjet based printing of proteins. Here, also biotinylated BSA was
transferred into a specific pattern and detected by a fluorescent dye coupled to
streptavidin [170]. This proves that the protein - at least its active site - is not
destroyed by the printing process. By laser printing of proteins the spot size
can be decreased dramatically compared to standard arraying procedures. This
results in an increase of array density and therefore also in an enhanced assay
efficiency [141]. Using inkjet printing, hydrated protein solutions can be used, in
contrast to other spotting techniques. This enables the use of liposomes in the
cartridges to print membrane-bound proteins. Those are difficult to immobilize
in patterns with other spotting techniques [170]. Bearing the above mentioned
examples in mind, bioprinting may be used to detect diseases early and inexpen-
sively, by creating DNA, ribonucleic acid (RNA) or protein biochips containing
disease markers.
Similar to printing protein or nucleic acids in a controlled way, also different
types of cells were co-printed to form specific 2D patterns [141], [170], [14], [82].
An interesting application is to use bioprinting as a migration assay in 2D as
well as in 3D. To examine their interactions with respect to vessel formation,
ASC were printed together with ECFCs in a 3D migration assay using fibrino-
gen/hyaluronic acid and thrombin as a printing matrix [60]. The matrix served
to fix the transferred cells in their final position but also provided the height for
the 3D constructs. At first, the ASC migrated towards the ECFCs. After con-
tact, the ECFCs began to form vascular-like networks, growing towards the ASC
spots and remaining stable for two weeks in in vitro culture. As was shown be-
fore, cells can exactly be deposited in a grid pattern with a defined spot spacing.
Any cell-cell ratio, cell quantity and cell-type combination is possible. Therefore,
laser based bioprinting can be used to study complex relationships between cells
and their local environment.
A rather different assay in which a specific printed pattern could be useful
is an antimicrobial assay. Here, inkjet based bioprinting was used to deposit
living Escherichia coli bacteria onto agar-coated substrates with a high density.
Subsequently, gradient concentrations of antibiotics were placed onto them to
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determine their minimum inhibitory concentration (MIC) [178]. Also, other drugs
may be printed in different combinations with cells or proteins to prove their
effectiveness. The automation of bioprinting allows for a high throughput of
those applications.
Apart from using bioprinting to produce assays, it can also be used for gene or
protein transfer to (mammalian) cells. This is especially useful if other transfec-
tion techniques result in very low transfection rates or if rather large molecules
need to be inserted into the cells. This often proves difficult to achieve. Also, it is
much faster than microinjection. In this context, inkjet printing was used to tem-
porarily disrupt the cell membranes of NIH3T3 fibroblasts without affecting cell
viability [127]. During the printing process they incorporated the fluorescently
labelled g-actin monomers present in their surroundings in the bioink. Trans-
formation by bioprinting seems to be a potent technique for the generation of
genetically modified cells.
Returning to the field of tissue engineering, bioprinting can also be used to
deposit different cell types into a 3D scaffold. By laser based bioprinting, ovine
endothelial cells and smooth muscle cells were printed into a 3D scaffold made by
two-photon polymerization (2PP) technique and remained viable after transfer.
The cells did not leak out of the scaffold and remained at their deposition location
[126]. The combination of 2PP and laser based bioprinting may result in the
realisation of 3D multicellular tissue constructs as the location and density of
printed cells can easily be controlled.
But also plane surfaces can be printed with a specific pattern of different cell
types. In this context, MSC were co-printed with HUVEC cells in a specific
pattern onto cardiac patches. MSC are thought to inhibit apoptosis of endothelial
cells in hypoxic conditions, increase their survival, and enhance vessel formation
and angiogenesis. Therefore, HUVEC were printed onto the patches in a network
forming the edges of squares and MSC were deposited into the squares. Control
patches were randomly seeded with the same cells. The printed patches exhibited
increased vessel formation and significant functional improvement of the heart in
comparison to the controls after being used in an infarction model in rats. The
transferred cells were shown to be incorporated into the murine vascular system
[53].
In summary, laser or inkjet based bioprinting may be used for many different
applications, including different assays (DNA, protein, migration, and antimi-
crobial drugs), transfection of cells and the specific deposition of different cells
types in various surroundings and settings. For all these utilisations, the easy
automation of this technique is a major asset.
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In our co-operation, the fundamentals of a successful transfer of different cell
types and the creation of a simple skin equivalent via LIFT were established.
Nevertheless, this is only the beginning of an exciting and most important field
of tissue engineering as the creation of functional skin is only possible by the
addition of further different cell types. These comprise cells like hair follicle cells
and perspiratory glands, which are necessary for the ability to sweat. This in
turn is especially important in case of a large burned area, where the patient’s
ability to maintain a normal thermo homeostasis may be impaired.
Another critical problem and therefore really important challenge is the lim-
ited perfusion of skin substitutes. To ensure graft take, sufficient vascularisation
needs to be achieved, but its development is often protracted. This problem
may be solved by the incorporation of endothelial cells into the dermis via LIFT,
forming a preset network. The cells are expected to quickly form new vessels,
which are then connected to the host vessel system by inosculation. As possible
alternative and autologous cell sources, different cell types have been proposed,
including EPCs and MSC, the MSC originating from adipose tissue, bone mar-
row, or sweat glands. However, the safe use of stem cells is not ensured, as e.g.
tumour cells recruit stem cells into their surroundings, causing their transforma-
tion into malignant cells (see also section 4.3.2.3).
Furthermore, in order to increase the aesthetic outcome, melanocytes should be
included into the skin substitutes. Other cells types, which might be of advantage
to be included as well, are nerve cells or Schwann cells. Moreover, the addition of
growth factors like keratinocyte growth factor (KGF) or VEGF and their impact
on the differentiation of keratinocytes and vascularisation, respectively, may be
tested.
Skin substitutes produced by LIFT are not only suitable for the treatment of
burn injuries, but may also be used for other clinical applications, e.g. the therapy
of pigmentary abnormality. In this case, skin containing the right amount of
melanocytes could be produced. Also, the treatment of chronic wounds and ulcer
might benefit from the production of skin substitutes via LIFT. All in all, we aim
to develop a skin substitute which is as functional, physiological and true-to-life
as possible.
To approach clinical applicability of the here established LIFT and its applica-
tion for the creation of skin equivalents, the setup has to be enlarged and adapted
to sterile conditions. Up to now, the largest possible area of printing with our
setup is 2.5 x 2.5 cm2. However, for the treatment of burn injuries a much larger
sheet of skin is often needed. Therefore, a scale-up of the whole equipment needs
to be carried out, including the hardware as well as the controlling software. In
this context, a key issue is the reduction of the processing time via the use of a
higher repetitive laser. Additionally, several laser beams with a donor slide each
could be used to print the cells onto the same Matriderm® sheet in parallel, to
shorten the production time. Furthermore, the inclusion of the whole equipment
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into a laminar flow chamber for a sterile printing environment needs to be re-
alised. The complete automation of the LIFT process including the transfer as
such as well as all preparative steps would be very helpful to prevent human errors
and possible infection and furthermore would be very time-saving. If possible, an
automation of the cell culture would also be preferable for the same reasons. The
automation would clearly contibute to the realisation of the GMP guidelines,
as they enhance the quality of the production process immensely. Moreover,
technical and administrational requirements stated by the EU and German law
concerning advanced therapies need to be considered and realised appropriately
(see also section 4.3.3).
Concerning the biological aspects, new methods for the cultivation of the re-
sulting large skin constructs need to be developed. Finally, they need to be tested
in a large animal model (e.g. pig). For this, the isolation and culture of porcine
skin cells is necessary as no immunosuppressed pigs can be used.
Apart from the application of LIFT for tissue engineering, also other purposes
may be followed. As bioprinting allows for the deposition of very small volumes
of biomolecules with a high spatial resolution, cDNA or protein arrays could
successfully be produced. Furthermore, LIFT was used to print a 2D as well
as 3D migration assay or an antimicrobial assay. Even the transfection of cells
with rather large molecules was shown. Therefore, LIFT can be applied for many
different purposes, either for clinical use or for research.
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In conclusion, it can be said that bioprinting offers a great potential in tissue
engineering and other fields of research and clinical use. Cells are not harmed
by the transfer and behave like non-transferred cells, including stem cells, which
maintain their stem cell character. Because of its very high resolution, LIFT is
uniquely suited to create complex tissues, including many different cell types.
Also - in contrast to inkjet printing - LIFT enables the transfer of cells in a very
high density. This is especially important for tissues like skin.
As I could show in this thesis, LIFT was successfully used to create skin substi-
tutes. They showed functional tissue formation and proliferation in vitro and in
vivo as well as beginning keratinocyte differentiation and vascularisation in vivo.
The used printing matrix needs to be adapted to the desired purpose and the
employed cell types. As demonstrated by the printing of skin cells, this might
not be trivial at all.
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Appendix A Supplementary pictures
Figure A.1: HE staining of 3D printed skin cells in alginate after two
weeks The figure shows a 3D printed skin construct cultured at the air-liquid-interface
for two weeks. Keratinocytes were printed on top of fibroblasts, all of them embedded
in alginate as a printing matrix. As can be seen, the cells neither stretched out nor
formed a tissue. Nonetheless, nuclei and cell membranes indicated that the cells were
alive.
Figure A.2: LiveDead staining of 3D printed NIH3T3 The figure depicts
3D printed NIH3T3 (murine fibroblasts) using alginate as a matrix. (A) gives an
overview, whereas (B) shows the details. The cells were incubated with calcein-AM
and ethidium-homodimer-1, which mark living cells in green and dead cells in red. As
can be seen, the majority of the cells lived after two weeks of submerged culturing.
Note that the cells still exhibited a rounded shape and did not stretch out.
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Figure A.3: Growth of fibroblasts in different concentrations of alginate
gel To test the effect of alginate on the growth behaviour of fibroblasts, these were
seeded into different concentrations of alginate gels and cultured under submerged
conditions in vitro. In all concentrations of alginate gels the fibroblasts (NIH3T3)
did not stretch out but stayed rounded, even up to 6 days (A - F). In corresponding
controls, consisting of collagen gels, the fibroblasts already stretched out after 3 days,
resulting in a thick clot of cells and gel after 6 days (G - H). The cells were stained with
calcein-AM and ethidium-homodimer-1, indicating that most of the cells stayed alive
(green = live, red = dead).
113
A Supplementary pictures
Figure A.4: Sections of printed skin cells with fibrin as a matrix Skin cells
were printed in 3D with fibrin as a printing matrix and subsequently cultured in vitro at
the air-liquid-interface for different periods of time. 20 layers of keratinocytes (HaCaT,
red) were printed on top of 20 layers of fibroblasts (NIH3T3, green). Matriderm® serves
as a stabilizing matrix underneath. Two different printing processes were carried out
with three replicates for each investigated timepoint. Two typical pictures of each time
point are shown. The white dotted lines depict the borders of the Matriderm®. (A) and
(B) comprise the first printing process, which was ended after 14 days. The fibroblasts
migrated into the Matriderm®. Also the keratinocytes migrated into the Matriderm®,
forming mushroom-like structures. The second printing process (C - H) was carried
out with the same parameters for reproducibility. After 3 days the keratinocytes could
still be found on top of the fibroblasts, they started to migrate into the Matriderm®
after 7 days. In some skin constructs they completely invaded the Matriderm® after
21 days (G) while in other replicates they formed a dense and thick tissue above the
fibroblasts with only some keratinocytes migrating into the deeper layers (H). In this
case, the fibroblasts formed a layer directly underneath the keratinocytes on top of the
Matriderm® with only some of them migrating into deeper layers.
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